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Summary 
Chlamydia trachomatis is an obligate intracellular bacterium which causes 
the most prevalent sexually transmitted bacterial infection throughout the world. 
According to the World Health Organization, at least 90 million chlamydial 
infections are detected annually worldwide. While the role of C. trachomatis in 
female infertility is well established, data revealing that this organism cause male 
infertility are still controversial. 
In this study the effect of "home-made" C. trachomatis LPS and two LPS 
fractions, lipid A and Kdo on human spermatozoa were investigated in detail. 
The effect of heated C. trachomatis elementary bodies (EBs) on the viability 
of spermatozoa and the potency of C. trachomatis LPS in comparison with three 
LPSs from the Enterobacteriaceae family were also studied. Treatment of 
spermatozoa with heated-EBs caused a significant increase in sperm death rate and 
revealed that the toxic component of EB was LPS which is a heat-stable complex. 
Incubation of spermatozoa with chlamydial LPS showed that this LPS at a 
concentration of 0.1 pg/m1 induced significant death of spermatozoa, whereas LPSs 
from E. coli, Kpneumoniae, and S. marcescens, did so only at 50 µg/ml. 
The effect of the two main LPS fractions of C. trachomatis, lipid A and Kdo, 
on spermatozoa was also investigated. A small amount of lipid A was isolated from 
chlamydial LPS and Kdo was purchased. Spermatozoa were treated with these 
fractions separately. Kdo was shown to be as spermicidal as lipid A, however, unlike 
lipid A, Kdo was not affected by anti-CD14 antibody or polymyxin B. 
In an attempt to clarify the mechanism of interaction of chlamydial LPS with 
spermatozoa and the role of the TLR pathway and TNF-a production, an 
experimental model using HeLa and THP-1 cell lines was prepared. Because of a lack 
of a sufficient amount of chlamydial lipid A, lipid A like Kdo was also obtained 
commercially. While chlamydial LPS and commercial lipid A were able to signal via 
TLR2 and/or TLR4 in transfected HeLa cells and to induce TNF-a production in 
THP-1 cells, Kdo failed either to signal through TLRs or stimulate TNF-a secretion. 
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Finally, the role of chlamydial LPS, lipid A or Kdo in ROS production which 
could potentially induce sperm death, and the mechanism of sperm death induced by 
these fractions were also studied. In this investigation, spermatozoa were pre- 
incubated with five ROS scavengers; ascorbic acid, catalase, reduced glutathione, 
superoxide dismutase (SOD), and a-tocopherol, prior to treatment with the above- 
mentioned fractions. ROS scavengers used in this investigation neutralised the 
spermicidal activity of the fractions. It is suggested that these fractions possibly 
induce their pathogenic effect via ROS production. Results from an annexin V/PI 
binding assay and quantitation of caspase-3 activity in spermatozoa stimulated with 
chlamydial LPS, Kdo, and lipid A revealed that LPS and its fractions induced sperm 
apoptosis which was primarily caspase-mediated. In a hypothetical model which is 
shown in chapter 6, we illustrate how chlamydial LPS exerts its spermicidal activity 
which is via CD14, possibly TLRs, ROS production and finally apoptosis induction. 
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Chapter 1 
General introduction 
1.1 Historical aspects of chlamydial infections 
The genus Chlamydia encompasses obligate intracellular bacteria, causing 
infections in a wide range of animals which contribute to sexually transmitted, ocular 
including trachoma, and respiratory tract infectious diseases in humans (Bavoil et al., 
2000). Trachoma is an ancient disease, described in ancient Chinese writing and in 
the Ebers papyrus of 1500 BC (Schachter, 1999). It ranks in the top three causes of 
blindness worldwide (Thylefors et al., 1995). In 1907, the causative agent of 
trachoma was identified by Halberstaedter and von Prowazek who originally 
suggested the name Chlamydozoa, derived from the Greek chlamys meaning 
"mantle" describing the halo effect observed surrounding Giemsa stained inclusions. 
The contagious nature of the disease was recognised long before the cause was 
identified. 
In 1910, Fritsh, and colleagues recognised the link between ocular and genital 
infections of chlamydia (Grayston and Wang, 1975). In 1911, Linder explained the 
similarity of lesions from the conjunctiva, trachoma cases and from conjunctival 
scrapings in monkeys inoculated with ocular and genital materials (Linder, 1911). 
Professor Tang Feifan was the first scientist who successfully isolated and cultivated 
C. trachomatis in 1946. Jones et al., (1959) first recovered the organism from the 
cervix of an infected mother and the eyes of her infant. C. trachomatis was 
subsequently isolated from urethral secretions of men who had previous sexual 
contact with women with inclusion conjunctivitis, and from women diagnosed as 
having non-gonococcal genital tract infection (Jones, 1964; Holt et al., 1967). 
Serotyping of C. trachomatis confirmed the specific association of some serovars 
with ocular and genital infections although the overlap for both ocular and genital 
infections was shown for serovars in both C. trachomatis biovars, LGV and 
trachoma (www. chlamydiae. com). In the 1970s the importance of C. trachomatis 
was established as a cause of non-gonococcal urethritis (Hilton et al., 1974; Swanson 
et al., 1975) and acute salpingitis and pelvic inflammatory disease (Mardh et al., 
1977; Punnomen et al., 1979). It is estimated that over 600 million people are 
infected with C. trachomatis worldwide. (Gerbase etal., 1998). 
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The recent completion of the "Chlamydia genome project" is one of the most 
important breakthroughs in chlamydial research that has provided workers with an 
insight to the genetic make-up of these bacteria (Rockey et al., 2000). 
1.2 Classification within the order Chiamydiales 
Until recently the order Chlamydiales consisted of the single family 
Chlamydiaceae exclusively containing obligate intracellular bacteria. Based on 
comparative sequence analysis of different macromolecules, Everett et al (1999), 
reclassified these pathogens into nine species belonging to two different genera 
(Chlamydophila and Chlamydia) within the family Chlamydiaceae. The new 
classification provides appropriate groupings of chlamydial pathogens with 
distinctive underlying genetic relationships. In addition, three new families were 
created in the Chlamydiales to accommodate recently discovered chlamydia-like 
bacteria. Like Chlamydiaceae, chlamydia-like bacteria only grow in eukaryotic cells, 
have a similar developmental cycle, and have 16S and 23S rRNA that is at least 80% 
identical to that of the Chlamydiaceae (Everett et al., 1999). The Chlamydiales 
currently comprises four families: Chlamydiaceae, Para-chlamydiaceae, 
Simkaniaceae, and Waddliaceae (Everett et al., 1999a; Rurangirwa et al., 1999). 
1.2.1 Chlamydiaceae: 
All species are Gram negative and recognized by monoclonal antibodies 
(mAbs) that detect the LPS trisaccharide aKdo-(2 --- 8)-aKdo-(2-*4)-aKdo (Lobau 
et al., 1995). Species within the Chlamydiaceae have 16S rRNA gene sequences that 
are > 90% identical (Pettersson et al., 1997; Takahashi et al., 1997). The family 
Chlamydiaceae is distinguished from Simkaniaceae by 16S and 23S rRNA sequence 
differences and by the absence of detectable Chlamydiaceae-specific Kdo 
trisaccharide antigen in `Simkania' using a family-specific mAb (Kahane et al., 
1999). 
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1.2.1.1 Chlamydia trachomatis: 
Glycogen is easily detected in the human C. trachomatis serovars and is 
detectable to varying degrees in C. muridarum and C. Buis (Everett et al., 1999), but 
the absence of glycogen in inclusions is not a specific marker for Chlamydophila 
(Everett, 2000). Glycogen accumulation by C. trachomatis is readily detected by 
iodine staining of inclusions. The gene for the major outer-membrane protein 
(MOMP), ompA (omp 1), is widely used to distinguish C. trachomatis strains. Many 
but not all, C. trachomatis strains have the extrachromosomal plasmid, pCT. C. 
trachomatis strains are generally sensitive to sulfadiazine and tetracyclines (Everett, 
2000). 
C. trachomatis has only been isolated from people and is comprised of two 
human biovars (18 serovars) that are transmitted by sexual or other contact: trachoma 
(14 serovars) and lymphogranuloma venereum (LGV, 4 serovars which can invade 
lymphatic tissue) (Batteiger, 1996; Moulder et al., 1984). Serovars in both C. 
trachomatis biovars cause trachoma, sexually transmitted disease, some forms of 
arthritis, and neonatal inclusion conjunctivitis and pneumonia 
(www. chlamydiae. com), and are found in the temporomandibular joint (TMJ) of 
patients with TMJ disease (Henry et al., 1999). The trachoma biovar currently has 14 
serovars designated by the letters A through K, plus Ba, Da, and Ia. Infection is 
limited primarily to squamocolumnar cells of mucous membranes. Serovars A-C are 
primarily associated with endemic trachoma and serovars D-K with sexually 
transmitted infection. The LGV biovars consists of four serovars, L1, L2, L2a, and 
U. LGV serovars are sexually transmitted and can invade lymphatic tissue. 
Antigenic analyses of MOMP and sequence analyses of the ompA gene that 
expresses MOMP suggest that L1 and L2 are closely related to the B- and E- 
trachoma serovars and that L3 is related to the A-, C- and H-trachoma serovars (Fitch 
et al., 1993). 
1.2.1.2 Chlamydia suis: 
C. suis strains were previously referred to as C. trachomatis because of ompA 
DNA sequence homology. They have only been isolated from swine, where they 
cause conjunctivitis, enteritis, pneumonia, and a high incidence of apparently 
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asymptomatic infection. Some strains are resistant to sulfadiazine and/or tetracycline. 
Several strains of C. suis have an extrachromosomal plasmid, pCS (Everett, 2000). 
1.2.1.3 Chlamydia muridarum: 
Two strains of C. muridarum, mouse pneumonitis (MoPn) and hamster 
proliferative ileitis, also known as Stills Fox Paster Dewhirst (SFPD), have been 
isolated from mice and hamsters, respectively, and previously belonged to C. 
trachomatis (Everett, 2000). MoPn infection may be asymptomatic or produce 
pneumonia in mice. MoPn is sensitive to sulfadiazine, and its glycogen production is 
difficult to detect. The MoPn genome has been sequenced (Read et al., 2000) and 
this strain has an extrachromosomal plasmid, pMoPn. 
1.2.1.4 Chlamydophila psittaci: 
C. psittaci primarily infects birds. C. psittaci has eight known serovars using 
serovar-specific monoclonal antibodies (Andersen, 1991; Varompay et al,. 1993) and 
ompA sequence differences (Everett et al., 1999). All should be considered to be 
transmissible to humans. Serovar A is endemic among psittacine birds and has 
caused sporadic zoonotic disease in humans, other mammals, and tortoises. Serovar 
B is endemic among pigeons, has been isolated from turkeys, and has also been 
identified as the cause of abortion in a dairy herd. Serovars C and D are occupational 
hazards for slaughterhouse workers and for people in contact with birds. Serovar E 
isolates have been obtained from a variety of human or avian hosts worldwide. Two 
other serovars were isolated during outbreaks in mammals (Everett, 2000). C. 
psittaci strains did not accumulate glycogen and were usually resistant to 
sulfadiazine. Several C. psittaci strains have an extrachromosomal plasmid (Everett 
et al., 1999). 
1.2.1.5 Chiamydophila pneumoniae: 
C. pneumoniae has three biovars, TWAR which infects humans, Koala, and 
Equine. The species is responsible for approximately one in ten cases of atypical 
pneumonia in developed countries (Grayston, 1999). The name TWAR was formed 
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by a combination of the first two letters of isolates TW-183 and AR-39 (Grayston et 
al., 1989). TWAR is primarily a respiratory pathogen, and has been associated with 
obstructive pulmonary disease, and other acute and chronic respiratory diseases. In 
addition it has also been associated with non-respiratory diseases such as 
atherosclerosis, and Alzheimer's (Everett, 2000). 
1.2.1.6 Chlamydophila pecorum: 
C. pecorum strains are serologically and pathogenically diverse, having been 
isolated only from mammals: cattle, sheep and goats (ruminants), koalas 
(marsupials), and swine. They are generally non-invasive in a mouse model of 
virulence. In koalas, C. pecorum causes reproductive disease, infertility and urinary 
tract disease. In other animals, C. pecorum has been associated with abortion, 
conjunctivitis, encephalomyelitis, enteritis, pneumonia and polyarthritis (Everett, 
2000). 
1.2.1.7 Chlamydophila felis: 
C. fells is endemic among house cats worldwide, primarily causing 
conjunctival inflammation, rhinitis, and respiratory problems. It can be recovered 
from the stomach and reproductive tract. Zoonotic infection of humans with C. fells 
has been reported. Strains differ in pathogenesis and, although some have an 
extrachromosomal plasmid, the causes of pathogenic differences are not known 
(Everett, 2000). 
1.2.1.8 Chlamydophila caviae: 
C. caviae can be recovered from the conjunctiva of guinea pigs suffering 
from ocular inflammation and eye discharge. All known isolates have identical ompA 
sequences. The strain GPIC (Guinea Pig Inclusion Conjunctivitis) contains an 
extrachromosomal plasmid. C. caviae infects primarily the mucosal epithelium and is 
not invasive. C. caviae is markedly specific for guinea pigs (Everett, 2000). 
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1.2.1.9 Chlamydophila abortus: 
C. abortus strains efficiently colonize the placenta and are primarily 
associated with cases of abortion and weak neonates. By producing spontaneous 
abortion, stillbirth, or delivery of weak lambs, it is a major cause of reproductive 
failure in most sheep-rearing countries and, consequently, a serious economic 
problem (Schlossberg, 1995). C. abortus is endemic among ruminants and has been 
isolated from sheep, cattle, and goats worldwide as well as in association with cases 
of abortion in a horse, a rabbit, guinea pigs, mice, and pigs. It was first isolated from 
products of a septic human abortion in 1967 (Roberts et al., 1967). Women who 
work with sheep have suffered sporadic, documented cases of zoonotic abortion due 
to C. abortus (Everett, 2000). 
1.2.2 Parachlamydiaceae: 
The Parachlamydiaceae naturally infect amoebae, specifically Acanthamoeba 
and Hartmanella, and one isolate will grow in Dictyostelium. This family comprises 
two genera, of which the type strains are Parachlamydia acanthamoebae (Amann et 
al, 1997) and Neochlamydia hartmanellae (Horn et al, 2000). EBs of Parachlamydia 
acanthamoebae have a Gram positive cell wall structure using electron microscopy 
(EM). Isolates have been obtained from clinical and environmental sources, 
including nasal swabs, humidifier water, and water in a dental unit. Trophozoites of 
Acanthamoeba hosting Parachlamydiaceae strains were isolated from humans in an 
outbreak of humidifier fever in Vermont, USA ('Hall's coccus') and also from 
asymptomatic women in Germany (Everett, 2000). The Parachlamydiaceae are not 
recognized by monoclonal antibodies specific for the antigenic LPS trisaccharide 
aKdo-(2 --* 8)-aKdo-(2-*4)aKdo of the Chlamydiaceae (Everett et al., 1999). 
1.2.3 Simkaniaceae: 
Simkaniaceae currently includes only the type strain Simkania negevensis Z 
Originally found as a bacterial contaminant in cell cultures, PCR and serology 
indicate that S. negevensis is associated with pneumonia in humans. Strain Z does not 
contain an extrachromosomal plasmid and has an unusually slow developmental 
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cycle (12-14 days) in cultured Vero cells (African green monkey kidney cell line), 
compared to other Chlamydiales (Everett, 2000). The S. negevensis full-length 16S 
and 23S rRNA sequences are each 80-87% identical to those of members of the 
Chlamydiaceae, whereas all members of the Chlamydiaceae have > 90% identity 
with each other (Friedman et al., 2003). S. negevensis does not contain the LPS 
antigen common to all members of the Chlamydiaceae, neither is it recognized by 
monoclonal antibodies to the chlamydial major outer-membrane proteins nor by 
primers to the ompA gene (Kahane et al., 1999). 
1.2.4 Waddliaceae: 
The species Waddlia chondrophila currently includes only the type strain, W. 
chondrophila WSU 86-1044 (Everett, 2000). WSU 86-1044 was isolated from 
pooled lung and liver tissues of an aborted bovine foetus (Dilbeck et al., 1990). No 
case of human infection by W. chondrophila has been reported, but Waddlia - 
related phylotypes have been identified by PCR in human samples (Corsaro et al., 
2002). 
1.3 Developmental cycle of Chlamydiae 
The chlamydial developmental cycle consists of infectious and non-infectious 
stages that exhibit unique morphological, biochemical, and biological properties 
(Belland et al., 2003) (Figure 1.1). The infectious elementary bodies (EB) are 
metabolically inactive particles and resistant to a variety of physical insults, e. g., 
sonication, and variation of osmotic pressure. They are 0.2 to 0.5 µm in diameter, 
with a rigid, disulfide cross-linked outer membrane (OM) (Bavoil et al., 1984; Hatch 
et al., 1986) that enables the EB to attach to and enter host cells (Stephens et al., 
2001). Attachment of EBs to the mucosal epithelial surfaces of the host cells is the 
first step in the infectious process. At the very early stage of infection (1-3 h) the 
parasite exerts profound effects on the host. Through an unknown mechanism, 
dependent on both bacterial transcription and translation (Scidmore et al., 1996a), 
Chlamydia modifies the properties of the phagosome and prevent its entry into the 
lysosomal pathway (Scidmore et al., 1996b). After host cell entry, the EB is localized 
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to a phagosome, and the primary differentiation process is initiated. This 
developmental process involves the commencement of bacterial metabolism and the 
conversion of the EB to the intracellular replicating form of the organism, termed the 
reticulate body (RB) (Belland et al., 2003). RBs are metabolically active, sensitive to 
environmental variations (Bavoil et al., 1984), 0.5 to 1.5 µm in diameter, take up 
nutrients from the host cell, and undergo multiple rounds of binary division within 
the inclusion membrane for a period of 24-36 h (Everett, 2000). After division, the 
RB undergoes a secondary differentiation process back to an infectious EB. Entry of 
infective forms (EBs) into host cells and their differentiation into reproductive forms 
(RBs) is completed by 4 to 12 h postinfection. By 20 h postinfection, some of the 
RBs cease to divide and commence transformation to EBs; other RBs in the 
population continue to divide for up to 72 h after infection. Most of the infected cells 
lyse by 48 to 72 h, releasing a population of Chlamydia consisting mainly of EBs. 
The conversion of EBs to RBs and RBs to EBs is gradual and continuous (Hatch et 
al., 1986). The cycle is accomplished in 36 to 96 h, depending on the species 
(Corsaro et al., 2003). Some exceptions are Simkania negevensis, which has in vitro 
a life cycle of about 2 weeks with a stationary phase and with RBs that seemly retain 
infectious ability, and Neochlamydia hartmannellae, which has been described as 
living free in the ameobal cytoplasm (Kahane et al., 1999, and 2002). EBs and RBs 
are generally Gram negative and have inner and outer membranes with a variable 
periplasmic space (Everett, 2000). In contrast to the envelopes of Gram-negative 
bacteria, the envelopes of both forms of Chlamydia lack or contain very little 
muramic acid (Barbour et al., 1982; Garrett et al., 1974). Nonetheless, the possibility 
that Chlamydia possess peptidoglycan cannot be dismissed in that penicillin alters 
chlamydial growth by inducing the formation of swollen, abnormal RB forms 
(Barbour et al., 1982) and also bioinformatic analysis of the C. trachomatis genomes 
reveals a complete set of genes whose products are apparently capable of 
synthesizing peptidoglycan in these organism (Chopra et al., 1998; Kalman et al., 
1999). Tamura and Manire (1967) reported that EB envelopes have a higher 
phospholipid content than do RB envelopes and that RB envelopes lack both cysteine 
and methionine. Failing to detect muramic acid in Chlamydophila psittaci cell walls 
and noting that osmotically fragile RB envelopes lack cysteine, these workers 
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suggested that S-S bonding might play a role in the formation of rigid membranes of 
EBs. Observations based on metabolic studies independently support the view that 
formation of cysteine-containing structure is essential in RB-EB transformation 
(Hatch et al., 1983). 
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Figure 1.1. The Chla, nydiales developmental cycle of infection and replication. 
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1.4 C. trachomatis infections 
1.4.1 Epidemiology 
The role of C. trachomatis as an important sexually transmitted disease 
(STD) agent is well recognized. Infection with this organism is the most prevalent 
sexually transmitted bacterial disease in the world (Gonzales et al., 2004). The 
World Health Organization estimated that 92 million new cases of C. trachomatis 
infection occurred throughout the world in 1999 (WHO, 2001). Every year, an 
estimated four million new cases occur in the United States and three million in 
Europe (Peeling and Brunham, 1996). Moreover, infections with these bacteria are 
an important public health problem, especially in third world and developing 
countries (Gonzales et al., 2004). 
In addition to the STDs caused by C. trachomatis, the ocular serovars of this 
organism can cause trachoma that is the most common infectious cause of blindness 
(Mabey et al., 2003). It affects approximately 150 million people living in the 
world's poorest and rural communities (Kumaresan and Mecaskey, 2003). The WHO 
estimates that trachoma remains endemic in 48 countries including many of the 
countries of Africa as well as focal areas in the Middle East, and south and central 
Asia. 
Chlamydial infections are also acquired by the newborn during delivery and 
might cause conjunctivitis and pneumonia in these children. Considering that, there 
is a high need for correct, quick and cost-effective diagnosis and treatment of these 
oculourogenital infections. 
Chlamydia are transmitted by sexual intercourse of an infected partner of a 
sexually active couple (Eggert-Kruse et al., 1997), mother to child at delivery 
(Fenton, 2000), family cluster infections (Thompson et al., 2001) and by extragenital 
infection (mechanical deposition, flies, dirty fingers, towels and bad hygienic 
conditions) (Emerson et al., 1999). Therefore, people with a higher number of sexual 
partners, direct nonsexual family contamination, offspring of infected couples, 
personnel who deal with patients at hospitals and clinics, and clinical laboratory 
technicians would be at greater risk of infection (Gonzales et al., 2004). 
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1.4.2 Trachoma 
Trachoma is a chronic keratoconjunctivitis caused by repeated reinfection 
with the ocular serovars A, B, Ba, and C of C. trachomatis. After an incubation 
period of 5-10 days, infection with these ocular serovars causes a mild mucopurulent 
conjunctivitis, which is generally self-limiting and heals without permanent sequelae 
(Mabey et al., 2003). Repeated infections with the ocular strains result in chronic 
inflammation of the tarsal conjunctiva of the upper lid. The chronic condition results 
in scarring, shortening of the upper lid with in-turning of the eyelashes-ie, 
trichiasis. The painful abrading of the cornea, if not corrected, results in corneal 
scarring, opacity, and blindness. Women are blinded two to three times as often as 
men probably due to increased exposure and infection as a result of child rearing 
(Congdon et al., 1993). 
Trachoma is spread from eye to eye in endemic communities by fingers, 
shared clothing or towels, and probably by fluid-seeking flies in the poor, dry, and 
dusty areas where it is so often found. Transmission of the infection seems to require 
close personal contact and therefore the disease commonly clusters in families and 
villages (West et al., 1991). The prevalence of active trachoma is highest in children, 
peaking between 2 and 5 years of age. Prevalence rates of 20% in children are 
common in endemic areas and may rise to 90% in severely affected communities 
(Mecaskey et al., 2003). 
1.4.3 Adult inclusion conjunctivitis 
In both the male and the female, C. trachomatis causes inclusion 
conjunctivitis, characterized by conjunctival hyperemia, mucopurulent discharge, 
and lymphoid follicle formation (Garland et al., 1995). Infection is thought to occur 
from infected genital tract secretions via hand-to-eye contact. The illness is self- 
limiting, although treatment will shorten the clinical course. Progression to trachoma 
has not been documented, but pannus and conjunctival scarring may result from 
reinfection (Schachter, 1999). 
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1.4.4 Chlamydial infections in perinatal and neonatal periods 
Maternal C. trachomatis infections during pregnancy may cause a variety of 
perinatal and neonatal complications. C. trachomatis may lead to abortion, perinatal 
or neonatal death, and low birth weight (Witkin, 1995; Andrews et al., 2000). 
Although transmission of the organism from mothers to their infants 
generally occurs at the time of delivery with passage of the infant through the 
infected endocervix, the possibility of intrauterine infection at late pregnancy has 
also been reported (Nnumazaki and Niida, 2000). An infant born to a mother with 
active infection has a risk of acquiring infection at any anatomical site of 50 to 75%. 
Approximately 30 to 50% of infants born to chlamydia-positive mothers will have 
conjunctivitis, and at least 50% of infants with chlamydia conjunctivitis will also 
have nasopharyngeal infection. Chlamydial pneumonia develops in about 30% of 
infants with nasopharyngeal infection (Stamm, 1999). Pneumonia due to 
C. trachomatis is a disease limited for the most part, to infants less than 6 months of 
age (Numazaki et al., 2003). 
1.4.5 Urogenital infections in men and women 
Urogenital infections with C. trachomatis in women have a clinical course 
varying from asymptomatic infections to ascending infections leading to pelvic 
inflammatory disease (PID) associated with late ectopic pregnancy and tubal 
infertility (Lan et al., 1995). As many as 70 to 80% and 50% of C. trachomatis 
infections in women and men are asymptomatic respectively (Gonzales et al., 2004) 
and these infections can persist for several months. Despite the frequent absence of 
symptoms, at least one third of women have local signs of infection on examination 
(Stamm, 1999). The two most commonly reported signs are mucopurulant discharge 
from the cervix and hypertrophic cervical ectopy. 
Clinical manifestations of C. trachomatis infections in women include acute 
urethral syndrome, urethritis, bartholinitis, cervicitis, upper genital tract infection 
[endometritis, salpingo-oophoritis, or pelvic inflammatory disease (PID)], 
perihepatitis (Fitz-Hugh-Curtis syndrome), and reactive arthritis (Stamm, 1999). 
Infection of the urethra and lower genital tract may cause dysuria, abnormal vaginal 
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discharge, or postcoital bleeding, whereas infection of the upper genital tract may be 
manifested as irregular uterine bleeding and abdominal or pelvic discomfort. 
McGregor et al, (1995) suggested an association between colonization of the 
genital tract by C. trachomatis and an increased risk of premature rupture of the 
membranes (PROM). Ectopic pregnancy, stillbirth, early pregnancy loss or recurrent 
pregnancy loss may be among consequences caused by asymptomatic C. trachomatis 
infections (Gravett et al., 1986; Vigil et al., 2002a). 
Clinical signs and symptoms of genital chlamydial infections in men include 
urethral discharge of mucopurulent or purulent material, dysuria, or urethral pruritus 
(Peipert, 2003). Nongonococcal urethritis (NGU) is the most common clinical 
manifestation of C. trachomatis infection in men. In fact, C. trachomatis causes 
approximately 35 to 50% of all cases of NGU in heterosexual men. Symptoms of 
NGU may develop after an incubation period of 7 to 21 days and include dysuria and 
mild-to-moderate whitish or clear urethral discharge. In most cases, physical 
examination reveals no abnormalities other than the discharge. Using clinical and 
pathological evidence, Gonzales et al., (2004) suggested that there is a relationship 
between C. trachomatis and urethritis, urethritis and epididymo-orchitis, and 
epididymo-orchitis and infertility. 
In homosexual men, the rectum is the common site of infection by C. 
trachomatis. These infections are generally asymptomatic too (Gonzales et al., 
2004). Chlamydial infections are also responsible for 70-80% of post-gononococcal 
urethritis. Other clinical syndromes in men include acute epididymitis, acute 
proctitis, acute proctocolitis, conjunctivitis, and Reiter's syndrome. Male infertility, 
chronic prostatitis, and urethral strictures are possible results of infection. Both 
Reiter's syndrome (urethritis, conjunctivitis, arthritis, and mucocutaneous lesions) 
and reactive tenosynovitis or arthritis (without the other components of Reiter's 
syndrome) have been associated with genital C. trachomatis infection (Stamm, 
1999). 
1.4.6 C. trachomatis and its effect on female and male reproduction 
In women, untreated chlamydial infection can lead to severe reproductive 
complications. C. trachomatis is an important causal agent in PID, with sequelae 
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including infertility (Westrom et al., 1992). Up to two thirds of cases of tubal-factor 
infertility may be attributed to C. trachomatis infection (Paavonen and Eggert-Kruse 
1999). Women with previous chlamydial infections are four times more likely to 
have obstructed Fallopian tubes compared with women who had no infection. 
Besides the damage to tubal mucosa and smooth muscle, chlamydial infections cause 
tubal adhesion and obstruction, and therefore impair the function of the fimbriae and 
lead to infertility (Nalbanski et al., 1999; Barlow et al., 2001). 
Data revealing that C trachomatis cause male infertility are still conflicting. 
Some reports suggest that chlamydial infections probably do not significantly 
contribute to male infertility. Bjercke and Purvis, (1992) found no clear association 
between the presence of C. trachomatis-IgA antibodies in the seminal plasma of 
infertile patients and sperm quality. Eggert-Kruse et al, (1997) also showed that C. 
trachomatis antibodies in semen did not influence male fertility in terms of sperm 
parameters and pregnancy rate in asymptomatic infertile couples and Rezacova et al., 
(1999) were unable to demonstrate the presence of chlamydia in the ejaculate by a 
DNA amplification method. However, some workers found that chlamydial 
infections are related to male infertility. Witkin et al., (1995) showed that men with 
seminal antichlamydial IgA had a lower median sperm count than those without 
antichlamydial IgA. They also suggested that antisperm antibodies (ASA) were more 
associated to antichlamydial IgA in semen than seminal IgG antibodies to 
C. trachomatis, or circulating antichlamydial IgA and IgG antibodies in 
asymptomatic male partners of infertile couples with no history of exposure to C. 
trachomatis. The presence of heat shock protein 60 (HSP60) in semen correlated 
with the occurrence of antichlamydial antibodies and ASA (Munoz et al., 1996). 
Antibody to HSP60 may indicate long-standing infection with persistent chlamydial 
antigen (Paavonen and Eggert-Kruse, 1999). In addition, Radouani et al., (1996) 
observed that azoospermia was more frequently seen in patients who had 
antichlamydial antibodies and Penna Videau et al., (2001) found a strong association 
between antichlamydial antibodies in semen and a past history of STD. 
Galdiero et al., (1994) suggested that C. trachomatis probably influences 
sperm function. They showed that C. trachomatis LPS can decrease the percentage 
of vital spermatozoa in vitro. Similar experiments were reported by Hosseinzadeh et 
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al., (2001). In vitro, they observed a significant decline of sperm motility during 
incubation with EBs of serovar E. Furthermore, using electron microscopy, Erbengi, 
(1993) demonstrated the presence of EB and RB forms of C. trachomatis in 
spermatozoa. EBs of Chlamydia were also demonstrated in connective tissue from 
testes and in Leydig cells (Villegas et al., 1991). 
In spite of these controversial data, it is of tremendous importance to 
remember that the female partners carry the main risk of male chlamydial infection 
of the genital organs, as C. trachomatis infection of the female genital organs may be 
deleterious to female fertility. Purvis and Christiansen (1993) pointed out that an 
important aspect of C. trachomatis infection in men may be that the male accessory 
sex glands function as reservoirs for the organism, increasing the probability of 
infection in the female. Therefore, it is necessary to determine markers for the 
function of the prostate, i. e. zinc and citric acid. Eggert- Kruse et al., (2002) 
demonstrated that the zinc level in seminal fluid is neither associated with silent male 
genital tract infections, nor related to semen cultures in asymptomatic individuals 
however, Wolff et al., (1991) showed that citric acid is decreased in male infertility 
patients indicating possible inflammatory damage of the prostate induced by 
C. trachomatis. 
1.4.7 Lymphogranuloma venereum (LGV) 
LGV is a rare form of the STD caused by serovars L1, L2, L2a and L3 of C. 
trachomatis (Lynch et al., 1999). This disease is rare in industrialised countries, but 
is endemic in parts of Africa, Asia, South America, and the Caribbean. The LGV 
serovars infect predominantly monocytes and macrophages, pass through the 
epithelial surface to regional lymph nodes, and may cause disseminated infection. 
The clinical course of LGV can be divided into three stages. The first stage 
corresponds to a primary genital lesion at the site of inoculation (usually the prepuce 
or glans in men, and the vulva, vaginal wall or, occasionally, cervix in women), 
usually a small papule or a herpetiform ulcer, which often remains unnoticed. LGV is 
most often recognized at the second stage, which corresponds to a local 
lymphadenopathy (most often inguinal), which may evolve to a local abscess (or 
bubo), which ruptures in approximately 30% of cases, and fistulizes to the skin. This 
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stage may include systemic manifestations, such as fever, headaches, and myalgia. 
The third stage corresponds to late fistula and stricture formation (Maurin and 
Raoult, 2000). 
1.5 Chemical structure of the cell envelope of Ctrachomatis 
1.5.1 General characteristics of the chlamydial envelope 
The cell envelopes of both the EB and RB forms resemble those of Gram- 
negative bacteria, consisting of an outer membrane and an inner membrane (Tamura 
et al., 1971). While the chlamydiae share a common structure with other Gram- 
negative bacteria, there are some unique features. Perhaps the most striking feature 
of the chlamydial envelope is its apparent lack of peptidoglycan (PG), although 
chlamydiae contain genes that appear to encode products with PG biosynthetic 
activity (Hesse et al., 2003), possess three penicillin-binding proteins (Barbour et al., 
1982) and are sensitive to drugs that inhibit PG synthesis, such as penicillin G and D- 
cycloserine. These drugs interrupt normal development, giving rise to abnormally 
large RBs that are unable to divide by binary fission (Raulston, 1995). The 
conclusion that chlamydiae lack PG is based largely on the failure to detect muramic 
acid. Supporting observations include the failure to detect a PG layer by electron 
microscopy and the failure of antibodies directed against PG to react with 
chlamydiae (Barbour et al., 1982). Secondly, a predominance of cysteine-rich 
envelope proteins, which are cross-linked by disulphide bonding in EBs provide a 
supramolecular structure that may be responsible for the osmotic stability of EBs. 
This structure is not found in osmotically fragile RBs (Hatch, 1996). Hackstadt et al., 
(1985) showed that EBs are lysed when incubated for 30 min in the presence of 
dithiothreitol (that quantitatively reduces disulphides) and possibly this observation 
is the best evidence that disulphide bonds play a role in maintaining the structural 
integrity of EBs. Lastly, there are unique surface appendages, termed 'projections'. 
The chlamydiae have neither pili nor flagella but do possess unique 
macromolecular surface projections. These straight protrusions, approximately 18-22 
per EB, are clustered hexagonally on the surface and a radical nine component 
'rosette' surrounds each projection in the outer membrane (Matsumoto, 1982). These 
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structures are also present on RBs, but in a less-ordered array, and have been shown 
by electron microscopy to be in contact with the inclusion membrane (Raulston, 
1995). 
1.5.2 The structural proteins in the chlamydial envelope 
The envelope of EBs consists of disulphide-bond-cross-linked MOMP in the 
outer membrane and cross-linked cysteine-rich proteins (CRPs) in the periplasmic 
space (Tanzer and Hatch, 2001) (Figure 1.2). MOMP (40 kDa protein) that is 
encoded by ompl, constitutes nearly 60% of the total outer membrane protein, 
exhibits potential porin function (Bavoil et al., 1984), and may play a role in the 
attachment of C. trachomatis to host cells (Su and Caldwell, 1991). Although, the 
overall quantity of MOMP in the RB is similar to that found in EBs, the MOMP of 
RBs is predominantly in a monomeric form. Dimeric, trimeric and multimeric 
complexes of MOMP have been identified in EBs (Newhall and Jones, 1983). 
Large CRP (60 kDa, omcB) and small CRP (12 kDa, omcA) are encoded by 
omp2 and omp3 respectively (Raulston, 1995). Studies by Newhall, (1987) and 
Hatch et al., (1986) showed that RBs are deficient in CRPs and that they are found in 
the cell envelope of intracellular chlamydiae only late in the cycle, starting at 18 to 
24 h postinfection, when RB multiplication has decreased and they have begun to 
turn back to EBs. The property of being resistant to mechanical and osmotic stress is 
attributed to inter-and intramolecular disulphide cross-linking of the EB CRPs 
(Raulston, 1995). 
After EBs have entered the phagosome, one of the initial steps leading to the 
formation of RBs could be the cleavage of disulphide bonds in the reducing 
environment of the phagosome (Brade et al., 1997). 
Miyashita et al., (1993) reported that the periplasmic protein layer (P-layer) is 
in close association with the outer membrane in chlamydiae. The P-layer was 
observed by these workers like a regular array of hexagonally packed subunits on the 
inner surface of the outer membrane of EBs. As the P-layer may consist entirely of 
cross-linked large CRP, Matsumoto and Manire, (1970) suggested that RBs lack this 
layer. 
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Figure 1.2. Hypothetical model of the envelope of chlamydial EBs. 
21 
MOMP 
1.5.3 Chemical structure of LPS 
LPS is a heat-stable complex and unique glycolipid that seems to be present 
in all Gram-negative bacteria and is vital to both structural and functional integrity of 
the outer membrane of these bacteria. It covers nearly 75% of the outer surface of the 
outer membrane. LPS is also the immunodominant antigen of most Gram-negative 
bacteria and is considered to be intimately associated with the virulence of the 
pathogen (Rietschel el al., 1994). 
The LPS of F, nterohacteriaceae consists of three general parts (Figure 1.3): a 
variable region called the O-specific chain (repeating oligosaccharides, O-antigen), a 
relatively conserved core region (heterooligosaccharide), and a conserved lipid A 
(highly acylated and phsphorylated glucosamine disaccharide) (Erridge et al., 2002). 
Polysaccharide Phospholoipid 
Fatly acids 
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Figure 1.3. Schematic representation of the general structure of LPS (Smooth form). 
The abbreviations are as follows: GlcN, glucosamine; Kdo, 3-deoxy-D-manno- 
octulosonic acid, Hep, L-glycero-D-manno-heptose, Glc, glucose; Gal, galactose; S, 
sugar; n, number of repeating sugar units within the O-antigen. 
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1.5.3.1 O-polysaccharide 
A polymer of repeating saccharide subunits in the outermost part of the LPS 
called O-polysaccharide, or O-chain, is typically composed of common hexoses and 
is therefore the major antigen targeted by host antibody responses. These responses 
can be highly O-chain specific, and for this reason the O-chain is often also referred 
to as the O-antigen. 
Not all LPSs have a long repeating O-chain structure. Some bacteria express 
only saccharide joined to a short non-repeating polysaccharide unit. These LPSs, 
such as those from Neisseria meningitidis and N. gonorrhoeae have been termed 
'lipo-oligosaccharide' (LOS) to differentiate them. The repeating units of the 0- 
polysaccharide region consist of between one and eight glycosyl residues and differ 
between strains by the sugars, sequence, chemical linkage, substitution, and ring 
forms utilized. This leads to an almost limitless diversity of O-chain structure. In 
addition, the number of subunits used to complete the chain varies between 0 and 
-50 (Erridge et al., 2002). 
For many organisms (e. g., Salmonella), the O-chain is essential for survival 
in host serum as it prevents penetration of the complement membrane attack complex 
(Erridge et al., 2002). 
Depending on the size of the saccharide portion, there are two types of LPSs, 
i. e., smooth- and rough-form (S-and R-form) LPS. In the S-form LPS the core region 
is replaced by the O-specific polysaccharide and the colonies formed by such 
bacteria are glistening and smooth however, these colonies in the R-form that have a 
very short O-chain or lack it completely are dry and rough. Both LPS forms are 
found in wild-type Gram-negative bacteria: the S-form, for example, in Escherichia 
coli, Vibrio cholerae, or Klebsiella pneumoniae, and the R-form in Neisseria 
meningitidis, N. gonorrhoeae, and C. trachomatis. 
1.5.3.2 Core polysaccharide 
Although the O-chain region is extremely variable, the oligosaccharide 
structures in the core part are much more limited, with some regions being highly 
conserved between different strains and species. The outer core consists of common 
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hexose sugars such as glucose, galactose, N-acetyl galactosamine and N-acetyl 
glucosamine and is generally more variable than the inner core. 
The inner core is characterized by more unusual sugars, particularly Kdo and 
heptose. Kdo (Figurel. 4) is found in almost every LPS and is attached to the 
carbohydrate backbone of lipid A. The only exceptions yet seen to this rule are 
Acinetobacter and Burkholderia cepacia which employ the alternative 2-keto-D- 
glycero-D-talo-octonic acid (Ko) in its place. Although the O-chain and the majority 
of the core can be dispensed with in some viable mutants, Kdo is always required for 
bacterial viability and along with lipid A is the minimal structure compatible with 
bacterial viability. Helander et al., (1988) and Brade et al., (1987) respectively 
showed that the smallest saccharide component seen in the LPS of any organism is in 
that of a deep rough mutant of Haemophilus influenzae which has only one Kdo 
residue attached to its lipid A, and the Chlamydia spp LPS with the smallest core yet 
seen which consists of only a triplet of Kdo units. These findings confirm the 
essential role of Kdo in bacterial viability. Kdo has also been reported to act as the 
immunodominant sugar for the enterobacterial Re specificity (Luderitz et al., 1966). 
Both inner and outer core sugar residues can be substituted with a charged group like 
phosphate, pyrophosphate, 2-aminoethylphosphate and 2-aminoethylpyrophosphate. 
Rietschel et al., (1994) reported that these substituents in the inner core maintain a 
close association with the Ca2+ and Mg2+ ions that are required for membrane 
structure and function. While the endotoxically active part of LPS is lipid A, the 
nature and number of attached saccharide residues and substituents do have 
considerable impact on modulation of this activity (Erridge et al., 2002). 
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Figure 1.4 3-deoxy-D-manno-octulosonic acid (Kdo). 
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1.5.3.3 Lipid A structure 
Lipid A is composed of a ß-D-G1cN-(1-6)-a-D-G1cN disaccharide carrying 
two phosphoryl groups (Figure 1.5). Both phosphates can be further substituted with 
groups such as, ethanolamine, ethanolamine phosphate, ethanolamine diphosphate, 
and glucosamine (G1cN). Up to four acyl chains are attached to this structure and 
these chains can also in turn be substituted by further fatty acids to provide LPS 
molecules with up to seven acyl substituents, which vary quite considerably between 
species in nature, number, length, order and saturation. Erridge et al., (2002) 
reported that the major contributing factors to endotoxicity are the number and 
lengths of acyl chains present and the phosphorylation state of the disaccharide 
backbone. 
Netea et al., (2002) suggested that the shape of the lipid A component 
determines the bioactivity of LPS, with lipid A that adopts a conical conformation 
(E. cola) being more active than lipid A that adopts a cylindrical shape 
(Porphyromonas gingivalis). 
Pi 
0 
Figure 1.5. Chemical structure of lipid A (E. coli). 
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1.5.4 The characteristics of C. traclhomatis LPS 
Chlamydial LPS or, more correctly, (LOS) (http: //www. chlamydiae. com) is 
similar to the rough forms of enterobacterial LPS. It consists of the lipid A and core 
regions (Figure 1.6) that contain D-glucosamine, fatty acids, Kdo, and phosphate in a 
molar ratio of -2,5,3,2.6, and a concentration of 480,1185,715,625 nmol/mg 
respectively (Nurminen et al., 1985). The major lipid A component of chlamydial 
LPS is a glucosamine disaccharide that contains five fatty acids with up to 22 carbon 
atoms (pentaacyl) and a phosphate group in the distal segment. There is a complex 
mixture of long-chain, normal, 3-hydroxylated, and branched fatty acids. The most 
prominent fatty acids are tetradecanoic, iso- and anteiso-branched tetradecanoic, 
hexadecanoic, and 3-hydroxyeicosanoic acids (Qureshi et al., 1997). 
Fatty acids in LPS of Chlamydiae have acyl chains with up to 22 carbon 
atoms and 3-hydroxy fatty acids occur only with amide-linkage. All hydroxyl fatty 
acids are amide-linked (-(C=O)NH-) and all non-hydroxylated fatty acids are ester- 
linked (-COO-) (Nurminen et al., 1985). 
The core region of chlamydial LPS is composed of a unique trisaccharide of 
aKdo(2--+8)a Kdo(2--*4)aKdo (Brade et al., 1990; Holst et al., 1991). Since Kdo has 
been found to be a constituent of chlamydial LPS, Brade et al., (1986) suggested that 
the Kdo is probably involved in the Re specificity of chlamydial LPS. 
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Figure 1.6. Chemical structure of C. trachomatis LPS. 
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1.6 LPS recognition mechanisms by host cells 
The immune system of vertebrates has two components: adaptive immunity 
and innate immunity. Adaptive immunity is mediated by T and B lymphocytes that 
proliferate clonally in response to a specific pathogen or antigen. The generation of 
adaptive immune responses requires a number of days but is anamnestic through the 
generation of memory T and B lymphocytes. By contrast, the goals of the innate 
immune system are to provide protection in the first minutes to hours after an 
infectious challenge (Abreu and Arditi, 2004). The innate immune system as the first 
line of defence against microbial pathogens, is composed of macrophages, natural 
killer cells, neutrophils, mucosal epithelial cells, and endothelial cells. This system 
plays two crucial roles. First, it contains the infection prior to the induction of 
adaptive immune responses. Second, the innate immune system controls the 
activation of adaptive immunity and determines the type of effector responses that 
are appropriate for the infecting pathogen. Both functions critically depend on the 
ability of the innate immune system to detect the presence of infectious 
microorganisms and to induce a set of endogenous signals, such as inflammatory 
cytokines and chemokines (Medzhitov and Janeway, 2000). 
A wide variety of bacterial components or products, pathogen-associated 
molecular patterns (PAMPs), are capable of stimulating the innate immune system. 
These include LPS; peptidoglycan (PG) and lipoteichoic acid (LTA) from Gram- 
positive bacteria; formylated peptides from both Gram-negative and Gram-positive 
bacteria (Pan, 2004). LPS is a principal component of Gram-negative bacteria that 
potently activates the innate immune system (Miyake, 2004). 
LPS-induced cellular responses are the result of the interaction of LPS with 
various plasma components such as the soluble cluster of differentiation antigen 14 
(sCD14), LPS-binding protein (LBP) and membrane receptors such as membrane- 
bound CD14 (mCD14) and Toll-like receptors (TLRs). This initiation of cellular 
responses is essential for the host defense against bacterial infections. However, if 
large amounts of endotoxin are present in the circulation, an excessive cellular 
response can be deleterious for the host (Vreugdenhil et al., 2001). 
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LBP, a 452-aa protein with a molecular mass of 60 kDa, is an acute-phase 
reactant produced during Gram-negative bacterial infections (Tobias et al., 1988). It 
is synthesized mainly in the liver and also in pulmonary and gastrointestinal 
epithelial cells. LBP (Jack et al., 1997) and CD14 (Read et al., 1993) play key roles 
in the recognition of LPS. The main role of LBP is to bind and deliver LPS to CD14 
(Hailman et al., 1994). LBP also binds to glycolipids of mycobacteria (Savedra et al., 
1996) and lipoteichoic acid of Gram-positive bacteria (Schroder et al., 2003). 
LBP facilitates the interaction of LPS with CD14 by two basic processes. 
First, LBP acts as an opsonin for LPS-bearing particulates enhancing the interaction 
with CD 14 (Wright et al., 1989), and secondly, LBP enables cells to respond to 
extremely low concentrations of LPS via a CD14-dependent pathway (Schumann et 
al., 1990). 
CD14 is a 55 kDa glycosyl phosphotidylinositol (GPI)-anchored protein that 
belongs to a family of receptors, termed pattern recognition receptors, which are 
involved in innate immune recognition of pathogen-associated molecular patterns 
(Wright, 1995). Membrane forms of CD 14 are expressed on the surface of 
monocytes, macrophages, neutrophils (Haziot et al., 1993), and spermatozoa (Harris 
et al., 2001). Soluble forms of CD14 have been reported in plasma, cerebrospinal 
fluid, amniotic fluid, breast milk, and synovial fluid. This form of CD14 is also 
present in seminal plasma at levels comparable to those in serum (Harris et al., 
2001). sCD14 is reported to facilitate the LPS signal at low concentrations, but 
suppresses it at high concentrations (Bazil and Strominger, 1991). CD14 is critical 
for an efficient recognition not only of LPS but also of a number of other bacterial 
cell wall components from diverse organisms, heat shock proteins and some viruses 
(Aderem and Ulevitch, 2000). 
In the presence of LBP, CD14 has been implicated as a high-affinity LPS 
receptor, facilitating LPS-induced macrophage activation in response to endotoxin. 
CD14 is not capable of initiating a transmembrane activation signal because it is a 
(GPI)-anchored protein and thus, lacks transmembrane and intracellular domains. 
The main function of CD14 is to catalyze the transfer of LPS from extracellular 
space to the membrane where it associates with a complex of receptors including 
TLR4-MD2 (Triantafilou and Triantafilou, 2002). CD14 also enhances the responses 
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of phagocytes to bacterial products that activates cells via TLR2 (Moore et al., 
2000). 
Toll receptors were first discovered in the fruit-fly, Drosophila. TLRs are 
expressed by myelomonocytic cells, endothelial and epithelial cells as well as cells 
from various organ systems (Zarember and Godowski, 2002). Toll-like receptors are 
transmembrane proteins, all of which have a common extracellular leucine-rich 
domain and an intracellular region belonging to the IL-1R family called the Toll/ IL- 
1 receptor (TIR) (Beutler and Rehli, 2002). Both the IL-1 receptor and the TLRs 
share similar downstream affects, such as the activation of immune response genes, 
which are initiated by the activation of myeloid differentiation factor 88 (MyD88) by 
the intracellular domains of the IL-1 and Toll-like receptors (Abreu and Arditi, 
2004). 
The primary role of TLRs is to recognize bacterial, viral, fungal, and other 
pathogens that may be deleterious to the host (Abreu and Arditi, 2004). Ten human 
TLRs have been characterized so far (Underhill and Ozinsky, 2002). TLR2 is 
essential for the recognition of a variety of PAMPs, including bacterial lipoproteins, 
lipoteichoic acids and peptidoglycan, and TLR4 is predominantly activated by LPS 
(Jurk et al., 2002). TLR4 alone is not sufficient to confer LPS responsiveness. TLR4 
requires MD-2, a secreted molecule, to functionally interact with LPS. MD-2 is thus 
a link between TLR4 and LPS (Shimazu et al., 1999). MD2 also increases TLR2 
responsiveness to TLR2 ligands (Dziarski et al., 2001). 
Stimulation of TLRs by PAMPs initiates a signaling cascade (Figure 1.7) 
that involves a number of proteins, such as MyD88 and interleukin receptor- 
associated kinase (IRAK). This signaling cascade leads to the activation of two 
transcription factors, activator protein-1 (AP-1) and nuclear factor-kB (NF-kB) 
which in turn induce the secretion of pro-inflammatory cytokines including tumor 
necrosis factor alpha (TNF-a), IL-1, IL-6, IL-8 (Medzhitov et al., 1997), IL-12, and 
interferon-y (IF-, y) (Dentener et al., 1993). 
TNF-a, one of the major mediators of inflammatory responses in mammals, is 
a multifunctional cytokine with effects not only in the pro-inflammatory response 
(Fiers, 1991) but in immuno-regulatory responses (Beutler, 1995), and apoptosis 
(Baker and Reddy, 1998). It also plays a prominent role in bridging the innate and 
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adaptive phases of immunity (Ma, 2001). These functions are mediated by the 
binding of TNF to at least two receptors, TNF-receptor 1 (TNF-R1) and TNF- 
receptor 2 (TNF-R2), which are expressed by most nucleated cells and are members 
of a family of related receptors (Beutler and van Huffel, 1994). Stimulation of TNF- 
Rl induces an increase in reactive oxygen species (ROS) production via 
mitochondria as a major source of TNF-a-induced ROS production (Schulze-Osthoff 
et al., 1993). Also it has been shown that TNF-induced apoptosis is mediated 
primarily through the activation of TNF-R1 (Rath and Aggarwal, 1999). ROS 
overproduction induced by TNF-a is accompanied by a cytotoxic or pro-apoptotic 
effect (Garcia-Ruiz et al., 1997). 
The principal cells producing TNF-a are monocytes and macrophages with 
additional producers including B and T lymphocytes. TNF-a is a double-edged 
sword with both pro-inflammatory and anti-inflammatory propensities. Natural 
induction of TNF-a is protective and important for the efficient control of growth 
and dissemination of invading pathogens, but its overproduction may be detrimental 
and even lethal to the host (Ma, 2001). 
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Figure 1.7. A model of TLR2 and TLR4 signaling pathway and cytokines and ROS 
induction. Upon recognition of pathogen by TLRs a signaling cascade is initiated. 
This signaling cascade leads to the activation of AP-1 and NF-kB which induces the 
secretion of pro-inflammatory cytokines. The cellular damage induced by ROS may 
be lead to cell death via apoptosis or necrosis. 
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1.7 Cellular damage and defence mechanisms in ROS 
production 
Aerobic organisms, which derive their energy from the reduction of oxygen, 
are susceptible to the damaging actions of the small amounts of superoxide anion 
radicals (02', "= unpaired electron), hydroxyl radicals (OH) and hydrogen peroxide 
(H2O2) that inevitably form during the metabolism of oxygen, especially in the 
reduction of oxygen by the electron transfer system of mitochondria. These three 
species, with other free radicals such as nitric oxide (NO) and nitrogen dioxide 
(NO2) are referred to as reactive oxygen species. Other sources of ROS include 
cigarette smoke, radiation (e. g., UV light), toxic chemicals (e. g., paraquat) and drugs 
(e. g., adriamycin, bleomycin). ROS with free radicals such as O2ý or OH' contain 
unpaired electrons and have a lifetime in the range of nano-to milliseconds and 
therefore react with molecules in their direct surrounding. Others, such as H202, are 
not radicals. They are long-lived and, as they are not charged, can pass through 
plasma membranes (Ochsendorf 1998). 
Free radicals are not only produced as an unwanted product, they are also 
formed deliberately in the body for useful purpose and have important physiological 
functions (Rice-Evans and Burdon, 1993; Halliwell et al., 1995). Activated 
phgocytic cells (neutrophils, monocytes, or macrophages) for example, produce O1 
and OH' as a defence mechanism to kill bacteria and fungi and to inactivate viruses 
(Curnutte and Babior, 1987). 
ROS, in particular the hydroxyl radical, can react with all biological 
macromolecules (lipids, proteins, nucleic acids and carbohydrates). The initial 
reaction generates a second radical, which in turn can react with a second 
macromolecule to continue the chain reaction. Oxidative damage to DNA, proteins, 
and lipids can ultimately lead to outcomes such as disorganisation, dysfunction and 
destruction of membranes, enzymes and proteins (Halliwell, 1997). Among the 
susceptible targets, polyunsaturated fatty acids (PUFAs) are more susceptible to react 
with ROS (Gutteridge, 1995). Removing of a hydrogen atom from a PUFA initiates 
the process of lipid peroxidation. Peroxidation of membrane lipids may cause 
impairment of membrane function, decreased fluidity, inactivation of membrane- 
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bound receptors and enzymes, increased permeability to ions and possibly, 
eventually membrane rupture (Gutteridge, 1995). If the oxidative stress (disturbance 
in the balance between antioxidants and free radicals and other ROS) is severe, it can 
produce cell death (Halliwell, 1997). Death can occur by necrosis, however a mild 
oxidative stress can trigger the process of apoptosis (Hampton and Orrenius, 1997). 
1.7.1 Defence mechanisms 
There are a number of antioxidants present in the body and derived from the 
diet. Superoxide dismutase (SOD), catalase and glutathione peroxidase are 
intracellular antioxidant enzymes that convert potential substrates (02' and H202) to 
less reactive forms in the body and thus eliminate their damaging effects from the 
cells (Gutteridge, 1995). For example, SOD catalysis of the dismutation of 0i to 
H202 and 02 and the conversion of H202 to 2H20 by glutathione peroxidase or to 02 
+ H2O by catalase is a metabolic reaction against ROS. 
Antioxidants from dietary sources include lipid soluble vitamins such as 
vitamin E and carotenoids as well as the water-soluble vitamin C. Vitamin E is one 
of the most important free radical-scavenging antioxidants within membranes and 
lipoproteins. It is an effective chain-breaking antioxidant that protects PUFAs from 
peroxidation by scavenging peroxyl radicals (ROO) (Halliwell, 1997). 
1.8 Cellular death, necrosis and apoptosis 
Cells may die in either of two distinct processes: necrosis (pathological or 
accidental cell death) or apoptosis [physiological or programmed cell death (PCD)] 
(Vermes and Haanen, 1994). Necrosis is a pathological process which occurs when 
cells are exposed to a serious physical or chemical assault including toxins, radiation, 
heat, trauma, lack of oxygen due the blockage of blood flow, and also various 
viruses, bacteria, and protozoa etc. Necrosis begins with an impairment of the cell's 
ability to maintain homeostasis including ion homeostasis resulting in excess 
intracellular calcium and/or sodium. Excess influx of magnesium and zinc as well as 
acidosis can also induce necrosis (Trump and Berezesky, 1995). Intracellular 
organelles, especially mitochondria, within the whole cell swell and rupture and 
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finally the whole cell disintegrate. Following disruption of the cell membrane, the 
cytoplasmic contents including lysosomal enzymes are released into the extracellular 
fluid (Proskuryakov et al., 2003). Necrosis is often associated with extensive tissue 
damage resulting in an intense inflammatory response (Kelly et al., 2001). 
Apoptosis is a mode of cell death that usually occurs under normal 
physiological conditions. The term `apoptosis' from the Greek, meaning "to fall away 
from" and conjuring notions of the falling of leaves in the autumn from deciduous 
trees, defined as a controlled type of cell death that can be induced by a variety of 
physiologic and pharmacological agents, was first suggested by Kerr et al., (1972). 
Cells undergoing apoptosis show characteristic morphological and biochemical 
features. These features include plasma membrane blebbing, cellular shrinkage, 
condensation and margination of the nuclear chromatin, DNA fragmentation, and 
cytoplasmic vacuolisation (Kanduc et al., 2002). Eventually, the cells breaks into 
small membrane-surrounded fragments (apoptotic bodies), which are cleared by 
phagocytosis without inducing an inflammatory response (Reed, 2000). In the 
absence of phagocytosis, apoptotic cells may undergo secondary necrosis, a process 
associated with additional proteolytic degradation of specific autoantigens. 
Secondary necrosis may occur in vivo in autoimmune disorders associated with 
impaired clearance of apoptotic cells and serve as a source of modified forms of 
specific autoantigens that might stimulate autoantibody responses under 
proinflammatory conditions (Wu et al., 2001). Differences between necrosis and 
apoptosis regarding morphological, biochemical, and physiological features have 
been shown in Table. 1 and Figure 1.8. 
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Necrosis Apoptosis 
" Loss of membrane integrity 
" Membrane blebbing, but no loss of 
integrity 
" Aggregation of chromatin at the 
nuclear membrane 
" Begins with swelling of cytoplasm 
" Begins with shrinking of cytoplasm 
and mitochondria and condensation of nucleus 
" Ends with total cell lysis " 
Ends with fragmentation of cell 
into smaller bodies 
" No vesicle formation, complete lysis " 
Formation of membrane bound 
vesicles (apoptotic bodies) 
" Disintegration (swelling) of organelles " 
Mitochondria become leaky due to 
pore formation involving proteins 
" Loss of regulation of ion homeostasis " 
of the Bcl-2 family 
Tightly regulated process involving 
activation and enzymatic steps 
" No energy requirement 
" Energy (ATP)-dependent 
" Release of various factors 
(cytochrome c, AlF) into 
cytoplasm by mitochondria 
" Affects groups of contiguous cells " 
Activation of caspase cascade 
" Evoked by non-physiological " 
Affects individual cells 
disturbances (hypothermia, hypoxia, " Occur in both physiologic and 
ischemica, metabolic poisons) pathologic conditions 
" by macrophages Phagocytosis . 
Phagocytosis by adjacent cells or 
" Significant inflammatory response 
macrophages 
" No inflammatory response 
Table 1.1. Necrosis versus apoptosis (http: // www. roche-applied-science. com) 
The process of apoptosis is fundamental during normal developmental and 
physiological conditions such as cell turnover and tissue homeostasis, embryogenesis 
(Danial and Korsmeyer, 2004), maintenance of immunological tolerance 
(Lamhamedi-Cherradi et aL, 2003), and developmental of the nervous system 
(Martin, 2001). However, dysregulation of the apoptotic pathway has been 
implicated in a number of diseases. For example, in cancer and autoimmune 
disorders, cells fail to undergo apoptosis. Conversely, excessive apoptosis has been 
implicated in neurodegenerative disorders such as Alzheimer's disease and 
Parkinson's disease. Inappropriate apoptosis is also associated with AIDS, ischemic 
heart damage or viral infections (Harvey and Kumar, 1998). 
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Figure 1.8. Schematic model of the morpholiogical features of necrosis and 
apoptosis 
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1.8.1 Mechanisms of apoptosis and caspase activation 
Apoptosis can be broken down into four stages; stimuli, signals, regulations, 
and executors (Morita and Tilly, 1999). The first stage comprises of different 
physiological and pathological stimuli that interact with a cell. In normal 
physiological cell turnover the apoptotic stimuli can be represented by cytokines, or 
death factors, such as FAS ligand (FASL, also referred to as CD95 or APO-1 ligand) 
(Ashkenazi and Dixit, 1998). Pathological insults include chemical and radiation 
stimuli, environmental toxicants or hormone withdrawal. The second stage of 
apoptosis is the recruitment of early intracellular signalling molecules (e. g., TNFR 
and FAS) that relay the plethora of external information received by the cell to a 
central regulatory checkpoint for interpretation (i. e., the third stage) governed 
primarily by the Bcl-2 (B cell leukaemia-2) family proteins on the outer 
mitochondrial membrane. The signals at the second stage are processed by a 
regulatory mechanism, which evaluates the strength of the apoptosis inducing signal 
against anti-apoptotic signals in the third stage. If the death inducers prevail, the cell 
commits to apoptosis and enters the fourth and final stage (at the level of 
mitochondria) where specific executor proteins are responsible for the organised 
destruction of the cell (Green and Reed, 1998). 
There are at least two major pathways for caspase activation (Figure 1.9). 
The death receptor (extrinsic) pathway and mitochondrial (intrinsic) pathway (Reed, 
2000). The extrinsic pathway can be induced by members of the TNF family of 
cytokine receptors, such as TNFR1 and FAS. These proteins recruit adapter proteins 
to their cytosolic DDs (death domains), including FADD (FAS-associated death 
domain), which then binds DED-containing pro-caspases (death effector domain), 
particularly pro-caspase-8. FADD functions as a bridge between FAS and 
downstream signal transduction termed DED. FADD links TNF family death 
receptors to pro-caspase-8, using its DD to bind TRADD (TNFR-associated death 
domain) or interacts directly with the cytosolic DD of the TNFR family member 
FAS, and employing its DED to bind DED-containing caspases (Reed, 2000). 
The intrinsic pathway can be induced by release of cytochrome c from 
mitochondria, induced by various stimuli, including elevations in the levels of pore- 
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forming pro-apoptotic Bcl-2 fanmily proteins such as BAX (Bcl-2 associated x 
protein) and BAD (Bcl-Xi_ Bcl-2-associated death promoter). In the cytosol, 
cvtochrorne c binds and activates APAF-1 (apoptosis protease-activating factor 1), 
allowing it to bind and activate pro-caspase-9. 
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Figure 1.9. Major apoptotic pathways in mammalian cells and regulation of death 
receptor si, naliný. Activated FAS recniits an adaptor protein called FADD, through 
interaction with DDs. The TNFRI mediated pathway utilizes TRADD protein in 
recruitment of FADD. Bcl-2 prevents apoptosis by blocking the release of 
cvlochrome c from the mitochndria. Activated caspase-8 is able to induce apoptosis 
through a mitochondrial pathway by cleaving BID, or directly by activating 
downstream effector caspases. 
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1.8.1.1 Bcl-2 family proteins 
In humans, 20 members of the Bcl-2 family with pro- (e. g., BAX, BAD, BID) 
and anti-apoptotic [(e. g., Bcl-2 itself, Bcl-XI, and Mcl-1 (myeloid cell leukaemia-1)] 
functions have been described to date. Anti-apoptotic members of this family can 
inhibit not only apoptotic, but also necrotic death (Proskuryakov et al., 2003). The 
relative ratios of anti- and pro-apoptotic Bcl-2 family proteins dictate the ultimate 
sensitivity or resistance of cells to various apoptotic stimuli (Reed, 2000). If the 
apoptotic-inducing fraction of Bcl-2 family outbalances their anti-apoptotic relatives, 
cytochrome c as a principal apoptosis inducer is released from the mitochondrial 
compartment and associates with APAF-1 and pro-caspase-9. Release of cytochrome 
c from mitochondria, an event directly regulated by Bcl- family members, produced 
conformational changes in APAF-1, leading to caspase-9 activation. Together these 
three factors, cytochrome c, APAF-1, and caspase-9, create a holoenzyme termed 
apoptosome, which is a key connection between mitochondria and caspase 
activation. Active caspase-8 (extrinsic) and the apoptosome (intrinsic) proceeds to 
activate the executioner caspases 3 and 7. Active caspase-3, in turn, cleaves caspases 
2,6,8,10, and perhaps 9, providing a tremendous amplification loop (Liou et al., 
2003). Caspase-8 cleaves BID, which releases cytochrome c, bridging the "extrinsic" 
and "intrinsic" pathways (Henshall et al., 2001). 
1.8.1.2 The family of caspases 
Most of the morphological and biochemical changes that are recognised as 
apoptosis are the results of protease activity. Especially, activation of a family of 
intracellular cysteine proteases which cleave their substrates at aspartic acid residues, 
are known as caspases for Cysteine Aspartyl-specific Proteases (Alnemri et al., 
1996). Caspases are synthesized as precursor molecules (zymogens), which require 
proteolytic processing into two subunits for their activation (Earnshaw et al., 1999). 
Many caspases have two potential cleavage sites at the junction of the large and 
small subunits. These sites are separated by a few amino acids and cleavage may 
occur at one or both sites. Dimerization and proteolysis generates an active caspase 
composed of two large (-20 kDa) and two small (-10 kDa) subunits. 
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In mammals, approximately 14 caspases have been identified so far (Said et al., 
2004). Of the 14 caspases currently known, not all seem to play a role in apoptosis. 
For example, caspase-1 (ICE) and its close relatives caspase-4 (TX, ICH2), -5 (TY, 
ICErel-111) and -11 (ICH3) appear to be primarily involved in cytokine processing 
(Kumar, 1999). The subgroup of caspases involved in apoptosis has been referred to 
as either initiators (upstream) or effectors (downstream). Downstream caspases are 
largely dependent on upstream caspases for their proteolytic processing and 
activation (Reed, 2000). Caspases-8 (FLICE, MACH, MCH5), -9 (ICE-LAP6, 
MCH6), -10 (NICH4, FLICE2) and possibly, -2 (ICH-1) can initiate the caspase 
activation cascade and are therefore called initiators. The effector caspases-3 
(CPP32, Yama, Apopain), -6 (MCH2), and -7 (MCH3, ICE-LAP3, CMH-1) 
propagate the cascade and are activated by proteolytic cleavage by other caspases 
(Slee et al., 1999). 
1.8.1.3 Cellular targets of caspases 
Approximately 40 proteins are now known to be cleaved by effector caspases 
in cells undergoing apoptosis (Kumar, 1999) of which three are mentioned here. One 
of the end points in apoptosis is fragmentation of DNA into multiples of 
approximately 180 bp. The enzyme responsible for this action is termed caspase- 
activated DNase (CAD). CAD is an inactive complex that is normally bound to an 
inhibitory subunit, known as CAD inhibitor (ICAD), which is degraded by caspase-3 
in apoptotic cells. The free CAD then enters the nucleus and acts on chromatin (Enari 
et al., 1998). p21 (CDKNIA)-activated kinase 2 (PAK2), a serine/threonine kinase, 
is another substrate activated by caspase cleavage. Because PAK2 is involved in the 
regulation of the actin cytoskeleton, its activation seems to help formation of 
apoptotic bodies (Rudel and Bokoch, 1997). Bcl-2 and Bcl-XL proteins are also 
cleaved during apoptosis and the fragments generated by the cleavage appear to 
enhance apoptotic changes in dying cells (Clem et al., 1998). 
1.8.1.4 Inhibitors of apoptosis proteins 
A family of proteins named inhibitors-of-apoptosis (IAP), have the ability to 
bind procaspases and activated caspases, blocking their processing and activity. IAPs 
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were first found in baculoviruses as proteins that suppress apoptosis, so allowing the 
virus to replicate in infected cells (Birnbaum et al., 1994). IAPs are found in the 
genomes of mammals, insects, and certain animal viruses and characterised by a 
novel domain of 70 amino acids, termed the baculoviral IAP repeat (BIR) domain, 
which is essential for suppression of apoptosis (Reed, 2000). Human IAPs can arrest 
apoptosis induced via either the intrinsic or extrinsic pathways, probably because 
they target effector caspases common to both pathways (Zhou et al., 1998). 
Interestingly, IAPs also have a controlling factor termed second mitochondria- 
derived activator of caspases (SMAC) or Diablo that can prevent IAPs from binding 
caspases, allowing them to be activated and perform their part in the apoptotic 
process (Verhagen et al., 2000). SMAC is normally confined to the mitochondria, 
but once released, it binds to IAPs and removes this block in the cell death pathway. 
1.9 Structural and functional characteristics of human 
spermatozoa 
The spermatozoa originates from spermatogonial stem cells and are the end 
product of spermatogenesis (Abou-Haila and Tulsiani, 2000). A spermatozoon is a 
highly polarised and motile cell with a haploid nucleus that fuses with haploid egg 
nucleus forming 2n zygote nucleus during a process known as fertilisation. 
Fertilisation generally consists of four major events; contact and recognition between 
sperm and egg, regulation of sperm entry into the egg, fusion of the genetic material 
of sperm and egg, and activation of egg metabolism to start development. Successive 
stages in the process of spermatogenesis are in the following order; primary 
spermatocytes, secondary spermatocytes, spermatids, and spermatozoa. 
There are three main regions in the sperm cells; head, middle piece, and 
flagellum (Chavarria et al., 1997) (Figure 1.10). The head (4-5 µm in length) 
consists of; sperm cell membrane that covers the anterior portion of the head and 
contains receptors for recognising egg, acrosome with digestive enzymes for 
penetration of the material surrounding the egg that facilitates the fertilisation 
process, and highly condensed haploid nucleus that fuses with haploid egg nucleus. 
The acrosome itself consists of an anterior cap and a posterior region called 
41 
equatorial segment. The middle piece (3.5 µm) of the sperm mainly dominated by a 
spiral complex of mitochondria that are fused together generate energy for the 
flagellar movement. The flagellum (55 µm) has the same basic structure of other 
eukaryotic cilia or flagella, but also has particular characteristics due to the presence 
of the outer dense fibres and the fibrous sheath. The flagellum consists of 9+2 
microtubules (9 doublets +a pair of complete microtubules) which form the 
axoneme. Sliding of the microtubules generates motive force. 
End tail 
notch 
Acrosomal 
cap 
Flagellum Nucleus 
Middle iece p Head 
(containing 
mitochondria) 
Tail 
Figure 1.10. Basic structure of human spermatozoon 
Spermatozoa undergo several important maturation steps throughout their 
life, resulting from their interaction with the different environments through which 
they migrate and the various functions that they are expected to accomplish. In the 
epididymis the immotile and incompetent spermatozoa acquire the potential for 
motility and fertility by the action of epithelial cell secretions and constituents of the 
luminal fluids (epididymal maturation). At ejaculation, they become motile and are 
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developed by seminal fluid constituents although they are not yet able to fertilize 
oocytes. During their migration through the female genital tract, spermatozoa 
undergo a second phase of maturation termed capacitation, that enables them to reach 
and bind to the zona pellucida (de Lamirande et al., 1997). The most important 
change in spermatozoa after capacitation is its ability to undergo the acrosome 
reaction (AR) in response to zona pellucida glycoproteins 3 (ZP3), progesterone 
(Yanagimachi, 1994), and calcium ionphores (Russell et al., 1979). 
1.9.1 Capacitation 
Capacitation is a highly complex phenomenon occurring in the female genital 
tract. It was discovered independently by Austin and Cang in the early 1950s and 
was defined as the obligate period of residency of spermatozoa in the female 
reproductive tract, which confers on the spermatozoa the ability to fertilise an oocyte 
(Jha et al., 2003). Capacitation is a reversible phenomenon, which means that 
treatment of capacitated spermatozoa with specific substances or biological fluids, 
such as seminal plasma, reduces their ability to fertilise oocytes and therefore 
decapacitated these cells (de Lamirande et al., 1997). 
The main purpose of capacitation is to ensure that spermatozoa reach the egg 
at the appropriate time and in the appropriate state to fertilise this egg (de Lamirande 
et al., 1997). Capacitation can occur in vitro spontaneously in a defined medium 
without the addition of biological fluids, which suggests that this process is 
intrinsically modulated by the spermatozoa themselves such that these cells are 
preprogrammed to undergo capacitation when they are incubated in the appropriate 
medium (Yanagimachi, 1994). 
During capacitation various biochemical and biophysical changes occur in the 
spermatozoa and the spermatozoal membrane. These alterations in metabolism, 
intracellular ion concentration, membrane fluidity, intracellular pH, cAMP 
concentration and concentration of reactive oxygen species, ultimately make the 
spermatozoa fertilization-competent. In spite of the importance of capacitation, the 
43 
precise mechanisms of these cellular, biochemical and molecular events are still 
obscure (Jha et al., 2003). 
Modulation of a variety of ion channels of the spermatozoa is a characteristic 
event associated with capacitation and AR of mammalian spermatozoa. The major 
mobilisation of ions are the influx of calcium, potassium, chloride, bicarbonate and 
the efflux of zinc (Purohit et al., 1999). An increase in the intracellular pH has been 
observed during capacitation. This increase in pH is attributed to the bicarbonate 
anion (Cross and Razy-Faulkner, 1997). Bicarbonate levels are low in the epididymis 
and high in seminal plasma and the oviduct. Changes in the concentration of 
bicarbonate in the male and female reproductive tracts could play an important role 
in the suppression of capacitation in the epididymis and the promotion of this process 
in vivo in the female reproductive tract (Purohit et al., 1999). 
A very low and controlled concentration of superoxidase anion, hydrogen 
peroxide, and nitric oxide are involved in sperm acquisition of fertilizing ability 
(Purohit et al., 1999). The ROS produced during the capacitation and AR are known 
to activate several enzymes including protein kinase C (Gopalakrishna and 
Anderson, 1989) and tyrosine phosphorylation (Aitken et al., 1995), leading to 
changes in the fluidity of the membrane. ROS also regulates the fluidity of the 
membrane by lipid peroxidation in a controlled manner (Jain et al., 1994). Excess 
ROS generation is associated with a decrease in the fusion rates between sperm and 
oocytes (Aitken et al., 1991) and inhibition of the AR, motility and fertilizing 
potential of spermatozoa (Kodama et al., 1996). Accordingly, the needs for a fine 
balance between ROS production and scavenging, as well as the right timing for 
ROS production, are important for capacitation and AR (de Lamirande et al., 1997). 
During in 1no capacitation, spermatozoa may not be the only source of ROS. Fluids 
and cells from the female reproductive tract may also produce ROS or promote the 
formation of ROS by spermatozoa. Indeed, the concentration of oxygen in these 
fluids rises sharply at the time of ovulation (Maas et al., 1976). 
The other change which takes place during capacitation is the removal of 
cholesterol from the sperm plasma membrane. The efflux of cholesterol during the 
process of capacitation alters the permeability of the membrane to ions and generates 
areas which are prone to fusion and vesiculation process during the AR. The most 
\ 
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important consequences of the cholesterol efflux are the massive influx of 
extracellular calcium, a prerequisite for the AR (Purohit et al., 1999). There are 
cholesterol rich and cholesterol deficient regions on the head of the spermatozoa and 
during in vitro capacitation, loss of cholesterol takes place to form cholesterol-free 
patches and these patches are the sites of fusion at the time of AR (Tesarik and 
Flechon, 1986). The cholesterol/phospholipids (C/P) ratio of the sperm determines 
the capacitation state of the sperm (Hoshi et al., 1990). A freshly ejaculated 
spermatozoon has a high C/P ratio and during capacitation this ratio falls (de 
Lamirande et al., 1997). 
Another key intracellular event that occurs during capacitation is protein 
tyrosine phosphorylation. Protein tyrosine phosphorylation mediates a variety of 
cellular functions such as growth regulation, cell cycle control, cytoskeleton 
assembly, ionic current regulation, and receptor regulation (Hunter, 1996). 
Phosphorylation increases significantly with capacitation and is localized mainly to 
the principal piece of the flagellum. Following binding to the zona pellucida, the 
percentage of spermatozoa with phosphotyrosine residues is significantly higher in 
bound spermatozoa than in capacitaed spermatozoa in suspension (Sakkas et al., 
2003). 
1.9.2 Hyperactivation and capacitation 
Hyperactivated movement of spermatozoa was first reported by Yanagimachi 
(1969), who observed that, as spermatozoa gained the ability to fertilize oocytes in 
vitro, their flagella began beating more vigorously than before. Hyperactivated 
motility is defined as the swimming pattern shown by most spermatozoa retrieved 
from the oviductal ampulla at fertilization. The flagella of hyperactivated 
spermatozoa are thrown into deeper bends and their beating is usually less 
symmetrical than that of flagella of activated spermatozoa (Ho and Suarez, 2001). 
Sperm hyperactivation occurs at the site and time of fertilisation and it appears as an 
essential event of capacitation. It is associated with an increase velocity, a decreased 
linearity, an increased amplitude of lateral head displacement, and whiplash 
movement of the flagellum (de Lamirande et al., 1997). A number of physiological 
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factors, such as Cat+, cMIP, bicarbonate and metabolic substrates, are essential for 
the initiation and maintenance of hyperactivated motility in vitro. Human cervical 
mucus also induces sperm capacitation and hyperactivation (Zhu et al., 1994). Ca2+ 
and cA11MP not only induce hyperactivation they might also modulate protein 
phosphorylation (rash, 1989). Tyrosine phosphorylation has been associated with 
heat-induced hyperactivation in human spermatozoa (Chan et al., 1998). 
1.9.3 Acrosome reaction 
The process of the AR is of fundamental importance in the fertilisation of 
oocytes by spermatozoa. The AR is defined as the fusion of sperm plasma membrane 
and the outer acrosomal membrane. Physiological AR occurs upon interaction of the 
spermatozoon with the ZP3. AR as an exocytotic process in spermatozoa involves 
the fusion, vesiculation (fenestration) and loss of outer acrosomal membrane and its 
overlying sperm plasma membrane (Purohit et al., 1999). This is followed by 
liberation of several acrosomal enzymes including hyaluronidase, acrosin, esterases, 
and neuraminidase that facilitate penetration of the zona and expose molecules on the 
sperm equatorial segment that allows fusion of sperm membrane with the oocyte 
(Baldi et al., 2000). AR involves the anterior region of the sperm head and is not 
extended beyond the equatorial segment (Yanagimachi, 1994). 
Under physiological and in vitro conditions, ZP3 stimulates AR in 
mammalian sperm. Progesterone and its analogue 17a-OH-progesterone, a major 
component of follicular fluid, has also been found to rapidly induce AR 
(Yanagimachi, 1994). AR can be induced in vitro by ionophores which exchange 
Ca2+ for other ions such as W and Na+ (Russell et al., 1979). Fluxes of ions like 
sodium, chloride, hydrogen, and bicarbonate occur during the AR, suggesting that 
besides calcium, other ions also play a role in the process of calcium-dependent 
fusion of acrosomal membrane and the sperm plasma membrane (Purohit et al., 
1999). 
While superoxide anion production is shown to be a part of ionophore 
induced AR (Griveau et al., 1995), hydrogen peroxide is known to induce 
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hyperactivation and promote capacitation, but is not involved in the acrosome 
reaction of the spermatozoa (Griveau et al., 1994). 
1.10 Aims 
The aims of the thesis were to investigate: 
" The potency of chlamydial LPS compared with enterobacterial LPS against human 
spermatozoa. 
" The role of two main fractions of LPS, lipid A and Kdo, on human spermatozoa. 
" The role of chlamydial LPS, lipid A, and Kdo in stimulation of the TLR pathway 
and TNF-a production. 
" The effect of LPS and its fractions in ROS production. 
" The mechanism(s) of endotoxin-induced sperm death via necrosis, apoptosis, or 
both. 
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Chapter 2 
Comparison between the spermicidal activities of 
several LPSs including that from C. trachomatis 
2.1 Introduction 
Bacterial infections have long been recognised as having an association with 
infertility. Bacteria are also capable of agglutinating and immobilising spermatozoa 
(del Porto et al., 1975). In Gram-negative bacteria, LPS as a biologically active 
constituent of endotoxin is one of the major structural and immunodominant 
molecules of the outer membrane. LPS plays several roles in the pathogenesis of 
Gram-negative bacterial infections. First, it is a permeability barrier that is permeable 
only to low molecular weight, hydrophilic molecules. Secondly, it impedes 
destruction of the bacterial cells by serum components and phagocytic cells. Thirdly, 
LPS plays an important role as a surface structure in the interaction of the pathogen 
with its host. 
LPS consists of three components or regions, lipid A, core region and an 0 
antigen (more details in chapter 1). Both lipid A (the toxic component of LPS) and 
the polysaccharide side chains (the immunogenic portion of LPS) act as determinants 
of virulence in Gram-negative bacteria. The involvement of the polysaccharide chain 
in virulence is shown by the fact that small changes in the sugar sequences in the side 
chains of LPS result in major changes in virulence. The chemical composition of 
LPS varies widely among bacterial species. Regarding this diversity in the chemical 
structure of LPS, in this chapter the effect of four different kinds of LPS including, 
C. trachomatis, E. coli, Klebsiella pneumoniae, and Serratia marcescens, were 
investigated for their effect on human spermatozoa. Enterobacterial LPS were chosen 
as they would be derived from bacteria which could be found in the male urogenital 
tract and also the chemical structure of LPS from a great number of enterobacterial 
species have revealed common structural features (Haeffner-Cavaillon et al., 1989). 
Hosseinzadeh et al., (2000 and 2001) showed that chlamydial EBs can have a 
direct and detrimental effect on sperm physiology. Also, Galdiero et al., (1994) and 
Hosseinzadeh et al., (2003) demonstrated that C. trachomatis LPS can kill 
spermatozoa. 
E. coli is the most common cause of urinary tract infections and is also 
responsible for many different gastrointestinal diseases including travellers' and 
infantile diarrhoea. 
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K. pneumoniae is an opportunistic pathogen causing bacteraemia, pneumonia 
and urinary tract infections in humans. Offen associated with nosocomial infections, 
it is second only to E. coli as the culprit behind Gram-negative sepsis syndrome 
(Hansen et al., 1998) and is a major cause of mortality in hospital-acquired 
infections. 
The human opportunistic pathogen S. marcescens is a bacterium with a broad 
host range, and represents a growing problem for public health. S. marcescens is a 
recognized nosocomial pathogen that causes pneumonia, septicaemia, meningitis, 
and urinary tract infections (Bollmann et al., 1989). 
Compared to the classic exotoxins of bacteria, endotoxins are less potent and 
less specific in their action, since they do not act enzymatically. Endotoxins are heat 
stable (boiling for 30 minutes does not destabilize endotoxin), but certain powerful 
oxidizing agents such as superoxide, peroxide and hypochlorite, degrade them 
(http: //www. smtl. co. uk/MDRC/Gloves/Endotoxin). 
2.2 Aims 
The association of pathogenic bacteria with male infertility has been noted by 
researchers. The purpose of the present study was to compare the potency of the LPS 
of C. trachomatis, E. coli, K pneumoniae, and S. marcescens against spermatozoa and 
also to investigate the possible effect of heat-treated chlamydia EBs on spermatozoa. 
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2.3 Materials and methods 
2.3.1 Cell culture technique 
2.3.1.1 Growth and maintenance of the McCoy cell line 
For the growth of C. trachomatis, McCoy cells were used. These cells are a 
mouse fibroblast cell line that is widely used for the propagation of C. trachomatis 
(Schachter and Wyrick, 1994). The McCoy cells were grown at 37"C in 5% CO2 in 
25 cm3 (for the growth of serovar E), 75 cm3 (for the growth of serovar LGV) plastic 
disposable culture flasks (Sterilin Ltd., Felthan, UK), and lml Trac bottles with 
coverslips (for the quantification of EBs) in McCoy growth medium [Minimum 
Essential Medium Eagle ([EMEM], Cambrex Biosciences, Wokingham, UK)], which 
contained 10% foetal calf serum (Bioclear, Mile Elm, UK). The cells were subjected 
to passage as follows: 
A laminar flow cabinet was switched on for 15 min before use and all 
surfaces in the hood were disinfected with methyl alcohol. After checking the 
confluency of the cells by using a light microscope, the growth medium was 
discarded, the cells were washed with 1x phosphate buffer saline [(PBS), 1x 
working solution containing 0.14M sodium chloride, 0.003M potassium chloride, 
0.002M potassium phosphate, and 0.01M sodium phosphate] twice and they were 
then treated with sufficient volume of Trypsin-Versene mixture (Cambrex, UK) to 
coat the cell sheet. The cells were then incubated at 37"C for 5 min to detach from 
the surface of culture flasks. The detached cells were resuspended in 10-20 ml 
growth medium and the flasks were then incubated at 37"C in 5% CO2 for 24-48h 
until they were found to be confluent. 
2.3.1.2 Culture of C trachomatis serovars E and LGV on the confluent McCoy 
cells 
The growth medium from tissue culture flasks was replaced by maintenance 
medium [EMEM in 10% foetal calf serum and 2µg/ml cycloheximide (Sigma, UK)], 
and from fresh or frozen stocks of C. trachomatis EB 50-100 µ1(-10' EBs/ml) were 
added to the flasks separately. The flasks containing serovar E were centrifuged at 
4000 xg for Ih and then incubated for 48-72h. The flasks containing serovar LGV 
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were incubated directly. The tissue culture flasks were then checked under a light 
microscope to look for chlamydial inclusions. 
2.3.2 Purification of chlamydial EBs 
The EBs were isolated from McCoy cells by density gradient centrifugation 
as described by Caldwell et al., (1981). Infected McCoy cells were detached from the 
tissue culture using a cell scraper (Corning Costar Co, Boston, USA) and the 
resulting suspension disrupted by three bursts of sonication, 30 sec at amplitude of 
12 microns interspersed by 1 min intervals to allow the dissipation of the heat 
generated during sonication, using a sonicator (MSE, Liverpool, UK). The 
suspension was then centrifuged at 500 xg for 15 min and then transferred to a 
plastic centrifuge tube (Beckman, High Wycombe, UK) before centrifuging it again 
at 30,000 xg for lh at 4°C. The resulting pellet was then resuspended in 1 ml PBS 
and sonicated as before and was then made up to a volume of 8ml with PBS. The 
chlamydial suspension was placed on the top of 8ml urografin® 150 (Schering 
HealthCare Ltd, Burgess Hill, UK) in a Beckman centrifuge tube and the suspension 
centrifuged again as above. The final pellet was then gently washed by adding 1 ml of 
PBS without disturbing the pellet, before being resuspended in 2-3 ml of 2-sucrose 
phosphate transport buffer [(2SP); 74.62 g/1 sucrose, 0.512 g/1 KH2PO4,1.23 g/l 
K2HPO4 in one litre of glass distilled water (GDW) and filter sterilised (0.2 nm filter 
pore size)]. The solution was then vortexed and sonicated as above and 200 µl 
aliquots were kept at -70°C for further use. 
2.3.3 Quantification of infectious forming units in EB preparations 
McCoy cell monolayers were prepared in Trac bottles. Prior to infection, the 
growth medium was replaced with maintenance medium and the Trac bottles were 
subsequently infected with a dilution series of purified EBs (10-2 to 10-6). Following 
incubation for 48h (37°C, 5% C02), monolayers were fixed using 70% (v/v) ethanol 
for 5-10 min. The ethanol was decanted and the cells were then washed with PBS. 
The coverslips were removed using forceps and placed on microscope slides with the 
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cell monolayer facing upward. 20 p1 of IMAGEN chlamydia fluorescent stain 
(DAKO, Ely, UK) was added onto the monolayer and slides were incubated at 37°C 
for 30 min in a moist box. Coverslips were gently washed with PBS to remove any 
excess reagent and mounted using glycerol with 0.1 M Tris, pH 8 (1: 1, v/v). Slides 
were viewed using a fluorescent microscope with the FITC filter and the number of 
inclusions [(represented by apple green vacuoles within red counterstained cells) 
(Figure 2.1)] were counted for 25 fields at x 400 magnification. The number of 
inclusion forming units per coverslips for each dilution was determined and used to 
calculate an approximate number of IFUs/ml. 
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Figure Z. 1. Immunofluorescence staining of C. trachomatis inclusion bodies in 
McCoy cells. Four inclusions (apple green vacuoles) are shown. 
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2.3.4 LPS extraction from purified C. trachomatis EBs 
C. trachomatis LPS was extracted as previously described by Nurminen et al. 
(1985) with a few modifications. The purified EBs from serovars E and LGV were 
suspended in 2.5 ml of 90% aqueous phenol and homogenised for 5 min followed by 
magnetic stirring at 50°C for 30 min to dissolve and partition the EB proteins from 
the LPS. 4 ml petroleum ether (b. p. 90 to 100° C) and 2.5 ml of chloroform were then 
added to the mixture and stirring was continued for lh at room temperature (RT). 
After centrifugation at 10000 xg for 30 min, the supernatant was freed from organic 
solvents under reduced pressure using a rotary evaporator, and the remaining phenol 
phase was precipitated with 10 volumes of acetone at -20°C overnight followed by 
centrifugation at 10000 xg for 30 min. The precipitate (LPS) was washed twice with 
cold acetone, dried under vacuum and kept at -20°C after resuspension in sufficient 
volume of 2SP with 0.1% triethylamine. 
2.3.4.1 Detection of extracted LPS by polyacrylamide gel electrophoresis 
(PAGE) 
To confirm the successful extraction of LPS, 20 µl of the LPS was then run 
on a 14% polyacrylamide gel at 150 V according to the following method: 
Before preparing polyacrylamide gels, glass plates, dividers, and the comb were 
washed, dried and cleaned with 70% (v/v) methanol. The recipe for making a 14 % 
resolving gel and a1 cm 5% stacking gel is as follows (volume shown was sufficient 
for two gels). 
2.3.4.2 14 % Resolving gel 
30 % Acrylamidel 4.66 ml 
1.5 M Tris-HC1(pH 8.8)2 2.5 ml 
Distilled water 2.64 ml 
TEMED3 5 µl 
10 % (w/v) Ammonium persulphate4 0.35 ml 
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1- A 30% solution (electrophoresis reagent) of acrylamide/bis-acrylamide was 
purchased from Sigma and stored at 4° C. 
2- pH was adjusted with 1M HCI. 
3- N, N, N', N-Tetramethylethylenediamine. 
4- A fresh 10% (w/v) solution of ammonium persulphate was made up prior to gel 
preparation. 
2.3.4.3 5% Stacking gel 
30 % (w/v) Acrylamide 1.3 ml 
0.5 M Tris-HC1(pH 6.8) 2.1 ml 
Distilled water 4.4 ml 
TEMED 17 µl 
10 % (w/v) Ammonium persulphate 100 . tl 
2.3.4.4 Running buffer 
A5x stock solution of running buffer was prepared as follows; 24g Tris, 
115g glycine, 8g sodium dodecyl sulphate (SDS), and 2 litres GDW. The pH of the 
buffer was adjusted to 8.3 and stored at 4°C. Prior to use, a1x solution of running 
buffer was prepared with GDW. 
2.3.4.5 Sample loading buffer 
A stock solution of sample loading buffer (2 x) was prepared containing 4% 
(w/v) SDS, 20% (v/v) glycerol, 10% (v/v) ß-mercaptoethanol, 0.125 M Tris-HC1(pH 
6.8) and 0.005% bromophenol blue made up in GDW. 200 µl aliquots were stored at 
-20°C. 
The PAGE apparatus and polyacrylamide gels were assembled and prepared 
according to the manufacturer's instructions (Bio-Rad, Hemel Hempstead, UK). To 
prepare polyacrylamide gels, GDW, acrylamide, Tris buffer, and TEMED were first 
mixed, and just before pouring the gel, ammonium persulphate was added. After 
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pouring the resolving gel, water-saturated butanol was overlaid on the surface of the 
gel to ensure a flat interface between the resolving and stacking gel. Once the 
resolving gel was set, butanol was removed using blotting paper, the stacking gel was 
poured and a suitable comb was placed into position. The gel was left to polymerise, 
the comb removed and excess liquid was removed from wells using fine strips of 
filter paper. Gels were then inserted into the gel running apparatus, samples were 
loaded and electrophoresed at a constant 150 V for approximately lh. 
2.3.4.6 Silver staining 
The Bio-Rad silver stain kit was used for detection of LPS extracts. After 
LPS extracts were run on a 14 % PAGE gel, the gel was fixed either overnight 
statically or for 1h shaking in 50 ml fixing solution (40 % (v/v) methanol, 10 % 
(v/v) glacial acetic acid). The gel was oxidised for 5 min in 50 ml of 0.7 % (v/v) 
periodic acid prepared in fixing solution and subsequently was washed 5 times in 
distilled water for 5 min. The gels were then washed twice in 20 ml of 10 % (v/v) 
ethanol, and then soaked in 50 ml of silver stain oxidiser (5 ml stock solution / 45 ml 
water) for 5 min. The gel (orange coloured) was washed repeatedly in water until the 
gel became clear, and the gel was incubated in 50 ml of silver reagent (5 ml stock 
solution / 45 ml water) for 20 min with gentle agitation. The silver stain was 
discarded and the gel was washed for 1 min in distilled water, this was followed by 
addition of 50 ml developer solution (3.2 g/ 50 ml water, pre-warmed at 37° C for 1 
h prior to use) to wash off brown/orange colour residues after the addition of silver 
stain. LPS bands were developed by the addition of another 50 ml of developer and 
the reaction was stopped by addition of 5% (v/v) glacial acetic acid when the bands 
appeared. 
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2.3.4.7 LPS quantification 
A Limulus Amebocyte Lysate (LAL) (Cambrex Biosciences, UK) kit was 
used to quantify chlamydial LPS. The method was performed as recommended by 
the manufacturer. A micro-plate method with four standard endotoxin solutions was 
used as follows: 
A solution containing 1 EU/ml (standard 1) endotoxin was prepared by 
diluting 0.1 ml of the endotoxin stock solution with (X-1)/10 ml of LAL water (X= 
endotoxin concentration of the vial). This solution was vigorously vortexed for at 
least 1 min before proceeding. 0.5 ml of standard 1 was transferred into 0.5 ml of 
LAL reagent water, giving a concentration of 0.5 EU/ml (standard 2). Another 0.5 ml 
of standard 1 was added to 1.5 ml of LAL reagent water, giving a concentration of 
0.25 EU/ml (standard 3). Finally 0.1 ml of standard 1 was transferred into 0.9 ml of 
reagent water, giving a concentration of 0.1 EU/mI (standard 4). All standard 
solutions were vigorously vortexed for 1 min before use. 
The micro-plate was pre-warmed at 37°C in a heating block. 50µ1 of samples 
or standards were dispensed into the appropriate micro-plate well. Each series of 
samples included a blank plus the four endotoxin standards run in duplicate. The 
blank wells contained 5Oµ1 of LAL reagent water instead of samples. All reagent 
additions and incubation times were identical. At time 0,5Oµ1 of LAL was added to 
all micro-plate wells. The wells were then pipetted gently to facilitate mixing. At 
time 10 min, 100 pl of substrate solution (pre-warmed to 37°C) was added to each 
well and pipetted as before. At time 16 min, 100 pl stop reagent was added to stop 
the reaction. The absorbance of each microplate well was read using the UV-visible 
spectrophotometer (Shimadzu, Tokyo, Japan) at 405 nm. All assays were performed 
in duplicate. The Table 2.1 and Figure 2.2 show a dilution scheme for the 
construction of standards from the endotoxin supplied in the kit and the graphic 
method to calculate the concentration of LPS respectively. 
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Endotoxin 
stock solution 
Endotoxin 
std. solution 
1 EU/ml 
LAL 
reagent 
water 
Endotoxin concentration 
(EU/ml) 
0.1 ml - (X-1)/10 ml 1.0 
- 0.5 ml 0.5 ml 0.5 
- 0.5 ml 1.5 ml 0.25 
- 0.1 ml 0.9 ml 0.1 
Table 2.1. Dilution scheme for the preparation of standards from the endotoxin 
supplied in the kit. EU= Endotoxin unit, 10 EU= 1 ng, X= endotoxin concentration 
of the vial. The initial dilution from the endotoxin stock was 11X. This yielded an 
endotoxin solution containing 1.0 EU/ml. In this study for example, the potency of 
endotoxin was 23 EU/ml. Accordingly, the initial dilution was 1/23 or 0.1 ml of 
endotoxin stock into 2.2 ml of LAL reagent water. 
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Figure 2.2. Graphic method to determine the endotoxin concentration of samples. 
The absorbance at 405 nm was linear in the concentration range of 0.1 to 1 EU/ml 
(standard 4 to standard 1). The corresponding endotoxin concentration of the samples 
was determined from their absorbance. 
60 
0 0.2 0.4 0.6 0.8 1 
2.3.5 Human sperm preparation 
The human ejaculate is comprised of a mixture of seminal plasma, mature 
and immature spermatozoa, non-reproductive cells, various micro-organisms and 
non-specific debris. There are several sperm separation methods available. These 
include simple washing, sperm migration into culture medium (swim-up), Sephadex 
and glass wool columns and density gradient centrifugation [(single- (90%) or two- 
layers (40/80%) Percoll)]. All of these techniques are capable of effectively 
separating sperm from the seminal plasma, but to varying degrees (Centola et al., 
1998; Adiga and Kumar, 2001). Discontinuous (two-layer) Percoll gradients were 
shown to select sperm with better motion characteristics, increased hyperactivation 
and improved longevity compared with swim-up (Saad and Guerin, 1992; Moohan 
and Lindsay, 1995). In all experiments in this study the two-layer Percoll gradient 
method was used as follows: 
Semen samples were collected from normozoospermic male obtained from 
the Infertility Clinic at the Jessop Wing, Royal Hallamshire Hospital, Sheffield. 
Ethical approval for the use of semen samples in this study was granted by the South 
Research Ethics Committee (project number 02/337). The samples were obtained by 
masturbation and allowed to liquefy for 30 min at 37°C. All samples had a 
concentration of > 20 x 106 with >30% ideal morphological forms by the World 
Health Organization (WHO) 2000 criteria (WHO, 2000). A summary of the 
reference values of semen variables are shown in Appendix 1. 
Firstly, a 100% Percoll solution was prepared and diluted to 80% (v/v) and 40 
% (v/v) percoll fractions using 1x Earl's balanced salt solution (EBSS) (Invitrogen 
Ltd, Paisley, UK) containing 0.3% (w/v) Bovine serum albumin (BSA). The 
consistuents of 10 x EBSS, 40%, 80%, and 100% Percoll are as follows: 
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2.3.5.1 Constituents of 10 X Earl's balanced salt solution (EBSS) 
KCl 0.08g 
NaCl 1.36g 
NaH2PO4. H20 0.0242g 
D-Glucose 0.2g 
GDW 20m1 
(Sterile-filtered by 0.2 nm filter pore size) 
2.3.5.2 Constituents of 100% Percoll 
10 x EBSS 1 ml 
Percoll (Sigma, UK) 9 ml 
Bovine serum albumin (BSA) 30 mg 
Sodium pyruvate 0.3 mg 
Sodium lactate (60% syrup) 0.037 ml 
Sodium bicarbonate 20 mg 
2.3.5.3 Constituents of 80% Percoll 
100% percoll 6 ml 
1x EBSS (contains 0.3% BSA) 1.5 ml 
2.3.5.4 Constituents of 40% Percoll 
100% Percoll 4 ml 
1x EBSS (contains 0.3% BSA) 6 ml 
Carefully, lml of 80% Percoll was pipetted into a 15 ml sterile conical- 
bottomed tube (BD Biosciences, San Jose, USA). Gently, 1 ml of 40% Percoll was 
added to the top of the 80% Percoll layer. The interface was clearly visible between 
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the two layers. One ml of semen was deposited gently onto the top of the Percoll 
gradient and centrifuged at 500g for 20 min. After centrifugation, all supernatant was 
removed and the pellet with highly motile sperm was resuspended in pre-warmed 1x 
EBSS (containing 0.3% BSA) and adjusted to 5x 106 sperm/ml. 
2.3.6 Comparison of spermicidal activities of four different LPSs 
15 x 180 pl aliquots of sperm suspension were prepared. To two aliquots, 20 
µl of C. trachomatis LPS from serovars E and LGV were added, giving a final LPS 
concentration of 0.1 pg/ml. To 12 further aliquots, 20 µl of E. coli 055: B5 (Sigma, 
UK), K pneumoniae (Sigma, UK), and S. marcescens (Sigma, UK) LPS were 
added, giving a final concentration of 0.1,10,25, and 50 µg/ml for each LPS. 
Finally, to the last aliquot, 20 µl of 1x EBSS was added as a negative control. All 
aliquots were maintained at 37°C in 5% CO2 for 6h. After 6h incubation the sperm 
viability was measured using the HOS test described on page 64. 
2.3.7 The spermicidal activity of heated C. trachomatis EBs 
The purified EBs from serovars E and LGV were heated at 37°C, 56°C, and 
100° C separately for 30 min using a heated-block. 9x 180 pi aliquots of 5x 106 
sperm suspension were prepared. To 6 aliquots, 20 pl of heat-treated purified EBs 
from both serovars at the above-mentioned temperature were added, giving a final 
concentration of 6x 105 EBs/ml. To another two aliquots, 20 p1 of non-heated 
purified EBs from both serovars were added at a similar concentration. 20 p1 of 1x 
EBSS was added to the last aliquot as a negative control. The aliquots were kept at 
37°C in 5% CO2 for 6h and the sperm viability was assessed by the HOS test. 
2.3.8 Inhibitory effects of polymyxin B on the chlamydial Ell 
12 x 180 pl aliquots of 5x 106 sperm suspension were prepared as described 
earlier. To 4 aliquots, 20 pl of heat-treated purified EBs at 56°C and 100°C from 
serovars E and LGV was added at a final concentration of 6x 105 EBs/ml. To 
another 4 aliquots of heat-treated purified EBs at 56°C and 100°C from both serovars, 
polymyxin B (PMB) was added to give a final concentration of 100 pg/ml. In the 
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control aliquots, 20 p1 of non-heated purified EBs from both serovars at a similar 
concentration, 20 µl of 1x EBSS and 100 µ1/m1 of PMB were added separately. The 
aliquots were kept at 37°C in 5% CO2 for 6h before removing 20 p1 of each aliquot 
for the evaluation of sperm viability. 
2.3.9 Measurement of sperm viability by the Hypo-Osmotic 
Swelling test (HOS) 
The viability of spermatozoa was determined using the HOS test (WHO, 
2000). This test is based on the semi-permeability of the intact sperm cell. Live 
spermatozoa will swell when placed in a hypo-osmotic solution which causes curling 
in its tail due to bulging of its plasma membrane, non-viable spermatozoa do not 
swell. 20 µl of each incubate was transferred to 200 pl of pre-warmed HOS solution 
and incubated at 37° C for 30 min. Each incubate was then spotted onto a microscope 
slide and allowed to air dry overnight followed by fixing in absolute methanol for 45 
min. For each incubate or control, 100 spermatozoa were counted to establish the 
viability of the samples. The spermatozoa with swollen, curled-up tails were 
considered viable with intact membrane integrity and represented as percentage HOS 
positive (WHO, 2000). 
2.3.9.1 Constituents of HOS solution 
Sodium citrate dehydrate 0.735g 
Fructose 1.351g 
GDW l00m1 
The aliquots of this solution was stored at -20°C, thawed and mixed well before use. 
2.3.10 Statistical analysis 
The results of all experiments in this study were analysed using GraphPad 
InStat software version 3.0 (GraphPad Software, Inc. USA). The statistical 
significance of differences between two means was evaluated by Student's t test, 
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and p values of > 0.05, < 0.05, < 0.01, and < 0.001 were considered not significant 
(NS), significant (*), very significant (**), and extremely significant (***) 
respectively. 
2.4 Results 
2.4.1 Detection of extracted LPS on a 14% PAGE gel 
The LPS of C. trachomatis serovars LGV and E was extracted from purified 
EBs. The LPS was then run on a 14 % PAGE gel followed by staining with silver 
reagent (Figure 2.3). LPS from E. coli 055: B5 was used as a control. Because Kcoli 
LPS has polysaccharide side chains it produced a longer smear on the gel. 
ti 
LGV" 
:. 47' 
V 
Figure 2.3. The LPS of Ctrachomatis serovars LGV and E and E. coli 055: B5 
were electrophoresed through a 14% acrylamide gel and stained using the Bio-Rad 
silver stain kit. 
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2.4.2 C. trachomatis LPS quantification 
To calculate the concentration of LPS extracted from C. trachomatis, a 
standard curve was drawn and the concentration of LPS (EU/ml) was calculated 
according to the standard curve (Figure 2.2). The final concentration of LPS was 
recorded in pg/ml (10 EU =1 ng). Depending on the concentration of purified EBs 
used for the LPS extraction, the final concentration of LPS ranged from 55 pg/ml to 
345 pg/ml. 
2.4.3 Interaction between spermatozoa and four LPSs 
The sperm preparations after density gradient centrifugation had a mean 
sperm death of 8.7 ± 0.9%. Examples of viable and non-viable sperm using the HOS 
test are shown in Figure 2.4. 
After 6h incubation, the mortality rate in the control population did not 
change significantly (8.9 ± 0.6%, p>0.05). Spermatozoa that were incubated with 
0.1 pg/ml of C. trachomatis LPS from serovars E and LGV, showed a significant 
increase in sperm death (38.6 ± 1% and 36.8 ± 1% respectively, p<0.001). 
However, the sperm death rate in incubations that were treated with the same 
concentration of LPS from E. coli, K pneumoniae, and S. marcescens did not change 
significantly (8.8 ± 0.6%, 8.7 ± 0.5%, 9.1 ± 0.6% respectively, p>0.05) (Figure 2. 
5). 
In another experiment after 6h incubation with increasing concentration of 
these latter three LPSs, from 0.1 pg/ml to 25 µg/ml, no marked rise in sperm death 
was seen. Accordingly, only the result of one concentration (0.1 µg/ml) has been 
shown in Figure 2.5 as an example. When the LPS concentration was increased to 
50 pg/ml for E. coli, K. pneumoniae, and S. marcescens, spermatozoa showed a 
significant decrease in viability (21 ± 0.5%, 22.3 ± 1.9 %, 22.3 ± 1.1% respectively, 
p<0.001) (Figure 2.5). 
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Figure 2.4. HOS test is based on the semipermeability of the intact sperm cell. A, 
dead spermatozoa showing straight tails. B, live spermatozoa demonstrating various 
types of curled tails. 
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Figure 2.5. Percentage sperm mortality over a 6h incubation period with 0.1 Eid; /nil 
of LPS from C. trachoniatis serovars E and LGV, E. coli, K. pncunroniae, and S. 
marcescens (A) and 50 pg/m1 of LPS from the last three LPSs (B). Results are mean 
of six experiments ± SEM. ***, significant difference between response to LPS and 
control, p<0.001. NS, not significantly different from the control. 
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2.4.4 The effect of heating C. traclhomatis EBs and their interaction 
with spermatozoa 
At time 0, the aliquots of spermatozoa had a sperm mortality of 10.6 1 1.9 %. 
After 6h incubation in the absence of chlamydial EBs the percentage of sperm death 
did not alter significantly (10.9 ± 1.1%, p>0.05). However, in the presence of non- 
heated EBs from both serovars, E and LGV, values rose substantially (38.1 ± 2.1 and 
34.3 ± 2.5 respectively, p<0.001). The pre-heated EBs at 37° C, 56° C, and 100° C 
had a similar effect on spermatozoa (p < 0.001) (Figure 2.6). 
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Figure 2.6. Percentage sperm mortality over a 6h incubation period with 6x 105 of 
heat-treated (37° C, 56° C, and 100° C) purified EBs from C'. trachonrtis serovars E 
and LGV. After 6h incubation all groups in the presence of EBs regardless of the 
temperature showed a marked decline in sperm viability (p < 0.001) in comparison 
with the negative control. Data represent the average of six experiments ± SEM. ***, 
significant difference between response to LPS and control, p<0.001. 
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2.4.5 The effect of PMB on heated chlamydial EBs and their 
interaction with spermatozoa 
In this experiment, the effect of 100 pg/ml of PMB on heated chlamydial EBs 
was investigated to confirm the spermicidal activities of heated EBs observed in 
Figure 2.6 were due to LPS derived from EBs. Over the 6h incubation period, the 
sperm mortality rate of the negative controls (medium and PMB only) did not change 
markedly (12 f 2.4%, 11.7 1 2.9% respectively, p>0.05) from that seen 
immediately after preparation (11.5 ± 3.1%). In the presence of non-heated E and 
LGV EBs this value altered significantly (36.8: L 3.1% and 35.1 ± 1.7% p<0.001). 
Interestingly, the mortality rate of spermatozoa in aliquots which were incubated 
with heated chiamydial EBs showed a dramatic reduction in the presence of PMB 
(Figure 2.7). 
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Figure 2.7. Effect of PMB on heated chlamydial EBs serovars LGV (A) and I` (13) 
interacting with sperm following a 6h incubation period. PMB, polymyxin B. Data 
shown for six experiments ± SEM. ***, P<0.001). 
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2.5 Discussion 
The relationship between bacterial infection and male infertility has been 
constantly an interesting subject for researchers who work in the fertility-sterility 
field. Dennis in 1962, was among the first workers who demonstrated that endotoxin 
isolated from Vibrio fetus at 100 pg/ml, immobilised spermatozoa from rams or bulls 
after 4h incubation however, the first reported study of the effect of bacteria on 
human spermatozoa goes back to about 10 years earlier. In their 1951 study, 
Matthews and Buxton showed that certain bacteria cultured from the cervix were 
spermicidal. 
Twenty years later, Teague et al., (1971) treated human spermatozoa with 
E. coli obtained from cervical cultures. They reported that E. coli isolated from either 
cervical cultures or infected urine cause a significant decrease in spermatozoa 
motility and viability. However, in their study, E. coli LPS at unstated concentration 
failed to produce marked alterations in the spermatozoa parameters. In 1975 Del 
porto et al., found similar results when they exposed spermatozoa to E. coli at 106 
cfu/ml. 
In another study, Paulson and Polakoski (1977) isolated a low-molecular 
weight spermatozoal immobilisation factor (SIF) from E. coli cultures. However, the 
factor passed through the dialysis tubing and through a 500 molecular weight cut-off 
membrane, indicating that it was too small to be LPS. They showed this factor that 
was stable to heating, freezing, and lyophilization could immobilise spermatozoa. 
Galdiero et al., (1988) showed LPS extracted from E. coli killed about 80% 
of the spermatozoa at a concentration of 50 gg/ml after a 60 min incubation period. 
The influence of E. coli on human sperm motility was also studied by Diemer and 
co-workers (1996) in vitro. Using electron microscopy, they showed multiple 
adhesions of E. coli to spermatozoa, causing variable ultrastructural damage as 
probable morphological correlates of immobilisation. 
The effect of another organism, C. trachomatis, on male infertility has been 
also investigated but with controversial results. While some studies with diagnosis 
based on mostly serologic methods have suggested that chlamydial infections 
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probably do not remarkably contribute to male infertility (Bjercke and Purvis, 1992; 
Eggert-Kruse et al., 1997; Rezacova et al., 1999), there are other reports that show 
this infection can compromise the sperm function (Galdiero et al., 1994; 
Hosseinzadeh et al., 2001). These workers showed C. trachomatis LPS as a major 
component of this organism could lead to a significant degree of sperm death during 
an in vitro incubation. By the eosin exclusion test, Galdiero and co-workers (1994) 
demonstrated that LPS extracted from C. trachomatis at 0.1 µg/ml causes an increase 
in spermatozoa mortality rate. In their previous experiments Hosseinzadeh et al., 
(2000) suggested that C. trachomatis EBs increase tyrosine phosphorylation of sperm 
proteins that may be important for sperm function (Hosseinzadeh et al., 2000) and 
the serovar E EBs also could lead to premature sperm death (Hosseinzadeh et al., 
2001). These workers also demonstrated that chlamydial LPS has a spermicidal 
effect and using polymyxin B, a polycationic antibiotic known to neutralise LPS 
effects (Morrison and Jacobs, 1976; Duff and Atkins, 1982), they confirmed that this 
effect is primarily as a result of LPS activity (Hosseinzadeh et al., 2003). 
Based on these considerations, in our study we incubated human spermatozoa 
with not only house-made C. trachomatis LPS and commercial E. coli LPS, but with 
commercial LPS from K. pneumoniae and S. marcescens in order to compare their 
potency against spermatozoa in vitro. The two latter L PSs along with E. coli L PS, 
belong to the Enterobacteriaceae family which are involved in urinary tract 
infections. 
After 6h treatment of spermatozoa with these LPSs, the result of spermatozoa 
viability assessed by the HOS test showed that while C. trachomatis LPS at 0.1 µg/ml 
had a marked toxic effect on sperm viability, the other LPSs induced a significant 
increase in the percentage of dead spermatozoa only when their concentrations were 
increased to 50 gg/ml. 
As was described, there are several reports regarding interaction between 
human spermatozoa and C. trachomatis LPS or E. coli LPS. However, little is known 
about the effect of the two other LPSs used in the present study. For example, to our 
knowledge, Dumoulin et al., (1991) are the first researchers who investigated the 
effect of S. marcescens LPS on spermatozoa. In their study, they reported that these 
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LPS even at 500 pg/ml had no spermicidal activity and these findings contradict our 
results. However, there are two significant differences between their study and our 
investigation that might explain the controversial results of these two studies. Firstly, 
in their study they obtained spermatozoa pellet by centrifugation of semen using 
Whittingham's T6 culture medium supplemented with low-endotoxin bovine serum 
albumin that was totally different from the percoll gradient method that we used for 
sperm praparation. Secondly, to estimate the sperm survival, they counted the 
number of motile spermatozoa using a Makler counting chamber (see Appendix 2), 
however, we assessed sperm viability using the HOS test. 
The difference in the concentrations of LPSs used in our investigation, 
possibly can be ascribed to their differences in chemical structure that are briefly 
described below. 
There is evidence that shows C. trachomatis has a weak LPS with low activity 
(but not against spermatozoa): 
a) the potency of C. trachomatis LPS in activating LPS-responsive cells is -100 
fold less than other bacterial LPS (Qureshi et al., 1997). 
b) The chlamydial LPS were at least 10 times less active than typical endotoxins 
using LPS antagonist or monoclonal antibodies against chlamydial LPS (Heine et al., 
2003). 
The low endotoxic activity may be attributed to the presence of unusual long- 
chain fatty acids (C14-C21) in a penta-acyl arrangement and mono-phosphorylation 
of the diglucosamine backbone. While species expressing LOS typically attach 
between 10 and 20 sugars to their lipid A, chlamydial LPS makes do with only a Kdo 
tri-saccharide joined a-Kdo-2-8-a-Kdo-2-4-a-Kdo (Erridge et at, 2002). Chlamydial 
LPS lacks the O-chain and this is another reason that possibly explain the low 
endotoxin activity of this organism. 
The low potency of C. trachomalis LPS might help this organism to establish 
chronic infections like trachoma or upper genital tract infection. As LPS is an 
integral compound of the outer membrane of bacteria and therefore easily accessible 
to innate immune cells, it would be expected that the expression of highly 
stimulatory endotoxins results in severe and acute infections, whereas expression of 
low- or non-stimulatory endotoxins causes slowly progressing chronic infections. 
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Comparison of the known structures of core LPS from different 
Enterobacteriaceae reveals that the inner core structure contains two residues of 3- 
deoxy-D-manno-octulopyranosonic acid (Kdop) and three residues of L-glycero-D- 
manno-heptopyranose (L, D-Heppl, L, D-HeppIl and L, D-HeppIIl) (Vinogradov and 
Perry, 2001). E. coli LPS has a hexa-acyl diphosphorylated lipid A with acyl chains 
of length C12-C14 (Erridge et al., 2002). The properties of K. pneumoniae LPS 
include the unusual Kdo existing in the outer core, the existence of homo- 
polysaccharides in some O-chains, and bisphosphorylated lipid A substituted with six 
acyl chains of 12-16 carbon length (Erridge et al., 2002). The chemical 
characteristics of S. marcescens LPS in terms of the size of repeating units, 
molecular weight and the presence of glucuronic acid, galacturonic acid, and 
pyruvate as acidic components, indicate that S. marcescens LPS closely resembles 
Klebsiella and E. coli LPS (Aucken et al., 1997). 
In addition to these differences in the chemical structure of LPSs from the 
above-mentioned bacteria, based on our investigations and the other relevant studies 
we would also suggest that the type of host cells, i. e. monocytes, spermatozoa, and 
etc, the conditions and environment where the host cells interact with pathogenic 
bacteria i. e. in vitro or in vivo possibly are important and may determine whether 
pathogens show a weak or a strong activity against their hosts. 
Previous work from our group has demonstrated that C. trachomatis EBs are 
spermicidal. Using polymyxin B (a polycationic antibiotic known to neutralize LPS 
effects), they confirmed that the toxicity effect of EBs against spermatozoa was 
primarily a result of LPS activity which is released from EBs. It is well 
acknowledged that LPS is a heat-stable complex which could preserve its activities 
against host cells at boiling point for 30 min. Despite this fact, in one study by 
Teague et al., (1971), it was shown that E. coli killed by boiling for 10 min, has no 
toxic effect on human spermatozoa, however, the dose of killed bacteria was not 
stated in their study. 
Apart from LPS, a number of other bacterial cell components including 
porins and peptidoglycans from Gram-negative bacteria have been shown to have a 
toxic activity against spermatozoa (Galdiero et al., 1988; Gorga et al., 2001). In the 
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case of Gram- negative bacterial cells, the porin concentration is about 2x 105 
molecules of porins per cell, covering an area of approximately 1.8 µm2 or roughly a 
third of the cell surface area (Galdiero et al., 1990). Porins are able to induce 
immune and acquired immune responses and have diverse biological activities on 
several eukaryotic cell types. Porins are also capable of interfering with the host 
cell's apoptotic apparatus at different steps in the cascade of signal transduction 
(Galdiero et al., 2003). 
Contrary to LPS, most proteins are denatured above 50°C, a temperature well 
above the normal body temperature of 37°C. As the temperature is increased, a 
number of bonds in the protein molecule are weakened (www. life. sci. 
qut. edu. au. /epping/). 
In another experiment in the present chapter, we exposed human spermatozoa 
to heated-C. trachomatis EB to confirm the stability of LPS components from EBs 
against heating. Our findings demonstrated that the spermicidal activity of EBs were 
unaffected by heating at either 56°C or 100°C since the spermatozoa death rate did 
not alter significantly in the presence of heated-EBs compared to spermatozoa which 
were incubated with non-heated EBs. To inhibit the LPS toxicity and to rule out the 
effect of other bacterial components, which could be potentially toxic and interfere 
with our results, heated-EBs-induced spermatozoa were pre-incubated with 100 
pg/ml of polymyxin B (PMB) in control groups. PMB interacts strongly with 
phospholipids and penetrate into and disrupt the structure of cell membranes. PMB 
also binds to the lipid A portion of endotoxin and inactivates this molecule (Brown 
and Wood, 1972; Warner et al., 1985). 
The results of control groups also showed that PMB could inhibit the 
spermatozoa mortality when incubated with heated-EBs. However, no activities were 
observed from other bacterial components suggesting that the spermicidal properties 
of heated-EBs could be possibly ascribed to the LPS. In conclusion, we demonstrated 
that the spermicidal activity of chlamydial LPS is about 500 times more active than 
that of enterobatcterial LPS in vitro. We also confirmed that chlamydial LPS, similar 
to other LPS is a heat-stable complex. 
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Chapter 3 
The effect of two main LPS fractions, Kdo and lipid A, 
on human spermatozoa 
3.1 Introduction 
Endotoxin is a characteristic outer membrane entity of Gram-negative 
bacteria and a potent inducer of inflammatory responses. Exposure to even low 
amounts of LPS leads to a dramatic release of inflammatory mediators that are 
thought to be responsible for the deleterious effects in host cells. As described in 
chapter 1, LPS consists of three regions. The first and most essential part is lipid A, 
which is the hydrophobic anchor of LPS and has the same basic structure in 
practically all Gram-negative bacteria; it consists of a p-1,6 linked D-glucosamine 
disaccharide bearing phosphoryl groups in positions 1 and 4', and ester and amide 
bound fatty acids. It forms the outer leaflet of the outer membrane and is responsible 
for most of the toxic activity of LPS including induction of cytokine expression by 
LPS (Rietschel et al., 1987) and it is associated with Gram-negative septic shock 
(Trent, 2004). Lipid A from various Gram-negative bacteria express similar 
endotoxic features despite their chemical diversity (Tanamoto et al., 2001). 
The core, second region, including Kdo serves as a link between lipid A and 
the distal repeating-unit polysaccharide known as 0 antigen. The chemical structure 
of the core region, like lipid A, in LPS of many bacterial families is known to be 
common (Shimizu et al., 1992). The core oligisaccharide constitutes a domain of 
limited structural diversity within the same bacterial genera, e. g, only five unique 
core structures have been described forE. coli (Rietschel et al., 1993). 
The third moiety of the LPS molecules is the 0 antigen attached to the 
terminal sugar of the outer core composed of units of common sugars and is highly 
immunogenic. Only the Kdo and lipid A portions of LPS are required for cell growth 
and bacterial viability (Erridge et al., 2002). 
In order to maintain a functional outer membrane, LPS contains at least 
either an a-Kdo-(2--'4)-a-Kdo disaccharide or a single Kdo (Brade et al., 2002). The 
polysaccharide moiety expresses certain biological activities, such as induction of 
colony stimulating factors, interferon, adjuvanticity, B cell mitogenicity, and IL-1 
secretion (Haeffner-Cavaillon et al., 1989). 
There is evidence that endotoxins devoid of Kdo probably do not exist 
(Caroff et al., 1987). This specificity of Kdo has been as a promising target for the 
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development of novel antibacterials acting against Gram-negatives, as the inability to 
produce Kdo is a lethal event. Also since Kdo is not found in mammalian cells, 
agents directed against its biosynthesis should possess high selective toxicity 
(Hammond, 1992). 
CD14 is a glycophosphatidylinositol-linked protein expressed by myeloid 
cells (membrane CD 14) and also circulates as a plasma protein lacking the 
glycophosphatidylinositol anchor (soluble CD14). Membrane and soluble forms of 
CD14 have been reported on the surface of spermatozoa and in the seminal plasma 
respectively (Harris et al., 2001). Both membrane and soluble CD14 function to 
enhance activation of cells by LPS and a number of other bacterial cell wall 
components from different organisms (Aderem and Ulevitch, 2000; Viriyakosol et 
al., 2000). 
The interaction between LPS and the effector cell occurs via the CD 14 
receptor. This receptor as the main LPS receptor, has been identified as a high 
affinity cell-surface receptor for complexes of LPS and serum LPS-binding protein. 
CD14 may play a role in immune defence and cell activation in the male 
reproductive tract (Harris et al., 2001). 
LPS is only one of many bacterial products which is recognised by CD 14. 
peptidoglycan (Gupta et al., 1996), mycobacterial cell wall component 
lipoarabinomannan (LAM) (Peterson et al., 1995), uronic acid polymers which are 
common components of lipopolysaccharides (LPS) and extracellular polysaccharides 
from Gram-negative bacteria and are also in the cell wall (as teichuronic acid) and 
extracellular polysaccharides of Gram-positive bacteria (Jahr et al., 1997), and a 
surface adhesion molecule of the yeast Blastomyces dermatitidis (Hogan et al., 
1995), have all been found to stimulate cellular responses via CD14. 
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3.2 Aims 
The spermicidal properties of LPS are established by previous experiments. 
Since only Kdo and lipid A are required for bacterial bioactivity, in this chapter the 
effect of these fractions on sperm viability was separately investigated. The 
inhibitory effect of anti-CD14 antibody and polymyxin B (PMB) on Kdo and lipid A 
acting against sperm was also assessed. 
3.3 Materials and methods 
3.3.1 Preparation of lipid A from C. trachomatis LPS 
Lipid A was isolated from in-house C. trachomatis LPS serovar E and LGV as 
previously described by Maasby-Baltzer and Kaijser (1979) and Qureshi et al., 
(1982). Lipid A was extracted by hydrolysis of about 100 µg/ml LPS from E and 
LGV in 1 ml of 1% acetic acid. The suspensions were heated at 100°C for 90 min. 
The lipid A was precipitated from solution and was then removed by centrifugation 
at 10,000 xg for 10 min. The deposit was washed three times with hot distilled water 
and dissolved in 0.2% triethylamine. An LAL kit was used to quantify the extracted 
lipid A as described in chapter 2. 
3.3.2 Assay for 2-keto-3-deoxyoctonate (Kdo) in the lipid A 
To confirm the isolated lipid A is free of Kdo contamination, lipid A 
preparations were analysed for the presence of Kdo by the thiobarbituric acid method 
(Manthey and Vogel, 1994). 10 µl of each sample, estimated to contain about 20 pg 
lipid A, were added to 90 pl of 0.044 M H2S04 and boiled for 20 min to release 
bound Kdo. 10 pl, and serial 2-fold aqueous dilutions, were then mixed with 20 p1 of 
0.025 M periodic acid in 0.250 M H2S04 and allowed to oxidise for 40 min at RT. To 
each sample 30 pl of 2% sodium arsenite in 0.5 M HCI were added and briefly 
vortexed followed by 120 pl of 0.3% thiobarbituric acid. The samples were boiled 
for 20 min, neutralised by the addition of 15 p1 2M NaOH, and absorbance measured 
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at 548 nm. To obtain a standard curve, a stock solution of synthetic Kdo (Sigma, 
UK) at a concentration of 100 pg/ml was used. From the stock solution, six serial 
dilutions from 1 to 10 pg/ml were made and boiled for 20 min in 0.04 M H2SO4. Any 
Kdo present in a sample was determined by comparison with the standard curve. 
3.3.3 Assay for endotoxin in the synthetic Kdo 
To confirm the synthetic Kdo used in this study is free of LPS contamination, 
Kdo at 500 µg/ml was analysed for the presence of LPS by a Limulus Amebocyte 
Lysate (LAL) as described in chapter 2. 
3.3.4 The effect of isolated Ctrachomatis lipid A and synthetic Kdo 
on spermatozoa 
Semen samples were obtained from 6 patients and prepared as described 
in chapter 2 to give 8x 180 µl aliquots for each sample. To four aliquots, 1 and 2 
gg/ml of extracted lipid A from C. trachomatis E and LGV and to two aliquots, 25 
and 50 pg/ml of synthetic Kdo (Sigma, UK) were added. To the last two aliquots, 20 
µl of EBSS and 0.1 pg/ml of LPS from C. trachomatis LGV were added as controls, 
followed by 6h incubation at 37°C in 5% COZ. 
3.3.5 The effect of PMB and anti-CD14 antibody on Ctracliomatis 
lipid A and synthetic Kdo and their interaction with 
spermatozoa 
Semen samples were obtained from a further 6 patients and prepared as 
described above to give 12 x 180 µl aliquots for each sample. PMB (Sigma, UK) was 
used at a final concentration of 100 gg/ml as previously reported (Hosseinzadeh et 
al., 2003). Anti-CD14 antibody (BD PharMingen, Oxford, UK) was free of 
endotoxin and sodium azide and was used at a final concentration of 10 µg/ml 
(Raponi et al., 1997) with a 30 min pre-incubation time prior to adding lipid A and 
Kdo at 2 pg/ml and 50 gg/ml respectively. EBSS and 0.1 µg/ml LGV LPS were used 
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as a negative and positive control respectively. All aliquots were incubated for 6h at 
37° C in 5% CO2. 
In addition to the HOS test described in chapter 2, the sperm viability in all 
aliquots was also assessed using two additional methods, the Viability/Cytotoxicity 
assay and the Eosin-Nigrosin technique to confirm our HOS results. 
3.3.6 Viability/Cytotoxicity assay 
By using the Viability/Cytotoxicity Assay Kit (Molecular Probes, Invitrogen 
Technologies, Paisley, UK) containg Component A (Calcein AM) and Component B 
(Ethidium homodimer-1) the spermatozoa death rate was assessed. This method is a 
fluorescence-based technique to assay cell vibility which allows simultaneous 
detection of live cells (green) and dead cells (red) in the same population. 
2µl of component B was added to lml of PBS and then mixed followed by 
adding 1 µl of component A. I Ogl of each incubate was added to the same volume of 
mixed components and incubated lh prior to making a smear. 200 sperm were 
counted at x 1000 under a fluorescent microscope (Leica Microsystems Ltd, Milton 
Keynes, UK). The ratio of viable (green) to non-viable (red) sperm was then 
calculated. 
3.3.7 Eosin-Nigrosin technique (WHO) 
This method is based on two stains, eosin that is taken up by dead cells, and 
nigrosin as a background stain, to increase the contrast between faintly stained cells 
and an otherwise bright background 
10 µl of each incubate was mixed with 20 µl of 1% eosin Y. After 30 sec, 30 
µl of 10% nigrosin solution was added and gently mixed. One drop of the sperm- 
eosin-nigrosin mixture was then placed on a microscope slide and a smear was made 
within 30 sec of adding the nigrosin. Care was taken not to make the smear too thick. 
The smears were allowed to air-dry and were examined under oil immersion (1000 x) 
with a light microscope. 
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3.3.8 Statistical analysis 
The results of all experiments in this study were analysed using GraphPad 
InStat software version 3.0 (GraphPad Software, Inc. USA). The statistical 
significance of differences between two means was evaluated by Student's t test 
and/or one-way analysis of variance (ANOVA), and p values of > 0.05, < 0.05, < 
0.01, and < 0.001 were considered not significant (NS), significant (*), very 
significant (**), and extremely significant (***) respectively. 
3.4 Results 
3.4.1 Lipid A quantification and Kdo assay 
The concentrations of isolated lipid A from 100 µg of in-house C. 
trachomatis LPS from both serovars, E and LGV, using the LAL test were 27 pg and 
35 µg respectively (Table 3.1). No Kdo was detected in isolated lipid A. The data of 
the Kdo standard curve (Figure 3.1) showed that the concentration of Kdo in lipid A 
was less than 1 µg (OD < 0.1). 
Also, the results of the LAL test showed that the synthetic Kdo at 500 µg/ml 
was free of LPS contamination at the minimum detection level of 0.01 ng/ml. The 
data is shown in Table 3.1. 
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Figure 3.1. A standard curve using 1 to 10 µg of Kdo. 
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2468 10 
Kdo (µg) 
Absorbance 
(mean OD) 
Standard* 
0.119 
(0.1 EU**/ml) 
Standard 
0.434 
(0.25 EU/ml) 
Standard 
0.938 
(0.5 EU/ml) 
Standard 
1.440 
(1 EU/ml) 
E Lipid A (df=6) 
0.441 
(0.27 EU/ml) 
LGV Lipid A (df--6) 
0.693 
(0.35 EU/ml) 
Kdo (500 µg/ml) 
0.108 
(0.091 EU/ml) 
Table 3.1. The absorbance of each concentration of endotoxin standard and Kdo 
using a UV-visible spectrophotometer at 405 nm. *, Standard was prepared using 
E. co1i LPS; **, Endotoxin Unit; df, dilution factor. 
3.4.2 Comparison of three different methods for assessment of 
sperm viability 
The percentage of dead spermatozoa in all incubations was investigated using 
three different methods. After 6h incubation, the mortality rates of spermatozoa in 
the control group were 9.5 ± 1.4% (HOS test), 10.8 ± 1% (Viability/Cytotoxicity 
assay), and 10.1 ± 1.9% (Eosin-Nigrosin technique). The spermatozoa death rate 
increased significantly (p < 0.001, Student t test) in the presence of 0.1 pg/m1 of 
C. trachomatis LPS from serovar LGV; 35.5 ± 4.1% (HOS test); 33.8 ± 3.3% 
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(Viability/C. ytotoxicity assay) and 34.4 ± 3.9% (Eosin-Nigrosin technique) (Figure 3. 
2). 
Since the results of these methods did not show any significant diffcrcnccs (p 
> 0.05, one-way ANOVA), the results of two groups, control and LGV LPS, were 
shown as a representative of all incubations which were assessed by these methods 
(Figure 3.2) and only the results of the HOS test were chosen br experiments in this 
chapter. For each method, examples of viable and non-viable sperm are shown in 
Figure 3.3 (Viability/Cytotoxicity assay), and 3.4 (Eosin-Nigrosin technique). The 
examples of viable and non-viable sperm assessed by the HOS test are also shown in 
chapter 2, Figure 2.4. 
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Figure 3.2. A comparison of three methods for assessing sperm mortality alter 611 
incubation using; HOS, Viability/Cytotoxicity assay, and Eosin-Nigrosin technique. 
Results are the mean of 6 experiments ± SEM. HOS, hypo-osmotic swelling test; 
V/C, Viability/Cytotoxicity assay; E-N, Eosin-Nigrosin technique. 
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Figure 3.3. Fluorescent microscopy pictures of viable (green) and non-viable (red) 
spermatozoa using the Viability/Cytotoxicity assay kit. 
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Figure 3.4. Two spermatozoa stained by the Eosin-Nigrosin technique. The live 
spermatozoon is white and the dead one is red. 
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3.4.3 The effect of C. trachmatis lipid A and synthetic Kdo on human 
spermatozoa 
The percentage of dead spermatozoa in the sperm preparation after density 
gradient centrifugation was 9.7 ± 0.8%. After 6h incubation this characteristic did not 
change markedly in the control group (9.5 ± 0.96%, p>0.05) however, spermatozoa 
which were treated with 0.1 gg/ml of LGV LPS showed a significant change in the 
sperm mortality (34.3 ± 1.7%, p<0.001). Spermatozoa in the presence of 2 pg/ml of 
extracted lipid A from Ctrachomatis serovars E and LGV also showed a 
considerable increase in the percentage of sperm death (23.6 ± 1.2% and 19.7 ± 2.3% 
respectively, p<0.001). Lipid A at a concentration of less than 2 gg/ml had no 
significant effect against spermatozoa (p > 0.05). Interestingly, synthetic Kdo 
showed a spermicidal activity only when the concentration increased to 50 µg/ml 
(20.6 ± 1.32%, p<0.001) (Figure 3.5). All data in this experiment were analysed by 
Student t test. 
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Figure 3.5. Co-incubation of spermatozoa with extracted lipid A from 
C. trachomatis serovars E and LGV and with synthetic Kdo for Oh. The results of the 
negative control (EBSS) and the positive control (LGV LPS) are also shown. The 
data shown are the mean of six experiments ± SEM. NS. Non-significant. ***, p< 
0.001, Student t test. 
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3.4.4 Inhibitory effects of anti-CD14 and PMB on lipid A and Kdo 
interactions with spermatozoa 
After 6h incubation, the spermatozoa death rate in the control groups was 
similar to the values of previous experiment (10.2 ± 1.6% and 37.9 ± 3.1% 
respectively) (Figure 3.5). The percentage of dead spermatozoa in the presence of 
anti-CD14 and PMB was also similar to the control group (Figure 3.6) (9.1 t 1.3% 
and 9.8 ± 1.1% respectively). Spermatozoa which were treated with 2 µg//ml of LGV 
lipid A and 50 pg//ml of synthetic Kdo showed similar findings to those seen 
previously (Figure 3.5) (21.9 ± 2.2% and 19.5 ± 1.9% respectively, p<0.001). 
When spermatozoa were pre-incubated with anti-CD 14 antibody and PMB, the 
sperm death was markedly decreased in the presence of LPS (17.9 ± 2.3% and 21.3 f 
3.1% respectively, p<0.001) and LGV lipid A (12.6 ± 1.9%, p<0.01 and 9.6 f 
0.7%, p<0.001, respectively). The sperm mortality results of E lipid A were similar 
to LGV lipid A (11.1 ± 2.2%, 10.4 ± 4.1 respectively). Interestingly, this effect was 
not seen with Kdo (18.4 ± 1.6%, and 20.1 ± 0.8 respectively, p>0.05). Therefore, 
anti-CD14 antibody and PMB were only able to inhibit the spermicidal activity of 
LPS and lipid A but not Kdo (Figure 3.6). All data in this experiment were also 
analysed by Student t test. 
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Figure 3.6. Effect of 100 µg/ml PMB and 10 µg/ml anti-CD 14 antibody on LGV 
LPS, LGV lipid A and synthetic Kdo on sperm viability after 6h incubation. Since 
the results of E lipid A was similar to LGV lipid A, only the results of the latter were 
demonstrated. Data shown are the mean of six experiments ± SEM. NS, Non- 
significant. ***, p<0.001, Student t test. 
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3.5 Discussion 
In spite of controversial literature about interactions between LPS and human 
spermatozoa discussed in chapter 2, based on recent results regarding the activity of 
LPS, the effect of two LPS domains, lipid A and Kdo, on human spermatozoa was 
investigated in the present study. As previously described, these LPS fractions are 
important for vital activity of Gram-negative bacteria. Lipid A is a toxic component 
and the biologically active moiety of bacterial endotoxin. Additionally, the 
polysaccharide moiety of LPS also has biological activity including induction of 
interferon and IL-1 secretion (Haeffner-Cavaillon et al., 1989). Van et al., (1996) 
also reported that the growth of Haemophilus inf7uenzae type b (Hib) completely 
stopped in the presence of 5 µg of anti-Hib capsular polysaccharide (PS) MAb. This 
finding might confirm the role of polysaccharides in bioactivity of bacteria. 
However, there is no evidence thus far to show the bioactivity of these two 
moieties of LPS against human spermatozoa. As lipid A is the main part of LPS and 
is responsible for most of the toxic activity of LPS, we could postulate that lipid A 
might be toxic for spermatozoa however, we demonstrated that this hypothesis 
cannot be generalised to Kdo due to no inhibition of its spermicidal activity by PMB. 
From our previous experiments we confirmed and showed that LPS from 
C. trachomatis at 0.1 pg/ml and from three genera of the Enterobacteriaceae family, 
E. coli, K. pneumoniae, and S. marcescens at 50 Vg/ml has spermicidal activity. 
Although in our present study we demonstrated that isolated lipid A from 
C. trachomatis LPS had a marked effect against spermatozoa however, this effect was 
observed at 2 pg/ml which is 20 times more than LPS. Additionally, the percentage 
of dead spermatozoa caused by lipid A alone was about 15% less than sperm death 
rate induced by LPS. This discrepancy might be explained by the following 
evidence. 
Usually, natural lipid As isolated from LPS by acid hydrolysis are very 
heterogeneous in their number of fatty acids and phosphates (Tanamoto , et al., 
2001). Erridge et al., (2002) reported that the major contributing factors to 
endotoxicity of lipid A are the number and lengths of acyl chains present and the 
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phosphorylation state of the disaccharide backbone. Therefore the isolation process 
of lipid A could affect the potency of lipid A interacting with spermatozoa. 
Furthermore, Kdo is seen in almost every LPS, being a-bound to the 
carbohydrate backbone of lipid A and is always absolutely required for bacterial 
viability (Erridge , et al., 2002). For example, the LPS of the deep rough mutant of 
Haemophilus influenzae has only one Kdo residue attached to its lipid A (Helander et 
al., 1988). 
The most significant result of the present study was the identification of Kdo, 
which to our knowledge, has not been described so far as a spermicidal agent. Also 
we showed that this spermicidal activity of Kdo was not affected by two LPS 
inhibitors, anti-CD14 antibody and PMB. We obtained this finding with the HOS test 
confirmed by two other sperm viability tests, i. e. the Viability/Cytotoxicity assay, 
and the Eosin-Nigrosin technique. It should be noted that the Kdo used in this study 
was synthetic and monosaccharide however, Lebbar et al., (1986) reported that 
synthetic Kdo alone has no biological activity. Haeffner-Cavaillon et al., (1989) 
suggested that the polysaccharide portion of LPS is able to produce interferon and 
IL-1. Also, Paradis et al., (1994) using extracted LPS from Actinobacillus 
pleuropneumoniae showed that the polysaccharide part of this LPS is involved in 
binding to porcine respiratory tract cells. 
As we are in the early stages of this study, induction of death in spermatozoa 
using synthetic and monosaccharide Kdo, cannot be generalised to all Kdos 
regardless of the source and the number of sugars. There were some limitations and 
difficulties described below that hindered our investigation to focus on C. trachomatis 
Kdo. 
Extraction of Kdo from C. trachomatis LPS was a big obstacle since LPS 
extraction from EBs as a preliminary stage for K do extraction was a difficult and 
time-consuming process. For example, for producing of about 100 µg of 
C. trachomatis LPS a large number of tissue culture flasks and a time of 2-3 months 
was needed; this could be increased in the case of culture contamination. 
Additionally, Kdo extraction at a high concentration was not achieved with only 100 
pg of LPS. For these reasons, the effect of C. trachomatis Kdo on spermatozoa 
currently remains a mystery. 
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As described in chapter 2, polymyxin B (PMB) is a polycationic antibiotic 
which binds to the lipid A portion of bacterial lipopolysaccharide (LPS) and which 
thereby blocks many well-known biologic and toxic LPS effects. PMB is also 
frequently added to in vitro cell cultures in order to neutralize possible LPS 
contamination (Fibbe et al., 1988). In experiments looking at the inhibitory effects of 
PMB, incubation of sperm with 100 pg/ml was able to inhibit the toxic effect of 
extracted LPS and lipid A from C. trachomatis LPS, however, PMB was not able to 
inhibit the spermicidal activity of Kdo. Interestingly, the same inhibitory effect on 
LPS and lipid A but not Kdo was observed when spermatozoa were pre-incubated 
with anti-CD 14. 
Although the presence of CD14 on the surface of spermatozoa and in the 
seminal plasma has been reported, the function of CD14 on human spermatozoa is 
presently uncertain (Harris, et al., 2001). These workers proposed that spermatozoal 
CD 14 may have a complementary role to that of seminal plasma CD 14 (spCD 14) in 
permitting spermatozoa to respond to LPS and other bacterial products. Since the 
inhibitory effect of anti-CD14 was observed in the present study, this finding may 
lead us to conclude that CD14 receptors existing in spermatozoa and seminal plasma 
have a similar role to that of other cells, plasma, and biological fluids possessing this 
receptor. 
LPS and one of its active components, lipid A, induce various transcription 
factors via intracellular signalling cascades initiated by their receptor including 
CD14 (Reisser et al., 2002). Anti-CD14 antibody blocks these signalling cascades 
and it is also well established that PMB binds to the lipid A portion of endotoxin and 
inactivates this molecules. Therefore, we would expect anti-CD14 antibody and 
PMB to block the activity of LPS and lipid A; Kdo would not be affected by PMB. 
However, the fact that spermicidal activity of synthetic Kdo was unaffected by anti- 
CD14 antibody was an interesting finding. It is possible that anti-CD 14 antibody fails 
to block the activity of Kdo as it may not interact with the host cell in the same way 
that lipid A does. Although, the inhibitory effect of PMB on the spermicidal activity 
of LGV LPS used as a control in this study was statistically significant, however, this 
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effect was incomplete. The incomplete nature of inhibition might be ascribed to the 
toxic effect of Kdo components on spermatozoa which would not affected by PMB. 
To expand our knowledge in terms of the mechanism of Kdo toxicity against 
spermatozoa, more experiments were performed including the role of Kdo in TLR 
induction and TNF-a secretion which are essential in recognition of pathogens and 
activation of host defence mechanisms. These investigations will be described in the 
next chapter. 
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Chapter 4 
Mechanisms of LPS, Kdo, and lipid A acting through the 
TLR signalling pathway 
4.1 Introduction 
Bacterial LPS, a constituent of the outer membrane of the cell wall of Gram- 
negative bacteria, is a potent activator of cells of the immune and inflammatory 
systems, including macrophages, monocytes, and endothelial cells, and contributes to 
the systemic changes seen in septic shock including low blood pressure and low 
blood flow, and dysfunction of vital organs, such as the brain, heart, kidneys, and 
liver (Opal and Cohen, 1999). Recognition of LPS by monocytes/macrophages is a 
key event in host antimicrobial defence reaction which depends mainly on the 
presence of Toll-like receptors (TLRs) (Schietter et al., 1995; Prebeck et al., 2001). 
Ten different TLRs are recognised to date (Philpott and Girardin, 2004), and 
with the exception of TLR10, they are involved in the recognition of pathogen- 
associated molecular patterns like endotoxin, peptidoglycan, flagellin, bacterial DNA 
and others (Hemmi et al., 2000). 
For recognition of LPS by host cells, at least four molecules are required (as 
described in detail in chapter 1); the serum LPS-binding protein, which delivers LPS 
to CD14 (Tobias et al., 1995), the glycosylphosphatidylinositol-anchored cell-surface 
protein CD14 (Golenbock et al., 1993), the Toll-like receptor 4 that is present in 
monocytes/macrophages, PMNs, dermal micro-vessel, umbilical vein endothelial 
cells, and intestinal epithelial cells (Muzio et al., 2000). This receptor initiates a 
signalling cascade homologous to mammalian nuclear factor xB (NF-KB) (Poltorak 
et al., 1998). The fourth molecule required for LPS recognition is the extracellular 
molecule MD2 that physically associates with TLR4 on the cell surface (Shimazu et 
al., 1999). 
Although, TLR2 which is predominantly distributed in monocytes, 
macrophages, and PMNs, is mainly involved in the recognition of Gram-positive cell 
wall components such as bacterial lipoproteins, and fungi (Hirschfeld et al., 2000), it 
has also been reported to be a signal transducer of LPS. For example, LPS from 
Porphyromonas gingivalis (Hirschfeld et at, 2001) and Leptospira interrogans 
(Werts et at, 2001) may activate macrophages via a TLR2-dependent mechanism. 
Liu et al., (2001) using peritoneal macrophages from normal and TLR4-deficient 
mice also demonstrated that TLR2 gene expression is upregulated in macrophge 
responses to peptidoglycan and to a high concentration (2.5 pg/ml) of E. coli LPS. 
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Interestingly, N. meningitidis LPS seems to engage both TLR4 and TLR2 due to 
structural composition of its lipid A (Netea et al., 2002). 
Production of pro-inflammatory cytokines by macrophages upon an infection 
is a preliminary stage to the activation of the effector cells of innate resistance. It is 
established that the early inflammatory responses are also essential to the process of 
generating antigen-specific effector cells of adaptive immunity. TNF-a (also known 
as cachectin) is one of the major mediators of inflammatory responses in mammals, 
and it also plays an essential role in bridging the innate and adaptive phases of 
immunity (Ma, 2001). TNF-a is a polypeptide cytokine with a diverse range of 
biological activities. Systemic exposure to recombinant TNF-a causes a syndrome of 
shock and tissue injury indistinguishable from septic shock syndrome. TNF-a has 
also been implicated in the pathogenesis of chronic processes such as autoimmunity, 
rheumatoid arthritis (RA), Crohn's disease and the cachexia accompanying cancer 
and acquired immunodeficiency syndrome (AIDS) (Tracey and Cerami, 1994). 
Interferons are a class of cytokines possessing antiviral and antitumoral 
activity. The antiviral activity of interferons has led to the use of synthetic forms to 
control viral infections such as hepatitis C (Mogensen and Paludan, 2001). 
Interferon-y (IFN-y) acts as a powerful macrophage activator, increasing the 
molecule expression of the main class II histocompatibility complex and the 
potentialisation of the cell response, including the production of cytokines, nitric 
oxide, and the increase of cytolytic activity. In humans, individuals who presented 
with genetic mutations in the receptors for IFN-y were observed to have had a high 
susceptibility to acquire infections caused by atypical mycobacteria (Jouanguy et al., 
1996), suggesting an important role of IFN-'y in the protective response against 
tuberculosis (TB). 
Human leukocyte antigen-DR (HLA-DR), a human class II antigen of the 
major histocompatibility complex, is a transmembrane glycoprotein composed of an 
a chain (36 kD) and aß subunit (27 kD) expressed primarily on antigen presenting 
cells: B cells, monocytes, macrophages, and thymic epithelial cells. HLA-DR is also 
expressed on activated T cells. 
LBP, CD 14, TLR2, TLR4, and cytokines including TNF-a and IFN-y 
involved in LPS signal transduction, may lead to reactive oxygen species (ROS) 
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induction and finally cell death. As TLRs play a critical role in early innate immunity 
to invading pathogens by sensing microorganisms and failing to produce TNF-a in 
TLR4-knockout mice, this demonstrated the importance of TLR4 in LPS signalling 
(Hoshino et al., 1999). It is also reported that C. trachomatis LPS causes sperm death 
therefore, it would be an important question regarding the presence of TLRs on 
human spermatozoa. This hypothesis was strengthened when Harvey et al., (2000) 
described the spermatozoa asialoglycoprotein receptor which binds to gonococcal 
lipooligosaccharide. 
4.2 Aims 
In the present study, we examined the contributions of TLR2 and TLR4 for 
the stimulation of HeLa cells by LPS from C. trachomatis serovars E and LGV. In 
chapter 3 we demonstrated that the mortality rate of spermatozoa increased in the 
presence of lipid A and Kdo. To understand the mechanism of sperm death by lipid 
A and Kdo we investigated the role of these LPS fractions in signal production by 
transfected HeLa cells and their roles in TNF-a production by IFN-7-induced THP-1 
cells. Another objective of this study was to assess the effect of LPS on mouse 
spermatozoa to explore whether we could use TLR knockout mice to show the 
existence of TLR in mouse spermatozoa. 
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4.3 Materials and methods 
4.3.1 The role of C. trachomatis LPS, lipid A and Kdo in signal 
production via TLR 2 and 4 
4.3.1.1 Purification of in-house Ctrachomatis LPS, and commercial LPS and 
lipid A from Ecoli 
LPS from C. trachomatis serovars E and LGV, E. coli 055: B5 (Sigma, UK) 
and lipid A from E. coli F583 (Sigma, UK) were purified to remove protein and 
lipoprotein contamination according to the methods of Manthey and Vogel, (1994) 
and Hirschfeld et al., (2000) as follows: 
To prepare water-saturated phenol, 100 ml of endotoxin-free distilled water 
was added to 100 g of phenol, and then placed at 37°C overnight to dissolve. After 
vigorous shaking, the bi-phasic solution was mixed followed by placing at 4°C where 
the solution again became bi-phasic. The top layer was discarded and the lower layer, 
phenol layer, was used for the next stage. 
At room temperature, 5 mg of LPS and lipid A were individually resuspended 
in 1 ml of endotoxin-free (EF) water containing 0.2% triethylamine (TEA). Each 
sample was split into two 500-µl aliquots, and one aliquot was stored at 4°C without 
further manipulation (unpurified LPS). 25 pl of 10% sodium deoxycholate (DOC) 
(Sigma, UK) was added to the remaining aliquot to a final concentration of 0.5%, 
followed by the addition of 500 pl of water-saturated phenol. The samples were 
vortexed intermittently for 5 min, and the phases were allowed to separate at room 
temperature for 5 min. Samples were placed on ice for 5 min, followed by 
centrifugation at 4°C for 2 min at 10,000 x g. The top aqueous layer was transferred 
to a new tube (- 425 pl), and the phenol phase was subjected to re-extraction with 
425 pi of 0.2% TEA plus 22 pl of 10 % DOC. The aqueous phases were pooled and 
re-extracted with 1 ml of water-saturated phenol. The pooled aqueous phases were 
adjusted to 75% ethanol (1100 µl of 100%) and 30 mM sodium acetate (15 p1 of 3M) 
and were allowed to precipitate at -20° C for 1 h. The precipitates were centrifuged at 
4°C for 10 min at 14,000 x g, washed in 1 ml of -20°C 100% ethanol and re- 
centrifuged at 4°C for 2 min at 14,000 x g. The ethanol supernatant was poured off 
and the pellets were then air-dried. The precipitates were resuspended in the original 
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volume (500 µl) of 0.2% TEA. To quantify the concentration of purified LPS and 
lipid A the LAL test was performed as described in chapter 2. 
Because of insufficient amount of in-house C. trachomatis LPS, only 100 µg 
of E and LGV LPS were used for purification. All concentrations and volumes of 
reagents used for purification were also adjusted to the concentration of 
C. trachomatis LPS. However, the final LPS pellets were too small and our attempts 
to recover purified C. trachomatis LPS were insufficient. Therefore, unpurified 
C. trachomatis LPS preparations were used in this study. 
4.3.1.2 HeLa cell transfection, stimulation, and luciferase activity assays 
LPS, lipid A, and Kdo signalling via TLR2 or TLR4/MD-2 were assessed 
using an IL-8 promoter assay as previously described (Pridmore et al., 2001). 
Briefly, 1.5 x 104/well of HeLa cells (named after patient Henrietta Lacks in 1951, 
any of the cells of the first continuously cultured human carcinoma strain, originally 
obtained from cancerous cervical tissue and maintained for use in studying cellular 
processes) were seeded into 96-well tissue culture plates 24h before transfection. 
Transient transfections were done according to the manufacturer's instructions using 
an activated dendrimer (Superfect; Qiagen, West Sussex, UK) when the cells were 
-80% confluent. The reporter vectors that were used were pTK- rLUC and pIL8- 
pLUC containing the human IL-8 gene (Promega; Southampton, UK). Expression 
vectors were as follows: pSUI (TLR2), pNMI (MD2/TLR4), and pCDM8-CD14 
(CD 14). 
Wells of HeLa cells received 150 µl of Dulbecco's modified eagle medium 
(Invitrogen; Paisley, UK) containing 10 % of heat inactivated foetal calf serum, 105 
IU/100 ml of penicillin, and 50 mg/100ml of streptomycin, 400 ng of pIL8- pLUC, 
25 ng of pCDM8-CD14,100 ng of pTK-rLUC, 50 ng of each expression vectors, 
pSUI and pNMI, and 50 ng of pcDNA3 (Invitrogen, UK). The latter were added to 
keep the total DNA dose constant at 625 ng/well. 2.5 pl of superfect was also added 
to each well to optimise the entry of DNA into the cells and also to assemble DNA 
into compact structures. The cells were then incubated for 2.5h at 37°C in 5% CO2 
followed by changing the medium with 100 pl of serum free Dulbecco's modified 
eagle medium; the cells were then re-incubated. At 24 h following transfection, cells 
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were treated with tenfold serial dilutions of C. trachomatis LPS from E and LGV 
(from 0.01 pg/ml to 1 pg/ml), purified lipid A and synthetic Kdo (from 0.5 pg/ml to 
50 pg/ml), and 1 pg/ml of purified E. coli LPS and peptidoglycan from 
Staphylococcus aureus (Sigma, UK) for a further 6h. The latter were used as agonists 
for TLR4 and TLR2 respectively. 10 µl of PBS was also used as a negative control. 
Triplicate wells were transfected for each treatment and 30h after transfection, the 
cells were then lysed and luciferase reporter levels were measured using the Dual- 
Luciferase system kit (Promega, UK) as recommended by the manufacturer. 
The term "Dual-Luciferase" refers to the simultaneous expression and 
measurement of two individual reporter enzymes within a single system which 
allows more reliable interpretation of the experimental data by reducing extraneous 
influences. Normalized IL-8 promoter activity is the ratio of firefly to Renilla 
luciferase activity. Normalising the activity of the experimental reporter to the 
activity of the internal control minimises experimental variability caused by 
differences in cell viability or transfection efficiency. 
4.3.2 Investigation into the role of LPS, lipid A and Kdo in TNF-a 
release by IFN-y induced THP-1 cells 
THP-1 cells (myelomonocytic cells line originating from a child with 
acute leukemia) were treated with 250 U/ml of human IFN-y (Sigma, UK) for 48h as 
described by Raponi et al., (1997). IFN-y induced THP-1 cells were washed twice in 
RPMI 1640 medium (Invitrogen, UK) and resuspended to a concentration of 5x 105 
cells/ ml in a serum-free RPMI 1640 medium. The cells were then incubated with 
anti-HLR-DR (BD Pharmingen, UK) and anti-CD 14 (BD Pharmingen, UK) at a final 
concentration of 20 µ1/m1 and 10 tg/m1 respectively for 30 min at 37°C to establish 
the role of receptors in the release of TNF-a. 5x 105 cells/ ml were stimulated with 
0.1 pg/ml of C. trachomatis LPS from either serovar E or LGV, 50 µg/ml ofE. co1i 
LPS, lipid A, and Kdo for 18h in a5% CO2 atmosphere at 37°C. The cells were 
centrifuged at 600 xg for 5min, and TNF-a content was tested in the supernatants. 
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4.3.2.1 TNF-a assay 
The assay of TNF-a was done according to the R&D system kit (R&D 
Systems Europe Ltd; Abingdon, UK) as follows. 50 µl of assay diluent was added to 
each anti-TNF antibody coated well. 200 pl of standard or sample was then added 
and incubated 2h at RT. The wells were aspirated and washed three times with wash 
buffer followed by adding 200 µl of TNF-a conjugate to each well and incubated for 
Ih at RT. Aspiration and washing was then repeated prior to adding 200 µl of 
substrate solution for 20 min incubation time at RT in a dark place. In the final stage, 
50 pl of stop solution was added and reading was done at 450 nm in an ELISA 
reader (Shimadzu, Japan) within 30 min. 
4.3.3 Preparation of M2 medium and exposure of mouse sperm to 
LPS 
M2 medium was prepared as described previously by Wittingham, (1971) as 
follows: 
Five different stock solutions x 10 called A [NaCl, 5.534 g/100m]; KCI, 
0.360 g/100ml; KH2PO4,0.162 g/100ml; MgSO4H2O, 0.294 g/100ml; Na lactate 
60% syrup, 2.608 g/100ml (3.2 ml); glucose, 1 g/100ml; penicillin, (105 IU), 60 
mg/100ml; streptomycin, 50 mg/100ml], B (NaHCO3,2.106 g/l00ml), C (Na 
pyruvate, 0.36 g/100ml), D (CaC122H2O, 2.52 g/100ml), and E (HEPES adjusted to 
pH 7.4 with 2M NaOH before making up to 100 ml, 5.957 g/100ml) were prepared 
and filtered by Millipore filter (0.22 pm pore size) prior to storing at 4 C. From A-E 
stocks, 1 ml, 0.16 ml, 0.1 ml, 0.1 ml, and 0.84 ml were taken respectively and added 
to 7.8 ml water with 40 mg BSA to make up 10 ml of M2 media with pH 7.4. 
4.3.3.1 Exposure of mouse sperm to LPS 
Experiments were performed on male C3H/HeN mice aged 7-9 weeks old, 
obtained from the University of Sheffield Field Laboratories. The procedure was 
performed under UK Home Office Animal Procedures Act (1986); the project 
licence number was 40/2343. The vas deferentia were excised from the mice once 
they had been killed and were incised 5-10 times to allow sperm to exude into 1 ml 
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of M2 media at 37 C for 15 min in 5% CO2. Sperm were washed twice by diluting to 
1 ml and centrifuging (400g, 3 min). The final sperm concentration was 1-2 x 106/ml. 
Sperm were incubated 6h at 37 C in 5% CO2 with 0.1 pg/ml of LGV or E 
LPS or 50 pg/ml of E. coli LPS prior to staining with the Viability/Cytotoxicity 
Assay Kit (Molecular Probes, Invitrogen Technologies, UK) as described in chapter 
3. 
10 pI of incubate was added to the same volume of the mixed components 
and incubated for ih prior to making a smear. 200 sperm were counted at x 1000 
magnification under a fluorescent microscope. The ratio of viable (green) to non- 
viable (red) sperm was then calculated. 
4.4 Results 
4.4.1 Quantification of purified LPS and lipid A 
Although in theory if no LPS or lipid A is lost during purification process, the 
percentage of recovery is 100% (Manthey and Vogel, 1994; Hirschfeld et al., 2000), 
in our laboratory from 5 mg/ml of commercial E. coli LPS and lipid A used for 
purification, 4 mg/ml (80%) of LPS and 4.5 mg/ml (90%) of lipid A were recovered. 
These concentrations were calculated using the LAL test (see chapter 2). 
4.4.2 HeLa cell transfections and IL-8 promoter assays 
The ability of in-house C. trachomatis LPS from both serovars, purified lipid 
A and synthetic Kdo to signal via TLR2 and TLR4 was investigated. Induction of the 
IL-8 promoter of HeLa cells was used as an indicator of the cellular response to these 
agonists (Pridmore et al., 2001). These workers using RT-PCR also demonstrated 
that the HeLa cells express endogenous TLR4 message but not MD2 or TLR2 
message. 
The sensitivity of the IL-8 promoter reporter is illustrated in Figures 4.1 and 
4.2, which show the response of transfected HeLa cells to E LPS, LGV LPS, lipid A 
and Kdo respectively. 
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HeLa cells which were transfected with MD-2 responded with significantly 
higher IL-8 promoter activity to 1 pg/ml and 0.1 pg/ml of E LPS and LGV LPS (p < 
0.001) than to PBS alone (Figure 4.1A). While the cells stopped responding to LGV 
LPS at 0.01 pg/ml, this response was still kept in the presence of E LPS at this 
concentration (p < 0.001). Purified E. co1i LPS at 1 pg/ml which was used as a 
control, was able to produce a signal through MID-2 transfected cells. This signal was 
comparable to the response produced by E LPS at 0.1 pg/ml, but, was higher than 
LGV LPS at the same concentration (p < 0.01) (Figure 4.1A). 
Although LGV LPS at the concentration of 0.01 µg/ml failed to produce a 
signal by MD-2 transfected cells, the response of TLR2-transfected cells to both 
serovars at all concentrations used in this study were significant (p < 0.001) (Figure 
4.1B). The response of these cells to the control which was peptidoglycan was 
similar to E LPS and higher than LGV LPS (P < 0.01). 
When both MD-2 and TLR2 transfected cells were challenged with tenfold 
serial dilutions of lipid A and Kdo (from 50 µg/ml to 0.5 pg/ml), only responses to 
lipid A were observed in cells transfected with MD-2, and not in those transfected 
with TLR2; no activity from the transfected cells were detected in the presence of 
Kdo (Figure 4.2). The control vector-transfected cells were unresponsive to all 
agonists used. Data were analysed using Student t test. 
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Figure 4.1. Response of MD-2- (A) TLR2- (B) transfected HeLa cells to 
C. trachomatis LPS from E or LGV serovars. Blank bars shows the vector-transfected 
cells. Results are mean of six pool of transfected cells ± SEM. IL-8, interleukin-8; 
PGN, peptidoglycan, PBS, phosphate buffer saline. ", LPS from E. cri/r 055: B5, 
NS, not significant; ***, significant difference between response to LPS and PBS 
alone (P < 0.001, Student I test). 
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Figure 4.2. MD-2- (A) and TLR2- (B) mediated recognition of lipid A and Kdo. 
Blank bars show the vector-transfected cells. Results are mean of six pool of 
transfected cells ± SEM. IL-8, interleukin-8; PGN, peptidoglycan, PBS, phosphate 
buffer saline. ", LPS from E. coli 055: B5; NS, not significant; ***, significant 
difference between response to LPS and PBS alone (P < 0.001, Student t test). 
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4.4.3 Challenge of IFN-y induced THP-1 cells with LPS, lipid A, and 
Kdo and measurement of TNF-a 
To firstly establish the role of IFN-y in induction of TNF-a , the THP-1 cells 
were treated with 0.1 pg/ml of E LPS before and after incubation with IFN-y. The 
level of TNF-a was detectable only when the cells were incubated with IFN-y (403 f 
37.5 pg, p<0.001, Student t test) [data shown in Figure 4.3]. 
The IFN-y induced THP-1 cells released non significant amounts of TNF-a in 
the cell control and the cells which were only treated with anti-HLR-DR and anti- 
CD 14 antibody (53: 1: 7 pg, 53 ± 4.5 pg, and 56 ±4 pg respectively, p>0.05) [Figure 
4.4]. When these cells were stimulated with 0.1 pg/ml of E or LGV LPS, and 50 
pg/ml of E. co1i LPS and lipid A, TNF-a levels measured in the supernatants 
increased dramatically (601 ± 90 pg, 656 ± 108 pg, 709 ± 115 pg, and 372 ± 61 pg 
respectively, p<0.001). Interestingly, synthetic Kdo at 50 µg/ml failed to produce 
TNF-a (57: h 9 pg, p>0.05). 
To investigate the role of HLR-DR and CD14 receptors in the mechanism of 
TNF-a release from IFN-y induced THP-1 cells, these cells were incubated with 
either anti-HLR-DR or anti-CD14 monoclonal antibodies (MAbs). Pre-incubation 
with these MAbs individually did not reduce the amount of cytokine release 
significantly (p > 0.05), however, when the cells were exposed to anti-HLR-DR and 
anti-CD14 in combination, a significant decrease of TNF-a levels was measured in 
the cell supernatants stimulated with LPSs from E, LGV, E. coli, and lipid A (187 f 
54 pg, 276 ± 51 pg, 268 ± 70, and 152 ± 18 pg respectively, p<0.001). 
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Figure 4.3. Response of THP-1 cells to 0.1 pg/ml of C. lrachomatis LPS serovar E 
in the absence/presence of IFN-y at 250 U/ml as shown by TNF-a production. Data 
are the mean of three experiments ± SEM. ***, P<0.001, Student I test. 
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Figure 4.4. TNF-a released by IFN-y induced THP-1 cells stimulated with 0.1 
µg/ml of C. trachomatis LPS serovars E or LGV (A), lipid A, or synthetic Kdo (B). 
50 µg/ml of E. coli LPS was used as a positive control. As the result of LPS from 
C. trachomatis E and LGV was essentially the same, only the LGV LPS data are 
shown as an example. Results of TNF-a levels were expressed as the mean and the f 
SEM of six experiments. ACM, anti-CD14 antibody, AHM, anti-HLR-DR antibody, 
NS, not significant. ", LPS from E. coli 055: B5, NS, ***, P<0.001, Student t test. 
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4.4.4 Interaction between 
spermatozoa 
CI . trachomatis LPS and mouse 
Immediately after 3 min centrifugation at 400g, the sperm preparations in M2 
medium showed a sperm mortality of 19.8 ± 5.5 %. Over the 6h incubation period, 
this value was 23.8 ± 8% (Figure 4.5). Interestingly, spermatozoa that were 
incubated for 6h with 0. I µg/ml LPS from either C'. trachomatis, E or LGV, or with 
50 µg/ml LPS from F.. coli showed a non significant rise in the percentage of dead 
spermatozoa (22.7 ± 9%, 24.9 ± 8.4%, and 23.2 ± 6% respectively, p>0.05). 
Examples of viable and non-viable mouse spermatozoa are shown in Figure 4.6. 
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Figure 4.5. Percentage of dead spermatozoa over 6h incubation with C. trachomaü., 
LPS from either serovar, E or LGV, using fluorescence microscopy. Data shown are 
the mean of 6 experiments t SEM. ", LPS from E. coli 055: B5. 
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Figure 4.6. Fluorescent micrographs using the Viability/Cytotoxicity method from 
four viable (green) and five non-viable (red) mouse spermatozoa incubated for 6h 
with LPS from Ctrachomatis and E. coli. Photographs show only the head of 
spermatozoa. 
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4.5 Discussion 
We demonstrated in chapter 3 that treatment of human spermatozoa with the 
Kdo portion of LPS at 50 µg/ml significantly compromised the sperm viability. We 
also showed that while anti-CD 14 antibody and PMB inhibited the toxic effect of 
LPS or lipid A on human spermatozoa, Kdo could maintain its spermicidal properties 
even in the presence of anti-CD14 antibody and PMB. This observation encouraged 
us to investigate further whether Kdo like other PAMPs is able to initiate a signalling 
pathway via TLRs with involvement of TNF-a secretion. The two well-known cell 
lines, HeLa and THP-1, and different TLR agonists including C. trachomatis and 
E. coli LPS, Ecoli lipid A, peptidoglycan and Kdo were used to attempt to answer 
this question. 
Our results clearly demonstrated that the synthetic monosaccharide Kdo used 
in this study failed to produce a signal via either TLR2 or TLR4 or to release TNF-a 
in the IFN-y-induced THP-1 cells stimulated by Kdo. These observations were in 
agreement with the previous studies described below. 
Lebbar et al., (1986) reported that the Kdo alone (monosccharide) is not 
sufficient to induce IL-1 secretion from human monocytes whereas synthetic 
disaccharide containing 3-deoxyoctulosonic acid can trigger IL-1 secretion like the 
native endotoxin. In another study by Tanamoto and Azumi, (2000) it was shown 
that the polysaccharide portion of the Salmonella LPS by itself is unable to exhibit 
TNF-a induction activity in human-derived cells. Although it is widely accepted that 
the lipid A is responsible for the biological activity of LPS, they also found that the 
activity of lipid A from various Salmonella as assessed by TNF-a induction and NF- 
xB activation in THP-1 and U937 human-derived cells, is very low compared with 
E. coli lipid A, although Salmonella LPS preparation is highly active. Later, Muroi 
and Tanamoto, (2002) suggested that Salmonella LPS requires at least a disaccharide 
structure (2-keto-3-deoxyoctonic acid) covalently bound to lipid A for its activity. 
As we mentioned in chapter 3, because of the small amounts of 
C. trachomatis LPS extracted, only commercial lipid A and Kdo were used. Further 
studies using isolated lipid A and Kdo from C. trachomatis LPS are required to 
generalise our findings to the portions of C. trachomatis LPS. This additional 
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information may be beneficial for the understanding and expanding of our 
knowledge regarding interaction of C. trachomatis LPS and spermatozoa. In the next 
chapter we will describe the mechanism of Kdo-induced spermatozoa death in more 
detail. 
In this work we also showed C. trachomatis E LPS and LGV1 LPS signalled 
through both TLR2 and TLR4, although MD-2 transfected HeLa cells did not 
respond to LGV LPS when the concentration was decreased to 0.01 µg/ml. To date, 
there are a few reports on the interaction between C. trachomatis LPS and TLR2 and 
TLR4. Heine et al., (2003) and Prebeck et al., (2003) reported that C. trachomatis 
serovars E and LGV2 respectively, only signal via TLR4. In contrast, Erridge et al., 
(2004) suggested that C trachomatis serovar LGV 1 signals via TLR2 not TLR4. 
These controversial findings might be explained by methodological 
differences of LPS extraction or of the cells transfection. For example, for extraction 
of LPS from C. trachomatis serovars E and LGV2, Prebeck et al., (2001) and Heine 
et al., (2003) used 45% phenol containing 2% N-lauroylsarcosine sodium salt and 
for transfection they used HEK 293 cells, however, we used 90% aqueous phenol 
followed by ether and chloroform for LPS extraction and HeLa cells for transfection. 
Also, in their study, Erridge and co-workers used different batches of extracted 
C. trachomatis LPS. 
In spite of the C. trachomatis LPS results, our findings showed that lipid A 
from E. coli similar to Ecoli LPS used as a control, was able to produce a signal only 
via MD-2 transfected cells, indicating that lipid A was recognised by TLR4 and not 
by TLR2. The exact structural features of LPS, especially its main portion, lipid A, 
probably define whether they are recognised by TLR2 or TLR4. For example, there 
are differences in the number and the length of lipid A acyl chain from C. trachomatis 
and E. coli. The chemical structure ofE. coli lipid A consists of six acyl chains of 12- 
16 carbons in length whereas, C. trachomatis LPS has only five chains of 14-21 
carbons. Furthermore, the shape of lipid A might also determine the interaction of 
LPS with the TLRs (Netea et al., 2002). They proposed that lipid A with a conical 
shape (e. g., from E. coli) induces cytokine production via TLR4 however, cylindrical 
lipid A (e. g., from Porphyromonas gingivalis) induces expression of cytokines 
through TLR2. 
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Similar to Kdo, we were not able to investigate the interaction of transfected 
HeLa cells with C. trachomatic lipid A therefore, further investigation regarding the 
responses of these cells to the isolated lipid A from C. trachomatis LPS is warranted. 
As is described earlier although, TLR2 are mainly involved in recognition of 
variety of PAMPS, including lipoproteins and peptidoglycan rather than interacting 
with LPS. Apart from the separate roles of TLR2 and TLR4 in recognition of 
PAMPS, they both are important in the inflammatory response to Gram-negative 
bacterial infection because both endotoxin proteins and LPS are present in whole 
bacteria. These findings may be useful in the development of alternative therapies 
aimed at reducing excessive inflammatory responses during infections involving the 
TLR pathway. 
A lipopolysaccharide present in the bacterial cell wall is considered to be 
responsible for the activation of humoral and cellular immune mechanism, resulting 
in increased production of cytokines including IFN-y, TNF-a, IL-1 and IL-8. IFN-y 
can cause profound changes in monocytic cells, including cellular morphology, 
expression of cell surface antigen and antimicrobial capacities (Murray and Cartelli, 
1983; Virelizier et al., 1984). Cytokines migrate to the site of infection and are also 
found in significant concentrations in plasma including the semen of infertile men. 
Depending on the rate of cytokine production, their activities range from an anti- 
inflammatory to a pro-inflammatory propensity (Ma, 2001). 
Estrada et al., (1997) demonstrated that the sperm parameters decrease as a 
result of a combination of TNF-a and IFN-y in-vitro. They incubated washed 
spermatozoa from normal volunteers with TNF-a and IFN-y for 0,30,60 and 180 
min. The data showed a time-dependent negative effect of TNF-a and IFN-y on 
sperm parameters including motility and viability. 
Sikka et al., (2001) also reported that when spermatozoa are exposed to LPS 
and IFN-'y in combination, sperm motility, viability and integrity are compromised 
which shows the synergistic effect of LPS and IFNi' against spermatozoa. The 
results of their investigation showed that after lh of incubation with a combination of 
LPS plus IFN-y, human sperm motility, viability and membrane integrity were 
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significantly reduced by 20-25%. However, LPS and IFN-y individually did not alter 
sperm viability or motility. 
Another reason for this synergism was explained by Raponi et al., (1997). In 
their study they observed a TNF-a release from the THP-1 cell line only when these 
cells were pre-incubated with IFN-y. These findings support our results when we 
compared the levels of TNF-a secretion in the supernatant of the TIP-1 cell line 
with and without pre-incubation with IFN-y. 
THP-1 is an undifferentiated cell line which reacts to chemical and 
immunological inducers by enhancing the expression of several receptors. In THP-1 
cells, IFN-y can enhance the expression of the HLA-DR receptor and allow the 
production of cytokines including TNF-a (Vey et al., 1992). Furthermore, CD 14 
receptor acts as co-receptor and triggers cytokine secretion via a putative signal 
transducer-associated cell surface structure (Tobias et al., 1993). In our results, a lack 
of significant reduction in TNF-a release in the presence of separate anti-HLA-DR 
and anti-CD14 antibody, and a marked decline in the production of TNF-a using 
combined anti-HLA-DR and anti-CD14 antibodies showed a synergy between these 
two receptors. This finding was consistent with the previous report by Raponi et al., 
(1997). They suggested that HLA-DR receptor together with CD14 receptor trigger 
TNF-a release by IFN-y-induced THP-1 cells. 
Adherence to host cells is an important prerequisite for the pathogenesis of 
many bacteria. Bacterial cell components including LPS and LOS have been shown 
to be involved in adherence and invasion of host cells (Jacques and Paradis, 1998). 
Our studies showed that C. trachomatis LPS and synthetic Kdo have a toxic effect on 
human spermatozoa. Also recent studies have revealed that mammalian TLRs are 
important molecules for recognising pathogen-associated microbial patterns 
(PAMPs) including LPS and the other bacterial cell wall components (Kopp and 
Medzhitov, 1999). 
Harvey et al., (2000) demonstrated the presence of the asialoglycoprotein 
receptor (ASGP-R) on human sperm in the head, neck and tail regions under 
immunofluorescence confocal microscopy using the red nucleic acid stain ethidium 
bromide and fluorescein isothiocyanate (FITC)-conjugated antirecombinant ASGP-R 
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monoclonal antibody. They also suggested that this receptor on human sperm serves 
as a binding and attachment site for gonococcal lipooligosaccharide. 
All these previous findings together led us to the objective of the current 
study, which was to determine how sperm respond initially to LPS, lipid A or Kdo 
and to investigate the possible presence of TLRs on human spermatozoa. To shed a 
light on this latter study we treated mouse spermatozoa with LPS. The rationale 
behind this experiment was to establish whether LPS has a deleterious effect on 
mouse spermatozoa similar to human spermatozoa. This experiment would then be 
continued with the TLR-knock-out mouse spermatozoa to assess whether they 
responded to LPS. Since LPS failed to kill wild-type mouse spermatozoa, continuing 
this study with the TLR knock-out mouse spermatozoa unfortunately would be 
pointless. 
Weil et al., (1998) also reported that treatment of mouse sperm with 
staurosporine (STS) and cycloheximide (CHX) or a peptide caspase inhibitor does 
not accelerate or delay cell death. As STS and CHX are apoptotic reagents via 
interaction with protein synthesis and mouse sperm did not respond to these reagents, 
they suggested that possibly caspases are absent in the mouse sperm and these cells 
have a death programme that may not depend on caspases. Although their 
suggestion could not exclude the possible existence of TLRs on mouse sperm, since 
both receptors and apoptosis enzymes, TLRs and caspases, are involved in the death 
pathway via apoptosis, lacking in any of these two receptors would conflict with 
apoptosis which will be described in detail in the next chapter. 
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Chapter 5 
Reactive oxygen species (ROS) production and apoptosis in 
spermatozoa stimulated with LPS, Kdo, or lipid A 
5.1 Introduction 
The influence of ROS on human spermatozoa was first reported by McLeod, 
(1943). He observed that human spermatozoa rapidly lose their motility when 
incubated under high oxygen tension. Much attention has also been dedicated in 
recent years to the involvement of ROS in apoptosis of spermatozoa (Potts et al., 
2000; Agarwal and Saleh, 2002; Agarwal et al., 2003; Wang et al., 2003; Moustafa 
et al., 2004). 
Various ROS are generated in the body at stages where oxygen is utilised. 
ROS including superoxide anion, hydroxyl radical, hydrogen peroxide and oxygen 
ion, are unstable and fully reactive to attack molecules in the body resulting in ROS 
conversion to stable atoms and molecules (Ichikawa et al., 1999). ROS plays an 
important role in the pathogenesis of many reproductive processes. ROS-induced 
DNA damage may accelerate the process of germ cell apoptosis, leading to the 
decline in sperm counts associated with male infertility (Agarwal et al., 2003). Irvine 
et al., (2000) reported that there was a strong association between the presence of 
nuclear DNA damage in mature spermatozoa and poor semen parameters particularly 
sperm concentration. 
Oxygen has a paradoxical role in cells living under aerobic conditions. 
Oxygen is required to support life and a small amount of its metabolites such as 
ROS are necessary for spermatozoa to acquire fertilizing capabilities including 
capacitation and the acrosome reaction (Aitken et al., 1989). These investigators 
suggested that low levels of ROS can enhance the ability of human spermatozoa to 
bind to the zona pellucida. de Lamirande and Gagnon (1993) found that incubating 
spermatozoa with low concentrations of hydrogen peroxide (H202) stimulates sperm 
capacitation, hyperactivation, the acrosome reaction, and sperm-oocyte fusion. Zini 
et al., (1995) also demonstrated that nitric oxide and superoxide anion (O2) promote 
sperm capacitation and the acrosome reaction. 
However, overproduction of ROS can interfere with sperm functions and 
threaten the survival of spermatozoa (de Lamirande and Gagnon, 1995; Aitken, 
1999). The increased formation of ROS has been correlated with a reduction of 
sperm motility (Armstrong et al., 1999). Gomez et al., (1998) reported that levels of 
ROS production by pure sperm populations are negatively correlated with the quality 
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of sperm in the original semen. Ichikawa et al., (1999) showed that there is a reverse 
correlation between seminal ROS levels and the acrosome reaction (AR). They 
demonstrated that many patients with low ROS levels show increased rates of the 
AR. The excessive levels of ROS can also cause a reduction of sperm-oocyte fusion 
(Henkel et al., 1997). Aitken et al., (1990) suggested that high levels of ROS 
production in human ejaculates may originate from morphologically abnormal 
spermatozoa and/or seminal leukocytes. 
Oxidative stress (OS) occurs as a consequence of excessive production of 
ROS and impaired antioxidant defense mechanisms (Sikka, 2001). It is suggested 
that OS precipitates the range of pathologies that currently are thought to afflict 
reproductive function (Sharma and Agarwal, 1996). In male-factor infertility, OS 
impairs the fluidity of the sperm plasma membrane and also the integrity of DNA in 
the sperm nucleus (Aitken, 1999). Spermatozoa are particularly susceptible to OS- 
induced damage because their plasma membranes contain large quantities of 
polyunsaturated fatty acids (PUFA) (Alvarez and Storey, 1995) and their cytoplasm 
contains low concentrations of scavenging enzymes like catalase and superoxide 
dismutase (de Lamirande and Gagnon, 1995). PUFA, fatty acids that contain more 
than two carbon-carbon double bonds and also methylene groups, are particularly 
susceptible to peroxidation (Halliwell, 1990). OS also attacks the other cellular 
components including proteins, nucleic acids, and sugars (Agarwal et al., 2003). 
ROS must be continuously inactivated by a defence mechanism to keep only 
a small amount necessary to maintain normal cell function. Seminal plasma has 
antioxidant defense mechanisms to protect spermatozoa against oxidants (Sikka, 
1996; Armstrong et al., 1998). It has been reported that levels of antioxidants in 
seminal plasma from infertile men are significantly lower than those in plasma from 
controls (Lewis et al., 1995). 
ROS have a tendency toward chain reaction production; that is, a compound 
carrying an unpaired electron will react with another compound to generate an 
unpaired electron therefore, the defence mechanisms are based on breaking this chain 
reaction by the formation of nonradical end products (Sies, 1993). 
a-tocopherol (vitamin E) is a chain-breaking antioxidant that inhibits lipid 
peroxidation (LPO) in membranes by scavenging peroxyl (RO) and alkoxyl (ROO) 
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radicals (Wefers and Sies, 1988). Another antioxidant defense mechanism is the 
prevention of excessive ROS formation. An example is the binding of metal ions, 
iron, and copper ions in particular, which prevents them from initiating a chain 
reaction (Sies, 1993). In spite of these defence mechanisms, spermatozoa are still 
susceptible to oxidative insult because they are unable to repair the damage caused 
by excessive ROS due to lacking the cytoplasmic enzyme systems that are required 
to do this repair (Aitken et al., 1989). 
There are two sources of ROS within the human ejaculate, spermatozoa and 
infiltrating leukocytes (Kessopoulou et al., 1992). Leukocytes are present throughout 
the male reproductive tract and are found in almost every human ejaculate 
(Tomlinson et al., 1992). They may be activated in response to a variety of stimuli 
including inflammation and infection (Pasqualotto et al., 2000). Leukocytes, 
especially polymorphonuclears (PMNs), are the major source of ROS such as super 
oxygen anion and hydrogen peroxide (Wang et al., 1997) in semen. Activated 
leukocytes can produce 100-fold higher amounts of ROS than nonactivated 
leukocytes (Plante et al., 1994). Sperm damage from ROS that is produced by 
leukocytes occurs if seminal leukocytes concentrations are abnormally high, such as 
in leukocytospermia [> 1x 106 leukocytes/ml of semen] (Shekarriz et al., 1995). At 
this concentration, LPS, IFN-7 , and TNF-a 
induce a significant ROS production by 
PMNs (Wang et al., 1997). 
Spermatozoa are enriched with mitochondria. The mitochondria in the sperm 
midpiece are the energy generators for mammalian sperm (Kao et al., 2004). The 
integrity of mitochondria is established by the presence of cytochrome c in the inner 
membrane space (Wang et al., 2003). These investigators using western blot analysis 
for cytochrome c, showed that high cytochrome c levels in seminal plasma associate 
with significant mitochondrial damage caused by high ROS in infertile men. They 
also suggested that release of a series of such proteins from the mitochondrial inner 
space is likely to accelerate the process of apoptosis, possibly leading to DNA 
damage. 
Apoptosis, is a distinctive form of cell death characterized by a series of 
morphological and biochemical changes including regular DNA fragmentation 
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(Wyllie, 1980), mitochondrial membrane potential changes (Kroemer et al., 1998) 
and caspase activation (Cohen, 1997) that result in efficient elimination of cells from 
tissues without eliciting an inflammatory response (Wyllie, 1980) (see more details in 
chapter 1). Recently, Print and Loveland, (2000) and Kierszenbaum, (2001) reported 
that germinal cell apoptosis is an underlying mechanism for normal spermatogenesis. 
Spermatogenesis refers to a dynamic process including the mitotic divisions of 
spermatogonia, meiotic divisions of spermatocytes, the morphological differentiation 
and maturation of spermatids, and finally the formation of sperm (Print and 
Loveland, 2000). Men with azoospermia or severe oligozoospermia have an 
increased frequency of apoptotic germ cells in their testicular tissues in comparison 
with those with normal spermatogenesis (Hikim et al., 1998). 
Caspases are cysteine proteases that promote apoptosis in mammals. 
Following activation of caspases, biochemical events occur that lead to DNA 
degradation and the characteristic morphological changes associated with apoptosis 
(Salvesen and Dixit, 1997). 
It is acknowledged that a central component of apoptotic machinery involves 
members of a family of caspases. In mammals, approximately 14 caspases have been 
identified so far (Thornberry and Lazebnik, 1998; Said et al., 2004). In healthy cells, 
caspases are expressed as inactive proenzymes (-30 kDa) that contain three domains: 
an NH2-terminal domain, a large subunit (-20 kDa) and a small subunit (-10 kDa). 
These enzymes participate in a cascade in response to pro-apoptotic signals and 
culminate in proteolysis of proteins essential for cell homeostasis, ultimately 
resulting in death of the cell. Caspase-3 is the main executor within this apoptotic 
cascade (Weng et al., 2002). 
The role of caspases is not limited to apoptosis. For example, caspases-1 and - 
11 are predominantly involved in the process of inflammatory responses, and 
caspase-4, -5, -12, -13, and -14, which are homologous to caspase-1 in amino acid 
sequences, may function as cytokine processors (Wolf and Green, 1999). 
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5.2 Aims 
In chapters 3 and 4, the role of LPS and its active fractions, Kdo and lipid A, 
in spermatozoa death were investigated. We showed that these components could 
compromise sperm viability. Of interest is our finding that the polysaccharide 
domain of LPS, Kdo, had a spermicidal activity not affected by two LPS inhibitors, 
anti-CD14 antibody and polymyxin B. The role of LPS, lipid A, and Kdo in 
signalling pathways via TLRs and in TNF-a production were also investigated. We 
demonstrated that although LPS and lipid A were able to stimulate TLRs in 
transfected HeLa cells and also to activate the IFN-y- stimulated THP-1 cells to 
secrete TNF-a, Kdo was not able to do this. Since it is well established that TNF-a as 
a product of the TLR signalling pathway, induces ROS production and ROS in turn 
to induce apoptosis, the objectives of this chapter were firstly, to determine if pre- 
treatment with antioxidants (ROS scavengers) can reduce sperm mortality induced 
by LPS and its fractions, and secondly, to clarify the role of LPS and its fractions in 
sperm apoptosis. 
5.3 Materials and methods 
5.3.1 Effect of ROS scavengers on spermatozoa treated with LPS, 
Kdo, and lipid A 
5.3.1.1 Identification and quantification of leukocytes in sperm preparation 
As was described in chapter 2, the two-layer (40/80%) percoll gradient was 
used in all experiments for sperm preparation. There are two potential sources of 
ROS in semen, spermatozoa and leukocytes (macrophages and neutrophils) 
(Kessopoulou et al., 1992; Wang et al., 1997). Since the presence of macrophages 
and neutrophils might interfere with our results, leukocyte contamination in sperm 
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preparation was assessed by two independent methods, immunocytochemistry and a 
cytocentrifuge preparation technique. 
5.3.1.1.1 Immunocytochemistry method (WHO, 2000) 
5.3.1.1.1.1 Reagents 
1. Dulbecco's phosphate buffered saline with the following constituents: 
CaC12.2H20 0.132 g/1 
KCl 0.2 g/1 
KH2PO4 0.2 g71 
MgC12.6H20 0.1 g/1 
NaC1 8.0 g/1 
Na2HPO4 1.159/1 
2. Tris buffered saline 10 x with the following constituents: 
Trizma base 60.55 g/l 
NaCl 85.20 g/l 
(pH was adjusted to 8.6 with 1M HC1) 
3. Alkaline phosphatase substrate with the following constituents: 
Naphthol AS-MX phosphate 2 mg 
Dimethylformamide 0.2 ml 
0.1 M Tris buffer. pH 8.2 9.7 ml 
(1.21 g of Trizma base dissolved in water. pH was adjust ed to 8.2 with 1M 
HCI. Made up to 100 ml with water) 
1M Levamisole 0.1 ml 
Fast red TR salt (was added just before use) 10 mg 
(All above-mentioned reagents were purchased from Sigma, UK) 
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4. Primary antibody. A mouse monoclonal antibody was obtained against 
the common leukocyte antigen, encoded CD45 (Dako, Glostrup, Denmark). 
We used this antibody because all classes of human leukocytes express a 
specific antigen (CD45) that can be detected by this monoclonal antibody 
(WHO, 2000). 
5. Secondary antibody (Antimouse immunoglobulins raised in a rabbit) 
(Dako, Denmark). 
6. Alkaline phosphatase anti-alkaline phosphatase complex (APAAP) (Dako, 
Denmark). 
5.3.1.1.1.2 Preparation of sperm smear and monoclonal antibody staining 
0.5 ml of spermatozoa that had been through a percoll gradient was mixed 
with five volumes of PBS and centrifuged at 500g for 5 min at RT. This procedure 
was repeated twice and the cell pellet resuspended in PBS to the original volume of 
the sperm sample. The suspension was then diluted with three times its volume of 
PBS. 
Two 5 µl aliquots of this cell suspension containing 5x 106 spermatozoa/ml 
were then air-dried onto a clean glass slide. The air-dried cells were fixed in absolute 
acetone for 10 min followed by washing twice with Tris buffered saline (TBS), and 
allowed to drain. The fixed cells were covered with 10 µl of primary monoclonal 
antibody and incubated in a humidified chamber for 30 min at RT. The cells were 
then washed twice with TBS and allowed to drain. 
The cells were covered with 10 µl of secondary antibody, incubated for 30 
min in a humidified chamber at RT, washed twice with TBS and drained. 10 µl of 
APAAP was added to each specimen and incubated for Ih in a humidified chamber 
at RT before being washed twice in TBS and drained. In order to intensify the 
reaction product, staining with the secondary antibody and APAAP was repeated, 
with a 15 min incubation period for each reagent. 
The cells were washed twice with TBS, drained, and incubated with 10 µl of 
alkaline phosphatase substrate for 18 min for inhibition of endogenous alkaline 
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phosphatase activity. After alkaline phosphatase colour development, the cells were 
washed with TBS and finally counterstained for a few seconds with 750 µl of 
haematoxylin (DAKO, Denmark) before being washed in tap water and mounted in 
an aqueous mounting medium. The slides were then checked for positive red-stained 
cells at x 400 magnification under a light microscope. 
Positive and negative control slides were also prepared from human 
peripheral leukocytes that were isolated from whole heparinised blood as described 
by Jack et al., (2001). Briefly, fresh whole blood (15 ml) from healthy laboratory 
volunteers was placed in 50 U of heparin. Dextran (6% wt/vol) in saline was mixed 
1: 10 with the whole blood, and the entire mixture was left to stand at RT for lh to 
allow the majority of erythrocytes to separate to the bottom of the tube (Hogg et al., 
1999). The upper plasma layer containing the leukocytes was gently removed by 
aspiration and centrifuged at 200g for 10 min. the cell pellet was washed with 20 ml 
of Hanks' balanced salt solution (HBSS) (GIBCO, UK) without Ca2+ and Mg2+ and 
centrifuged as before. The cell pellet was then resuspended in 1 ml of HBSS with 
Ca2+ and Mgt'plus 0.2% (wt/vol) BSA. 
For the negative control, the primary antibodies were omitted from the 
staining regimen. 
5.3.1.1.2 Cytocentrifuge preparation technique 
This procedure is commonly performed on clinical fluids to detect very small 
numbers of cells, which may be present in the specimens. It is also used to 
concentrate harvested mononuclear cells onto a small area of a slide prior to 
cytoplasmic antigen staining (Oertel et al., 1998). 
A labelled glass slide and a disposable carrier were inserted into the 
cytocentrifuge holder and clipped together. The holders were placed in the centrifuge 
in the appropriate position, ensuring that they were balanced. 0.5 ml of heparinised 
blood as a positive control and 0.5 ml of spermatozoa prepared through a percoll 
gradient were mixed with the same volume of foetal calf serum separately. Four 
drops of blood and sperm suspension were pipetted into the funnel of each carrier. 
The plastic lid over the centrifuge bowl was replaced prior to closing the centrifuge 
lid and centrifuging at 90 xg for 12 min. The slides were then removed from the 
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holders and using a diamond marker a ring of about 2 cm diam was drawn around the 
cell pellet. The slides were allowed to air-dry for a few min and were then stained 
using a modified Wright-Giemsa stain and a staining machine (ADVIA S60, Bayer 
HealthCare LLC Diagnostic Division, Tarrytown, USA). 
When the slides are stained using Wright-Giemsa stain, the white blood 
nuclus and cytoplasm take on the characteristic blue or pink coloration. The 
combination of purified eosin and thiazine dyes in the product eliminates inconsistent 
staining and yields reproducible chromogenic responses. 
5.3.1.2 Treatment of spermatozoa with LPS, Kdo, or lipid A with and without 
ROS scavengers 
30 x 180 µl aliquots of sperm preparation were prepared as described in 
chapter 2. The aliquots were incubated with 20 µl of C. trachomatis LPS, Kdo, lipid 
A, and five different ROS scavengers [ascorbic acid, catalase, reduced glutathione, 
superoxide dismutase (SOD), and a-tocopherol as described previously by Urata et 
al., 2001] with the details described in Table 5.1. All aliquots were incubated for 6h 
at 37°C in 5% CO2. The viability of spermatozoa in each aliquot was then determined 
using the HOS test as described in chapter 2. 
5.3.2 Evaluation of the apoptotic effect of LPS, Kdo, and lipid A on 
spermatozoa 
5x 106 /ml sperm were incubated with 0.1 pg/ml of E and LGV LPS, 50 
µg/ml of lipid A and 50 µg/ml of Kdo at 37C in 5% CO2 for 6h. 1 mm of 
staurosporine (Sigma, UK) and untreated percoll prepared sperm were used as 
apoptotic and negative controls respectively. In the other groups, prior to adding 
these reagents, the cells were incubated with 200 µM of pan-caspase inhibitor (Z- 
VAD-FMK) (Calbiochem, Darmstadt, Germany) and caspase-3 inhibitor I 
(Calbiochem, Germany) for lh at 37"C in 5% CO2. One aliquot of spermatozoa was 
incubated in a 56°C heated water bath for 6h as a necrosis control. 
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Content(s) Number of aliquot(s) Final concentration 
Ascorbic acid (control) 1 1 mm 
Catalase (control) 1 1 U/ml 
Reduced glutathione (control) 1 100 nM 
SOD (control) 1 100 U/ml 
a-tocopherol (control) 1 10 mM 
EBSS (negative control) 1 - 
E or LGV LPS 2 0.1 pg/ml 
Lipid A or Kdo 2 50 pg/ml 
E LPS + each ROS scavenger 5 0.1 pg/ml +* 
LGV LPS + each ROS scavenger 5 0.1 pg/nil +* 
Lipid A+ each ROS scavenger 5 50 pg/ml +* 
Kdo + each ROS scavenger 5 50 pg/ml +* 
Table 5.1. Experiment design for the exposure of human spermatozoa to 
C. trachomatis LPS from serovars E and LGV, lipid A, and Kdo with and without 
ROS scavengers. *, ROS scavenger concentration of above. 
5.3.2.1 Measurement of apoptosis by the Annexin V/PI binding assay 
To prepare the sperm samples for flow cytometry, the cells were then 
washed twice with PBS and then resuspended in 1x annexin binding buffer 
(Pharmingen, UK) at a final concentration of 1x 106 sperm/ml as described by 
Oosterhuis et al., (2000). 100 µl of the solution (1 x 105 cells) was then transferred to 
a 12 x 75 mm polystyrene test tube (Elkay, Basingstoke, UK) followed by adding 5µl 
of annexin V-FITC (Pharmingen, UK) and 50 pg/ml propidium iodide (PI) (Sigma, 
UK). The cells were then mixed by vortexing gently and incubated for 15 min at RT 
in the dark. 400 µl of 1x annexin binding buffer was added to each tube and the cells 
were then analysed by flow cytometry within Ih. A minimum of 10,000 spermatozoa 
were examined for each test. The sperm population was gated by using forward- 
angle light scatter. The FITC-labelled annexin V positive sperm cells were measured 
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in the FL1 channel and the PI labelled cells were measured in the FL2 channel of the 
flow cytometer. 
5.3.2.2 Quantitation of caspase-3 activity in spermatozoa treated with LPS, 
Kdo, or lipid A 
Sperm lysates were prepared as described by Weng et al., (2002). Briefly, 
1x 107 sperm (after 6h incubation with 0.1 pg/ml of E or LGV LPS or 50 µg/ml of 
lipid A or Kdo) were centrifuged to form a pellet. The pellet was then placed on dry 
ice (5-10 min) prior to lysing in 400 µl of 10 mM Tris buffer with 0.5% Triton X-100 
(Sigma, UK), pH 7.5, containing general protease inhibitors; 2 mM 
phenylmethylsulfonyl fluoride (Sigma, UK), lOµg/ml leupeptin (Sigma, UK), 
10µg/ml pepstatin (Sigma, UK), 10 mM dithiothreitol (Sigma, UK) for 15 min at 4 C. 
The lysates were vortexed and sonicated twice for 15 sec at amplitude of 12 microns 
interspersed by 1 min intervals before centrifugation at 12000 xg for 20 min at 4C 
to remove particular matter. The supernatant was then removed and protein 
quantification was performed using the Bradford method (Bradford, 1976) as 
follows: 
5.3.2.2.1 Bradford method 
5.3.2.2.1.1 Reagents 
Coomassie Brilliant Blue G-250 (Sigma, UK) was used in the preparation of 
the Bradford reagent as follows: 
Coomassie blue 100 mg 
95% (v/v) ethanol 50 ml 
85% (v/v) orthophosphoric acid (Sigma, UK) 100 ml 
The final volume was adjusted to 1L GDW, and the solution stored at 4°C. 
For the Bradford method a series of standard dilutions ranging from 3 µg/ml 
to 800 pg/ml were prepared from a freshly prepared stock solution of bovine serum 
albumin (BSA) in PBS. Subsequently 100 pl of each standard, test samples and PBS 
as a blank were placed into separate plastic cuvettes to which 1.2 ml of Bradford 
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reagent was added. After allowing between 5 min to 60 min for colour development, 
the OD of each sample was read at 595 nm and the protein concentration of the test 
samples determined directly from a standard curve. 
5.3.2.2.2 Measurement of fluorescent emission 
Aliquots of sperm lysate (100 µg, according to the Bradford method) were 
then diluted with 1 ml of buffer containing; 50 mM HEPES, 10% sucrose, 0.1% 
Chaps, {(3-[(3-chloamidopropyl) dimethylammoniol]-1-propanesulfonate), pH 7.5, 
and 50 pM of caspase-3 substrate, Ac-DEVD-AFC [(Asp-Glu-Val-Asp (DEVD) 
conjugated with 7-amino-4-trifluoromethylcoumarin (AFC)], (Bachem, Merseyside, 
UK) and incubated for 45 min at 37 C. The fluorescent emission (excitation 400 nm 
and emission 505 nm) was measured using a fluorimeter (Perkin Elmer, 
Beaconsfield, UK). Prior to performing the main experiments, the fluorimeter 
machine was tested at least three times using the AFC standard. AFC is a fluorescent 
molecule which is released from the substrate and can be used for standardisation 
and measurement of caspase-3 activity. Caspase-3 activity in the samples is 
proportional to the amount of free AFC produced. When AFC is attached to the 
substrate, it produces a blue fluorescence upon exposure to UV light (400 nm). 
Caspase-3 cleaves the AFC-substrate and releases free AFC, which produces a 
yellow-green fluorescence at 505 nm when exposed to UV light. Dimethyl sulfoxide 
(DMSO) that is a solvent for Ac-DEVD-AFC and AFC, was also tested by the 
fluorimeter as a zero control. 
Background fluorescence was determined using blanks without sperm. 
Standards containing 1-5 pM AFC were utilised to determine the amount of 
fluorochrome released, and apoptotic human neutrophils treated with 1 mmol/l 
cycloheximide were used as a positive control. Neutrophils were isolated from whole 
blood as follows: 
5.3.2.2.3 Isolation of neutrophils by density centrifugation using dextran 
Heparinised (-1 unit/ml) venous blood was obtained from healthy adult 
volunteers. Neutrophils were purified by sedimentation through a Ficoll-Paque 
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gradient, dextran sedimentation, and hypotonic lysis as described previously (Frenck 
et al., 1989) with a few modifications. Firstly, 25 ml of heparinised whole blood 
were layered over 12.5 ml of Ficoll-Paque (Amersham Biosciences, Bucks, UK) 
followed by centrifuging at 400 xg for 35 min. The top layer containing plasma, 
monocytes, and Ficoll-Paque was discarded. To separate erythrocytes from 
granulocytes, PBS 1x at the same volume of the bottom layer and 6% dextran at ' 
of total volume (for example, 25 ml of bottom layer + 25 ml of PBS 1x+ 12.5 ml of 
6% dextran) were then added and gently mixed once by pipetting. 
The suspension was then incubated at RT for about lh to allow the 
granulocytes to settle above the precipitation of erythrocytes. The supernatant was 
transferred into a separate tube followed by centrifuging at 115 xg for 8 min. The 
top layer was discarded and to the pellet 9 ml of GDW gently added and mixed prior 
to adding 1 ml of PBS 10 x. The suspension was then centrifuged as previously. The 
supernatant was discarded and the pellet was washed with normal PBS and re- 
centrifuged as before. The final pellet was re-suspended in 1 ml of HBSS without 
Ca2+ and Mgt. To confirm the successful separation of neutrophils, 2 slides from the 
suspension were prepared and stained as described earlier. 
5.4 Results 
5.4.1 Challenge of LPS-, Kdo-, lipid A-induced spermatozoa with 
ROS scavengers and measurement of sperm viability 
The microscopic assessment of prepared slides from sperm preparations, 
using immunocytochemistry and a cytocentrifuge preparation technique showed that 
the spermatozoa used for the recent study were free of leukocyte contamination at the 
minimum detection level. This equates to 143 leukocytes per 1x 107 spermatozoa 
in the 80% percoll fraction for the immunocytochemistry technique or 41000 
leukocytes/ml for the cytocentrifuge preparation technique. However, in the control 
group, leukocytes were detectable as expected (Figure 5.1). 
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Figure 5.1. Two slides from whole blood prepared using the cytocentrifuge 
preparation technique. Three neutrophils (left) and one monocyte (right) are shown. 
Neutrophils have segmented nuclei, typically with 2 to 5 lobes connected together by 
thin strands of chromatin. Monocytes are the largest cell type seen in blood smears. 
Their nuclei are not multilobular like granulocytes, but may be deeply indented or U- 
shaped, with reticular-appearing chromatin. 
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Immediately after sperm preparation, spermatozoa had a sperm death of 8.9 ± 
1.5%. After 6h incubation, this value did not change significantly (p > 0.05, Student t 
test) in the control groups; spermatozoa alone (8.8 ± 1%) and also in the presence of 
ascorbic acid (9.0 ± 1.1%), catalase (8.8 ± 1.7%), reduced glutathione (8.7 ± 1.2%), 
superoxide dismutase (9.0 ± 1.4%), and a-tocopherol (8.5 f 2.2%). Also, no 
significant variation in the recovery of sperm viability was seen in the aliquots with 
added ROS scavengers alone, compared to the control group (Figure 5.2A-D). 
Similar to previous experiments, the rate of which spermatozoa became non- 
viable increased markedly when they were incubated with E LPS, LGV LPS, Kdo, or 
lipid A for 6h (Figure 5.2A-D). Interestingly, when these LPS preparations and their 
fractions were also pre-incubated with the ROS scavengers, spermatozoa mortality 
significantly declined (p < 0.001). These scavengers had no effect on the viability of 
spermatozoa in the absence of LPS, lipid A, or Kdo. 
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Figures 5.2A and B. Effects of ROS scavengers on spermatozoa when co-incubated 
with ('. trachomatis E LPS (A) or LGV LPV (B). LPSs added to spermatozoa already 
co-incubated with five ROS scavengers; ascorbic acid (AA), catalase (C), reduced 
glutathione (RG), superoxide dismutase (SOD), and a-tocopherol (T) for 6h. The 
mortality of spermatozoa was investigated using the HOS test. Data are mean of six 
experiments ± SEM. ***, p<0.001, Student t test. 
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Figures 5.2C and D. Effects of ROS scavengers on spermatozoa when co-incubated 
with commercial lipid A from E. coli (C) or synthetic Kdo (D). These two LPS 
fractions were added to spermatozoa already co-incubated with five ROS scavengers; 
ascorbic acid (AA), catalase (C), reduced glutathione (RG), superoxide dismutase 
(SOD), and a-tocopherol (T) for 6h. The mortality of spermatozoa was investigated 
using the HOS test. Data are mean of six experiments ± SEM. ***, p<0.001, 
Student t test. 
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5.4.2 Measuring apoptosis in human spermatozoa using FITC- 
Annexin V/PI staining 
LPS-treated spermatozoa investigated in this work excluded the PI which was 
used in the cell viability assay while heat-shocked spermatozoa (necrosis control) did 
not. In cells with a damaged cell membrane PI induces a red fluorescence of the 
DNA, however, it is excluded by cells with an intact membrane. Therefore during the 
initial phase of apoptosis the cells were still able to exclude PI and do not show any 
red fluorescence signal, similar to that of living cells. Figures 5.3a and 5.3b show a 
number of dot-plots of annexin-V and PI staining in which three distinctive cell 
populations are demonstrated. The lower left quadrant of the cytograms shows the 
viable spermatozoa, which exclude PI and are negative for FITC-annexin V binding. 
The upper right quadrant represents the non-viable, necrotic spermatozoa, positive 
for FITC-annexin V binding and showing PI uptake. The lower right quadrant 
represents the apoptotic spermatozoa, FITC-annexin V positive and PI negative, 
demonstrating annexin V binding and cytoplasmic membrane integrity. Figures 5. 
4A-D show the results of FITC-annexin V/PI flow cytometry of LPS-, lipid A-, and 
Kdo-treated spermatozoa. The details of the annexin V/PI assay can be summarised 
as follows: 
After 6h incubation, the percentage of apoptotic cells in the control group; 
spermatozoa alone, spermatozoa + pan-caspase inhibitor, spermatozoa + caspase-3 
inhibitor were 9.8 ± 0.53%, 8.42 f 0.55%, and 8.7 ± 0.8 respectively (Figures 5.4A- 
D). The percentage of apoptotic cells in the necrosis control group; heat-shocked 
spermatozoa alone, heat-shocked spermatozoa + pan-caspase inhibitor, and heat- 
shocked spermatozoa + caspase-3 inhibitor was 6.4 ± 0.6%, 6.2 ± 0.9%, and 6.5 ± 
2.2% respectively (Figures 5.4A-D). Spermatozoa incubated with staurosporine 
(apoptosis control), C. trachomatis LPS, lipid A or Kdo showed a significant 
apoptosis rate of 22.5 ± 1.48% - 37.2 ± 3.4% compared with the sperm only control 
(p < 0.001, Student t test). Pre-incubation of spermatozoa with pan-caspase inhibitor 
and caspase-3 inhibitor markedly reversed the percentage of apoptosis in aliquots 
which were treated by the above-mentioned apoptosis inducers (Figures 5.4A-D). 
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Figure 5.3a. Examples of a counter diagram of FITC-annexin V/Pl flow cytometry 
of spermatozoa after 6h incubation with C. trachomatis LPS, Kdo, and lipid A with 
and without the pan-caspase and caspase-3 inhibitors. Heat-shocked spermatozoa and 
staurosporine-induced spermatozoa were used as necrosis and apoptosis controls 
respectively. Three cell populations are distinctive in each diagram; the lower left 
quadrant contains viable, non-apoptotic cells (both annexin-V- and PI-negative), the 
lower right quadrant shows apoptotic cells [(annexin-V (+)/PI (-)], and the upper 
right quadrant represents non-viable, necrotic cells [(annexin-V (+)/PI (+)]. A, 
spermatozoa control; B, heat-shocked spermatozoa; C, staurosporine-induced 
spermatozoa; D, LGV LPS-induced spermatozoa. 
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Figure 5.3b. Examples of a counter diagram of FITC-annexin V/PI flow cytometry 
of spermatozoa. For details see legend to Figure 5.3a. E, lipid A-induced 
spermatozoa; F, Kdo-induced spermatozoa; G, staurosporine + pan-caspase inhibitor; 
H, staurosporine + caspase-3 inhibitor. 
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Figures 5.4A and B. Induction of apoptosis in spermatozoa incubated with 
C. irachomatis LPS from serovars E (A) or LGV (B) for 6h, with and without pan- 
caspase inhibitor and caspase-3 inhibitor. Heat-shocked spermatozoa and 
staurosporine-induced spermatozoa were used as necrosis and apoptosis controls 
respectively. Data are mean of 6 experiments f SEM. C-3, caspase-3 inhibitor. HSS, 
heat-shocked spermatozoa. PCI, pan-caspase inhibitor. S, staurosporine. NS, not 
significant. ***, p<0.001, Student t test. 
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Figures. 5.4C and D. Induction of apoptosis in spermatozoa incubated with 
commercial lipid A from F. coli (C) and synthetic Kdo (D) for 6h, with and without 
pan-caspase inhibitor and caspase-3 inhibitor. Heat-shocked spermatozoa and 
staurosporine-induced spermatozoa were used as necrosis and apoptosis controls 
respectively. Data are mean of 6 experiments ± SEM. C-3, caspase-3 inhibitor. HSS, 
heat-shocked spermatozoa. PCI, pan-caspase inhibitor. S, staurosporine. NS, not 
significant. ***, p<0.001, Student t test. 
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5.4.3 Quantification of caspase-3 activity 
A second approach was used to determine the apoptotic properties of 
spermatozoa exposed to LPS, lipid A, and Kdo using the fluorogenic substrate Ac- 
DEVD-AFC. The caspase-3 activity in aliquots containing spermatozoa alone and 
caspase-3 inhibitor was 11.4 ± 1.9 nM/min/mg and 9.4 ± 2.1 nM/min/mg. The value 
in necrosis controls; heat-shocked spermatozoa alone and treated with caspase-3 
inhibitor was 3.1 ± 1.1 nM/min/mg and 1.3 ± 0.9 nM/min/mg respectively. A 
considerable increase in activity of caspase-3 was observed in spermatozoa treated 
with either E LPS, LGV LPS, lipid A, or Kdo (55.8 ± 13.7 nM/min/mg, 47.8 ± 5.8 
nM/min/mg, 43.9 f 5.2 nM/min/mg, and 51.3 ± 6.6 nM/min/mg respectively, p< 
0.001, Student t test) (Figure 5.5). Spermatozoa in the presence of staurosporine as 
an apoptosis control also showed a significant rise in caspase-3 activity, 41 f 5.5 
nM/min/mg, p<0.001 (Figure 5.5). This activity was significantly inhibited in all 
aliquots when pre-incubated with caspase-3 inhibitor (p < 0.001). 
Caspase-3 activity was also investigated in neutrophils as a control. The 
apoptosis activity in these cells with and without caspase-3 inhibitor was 8.1 ± 1.7 
nM/min/mg and 7.3 ± 1.3 nM/min/mg respectively. Neutrophils showed a highly 
significant caspase-3 activity (129.4 f 11.8 nM/min/mg) in the presence of 
cycloheximide as an apoptosis inducer which was about three times more than 
staurosporine-induced apoptotic spermatozoa. Similar to spermatozoa, apoptosis 
activity in neutrophils was considerably blocked by caspase-3 inhibitor (36.8 f 8.9 
nM/min/mg). The standard curve of AFC, raw data of this work and the method of 
calculation are shown in Figure 5.6 and Table 5.2 respectively. 
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Figure 5.5. Caspase-3 activity in spermatozoa exposed to ('. trachomatis LPS from 
either serovar E or LGV, lipid A, or Kdo. Caspase-3 activity was assessed in treated 
spermatozoa with and without pre-incubated caspase-3 inhibitor. Heat-shocked 
spermatozoa and staurosporine-induced spermatozoa were used as necrosis and 
apoptosis controls respectively. Data are shown as the mean t SEM from six 
independent experiments. C-3, caspase-3 inhibitor. HSS, heat-shocked spermatozoa. 
S, staurosporine. ***. p<0.001, Student t test. 
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Figure 5.6. Standard curve to determine the caspase-3 activity of samples. The 
corresponding free AFC concentration released by the samples was determined. Data 
are the average of three tests ± SEM. RFU, Relative Fluorescence Unit. 
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RFU 
nM 
(AFC concn 
AFC 
concn/180* 
AFC 
concn/180/0.1** SEM 
DMSO 0 0 0 0 0 
Control 41.2 206 1.14 11.4 1.95 
C-3 33.9 169.5 0.94 9.4 2.15 
HSS 11.16 55.8 0.31 3.1 1.15 
HSS + C-3 4.7 23.5 0.13 1.3 0.9 
S 147.8 739 4.105 41.05 5.55 
S+ C-3 77.8 389 2.16 21.6 3.75 
E LPS 201.1 1005.5 5.58 55.8 13.75 
E LPS + C-3 145.6 728 4.044 40.44 6.15 
LGV LPS 172.1 860.5 4.78 47.8 5.85 
LGV LPS + C-3 98.8 494 2.744 27.44 3.5 
Kdo 184.7 923.5 5.13 51.3 6.65 
Kdo + C-3 123.1 615.5 3.419 34.19 4.5 
Lipid A 158.2 791 4.394 43.94 5.2 
Lipid A+ C-3 105.6 528 2.933 29.33 5 
Table 5.2. The raw data of quantification of caspase-3 activity using a fluorimeter 
and the method of calculation are shown. AFC, 7-amino-4-trifluoromethylcoumarin. 
C-3, caspase-3 inhibitor. DMSO, Dimethyl sulfoxide, HSS, heat-shocked 
spermatozoa. RFU, Relative Fluorescence Unit. S, staurosporine. *, incubation time 
(min). * *, sperm lysate concentration (0.1 mg determined by Bradford method). 
145 
5.5 Discussion 
Oxidative stress caused by ROS in semen has been suggested to be an 
important factor in the aetiology of poor sperm function. There is a potential 
association between ROS generation and male urogenital tract infection (Wang et al., 
1997). In our previous work and the present study, we demonstrated that 
C. trachomatis LPS, commercial lipid A and Kdo decreased sperm viability, which 
was modified by treatment of the spermatozoa with ROS scavengers such as ascorbic 
acid, catalase, reduced glutathione, SOD, and a-tocopherol. The reversibility of the 
sperm viability by these ROS scavengers suggests that LPS-, lipid A-, and Kdo- 
induced production of ROS may be related to the decreased viability caused by these 
treatments. Urata et al., (2001) using these ROS scavengers demonstrated that there 
is a relationship between endotoxin-induced ROS production and a decrease in sperm 
motility. In their chemiluminescence studies, they also showed ROS-production is 
significantly higher in the LPS-induced spermatozoa than in control groups. In 
another study, Wang et al., (1997) reported that treatment of spermatozoa with 
cytokines including TNF-a and IFN--f or LPS at optimal concentrations (1 ng/ml, 
2000 unit/ml, and 100 nglml respectively) stimulate ROS production. In chapter 4, 
we demonstrated that LPS and lipid A, but not Kdo stimulated TNF-a production in 
IFN-y-induced THP-1 cells. Since TNF-a production in turn, stimulates ROS 
production (Schulze-Osthoff et al., 1993), and ROS induction might cause cellular 
death (de Lamirande and Gagnon, 1995; Aitken, 1999) accordingly, this suggests a 
close relationship between our results and these mentioned studies. 
Fraga et al., (1991) indicated that the level of oxidative damage to human 
sperm DNA that could affect sperm quality and increase the risk of genetic defects is 
inversely related to seminal plasma ascorbic acid levels. They also suggested this 
ROS scavenger, complements the sperm antioxidants including the sperm 
antioxidant defence enzymes SOD, glutathione peroxidase, and catalase that are 
required for optimal sperm motility. 
Kobayashi et al., (1991) measured the level of SOD, a highly specific 
scavenging enzyme for superoxide anion radicals (O2), and lipid peroxide produced 
by oxygen free radicals in human seminal plasma and spermatozoa. They showed 
that there is a close relationship between the SOD activity rate in human spermatozoa 
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and the number of motile spermatozoa, while the activity in seminal plasma does not 
relate to the sperm concentration or motility. These workers and Aitken (1995), 
suggested that an endotoxin-induced increase in ROS may cause the lipid 
peroxidation of spermatozoa and disturb its membrane conformation leading to loss 
of motility and could be a mechanism underlying male infertility. Because the sperm 
membrane has a high level of PUFA containing two or more double bonds, this could 
be readily attacked by oxygen radicals. Moreover, spermatozoa are unique cells 
because, during the terminal stages of differentiation, a considerable portion of their 
cytoplasm is removed and the remnants are confined to the mid-piece. Accordingly, 
the limited antioxidant systems within these cells are localized to this part of 
spermatozoa and as a result, they are not able to protect the plasma membrane 
bordering most of the the surface of the spermatozoa (Aitken, 1994). 
Endotoxin from Gram-negative bacteria including E. coli, C. trachomatis, and 
Neisseria gonorrhoeae which could be present in male genital tract infections, has 
the potential to activate leukocytes in the immune system. LPS-stimulated leukocytes 
produce a markedly higher level of ROS compared with sperm (Wang et al., 1997). 
Since inflammation may induce a defect in the ROS scavenging system (Rajasekaran 
et al., 1995) and this system is able to reverse the pathogen-induced ROS production 
either by leukocytes or spermatozoa, antioxidant therapy is another possible useful 
option for treatment of bacterial genital tract infections or improving fertilization. 
Since the possible presence of leukocytes in sperm preparations could 
interfere with our results, leukocyte contamination was investigated using 
immunocytochemistry and a cytocentrifuge preparation technique. The microscopic 
assessment of sperm preparations using a percoll gradient method, demonstrated that 
spermatozoa which were used in our experiment were free of leukocytes at the 
before-mentioned detection level. 
This finding is consistent with the previously published report that leukocyte 
concentrations in semen cells collected from the bottom of 80% percoll gradient 
were extremely low (Aitken and West, 1990). Kessopoulou et al., (1992) also 
showed that the median leukocyte number per 1x 107 spermatozoa in the 80% 
percoll fraction was 143 (range 0-55000) however, this value in the 40-80% fraction 
was 4221 (range 0-326333). 
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Although we tried to investigate the direct effects of C. trachomatis LPS, lipid 
A, and Kdo on ROS production by spermatozoa, for three reasons our attempts 
failed. Firstly, as described before, isolation of lipid A and Kdo from C. trachomatis 
LPS required a large quantity of LPS, and LPS extraction from C. trachomatis in turn 
was a time-consuming procedure. Secondly, in many cases because of a lack of the 
sperm donor's consent, the availability of good quality human spermatozoa was 
limited. Finally, because of a technical problem, the chemiluminescence machine 
failed to read a limited number of samples correctly. For example, for testing the 
machine at the first stage, we used spermatozoa with and without luminal or phorbol. 
The EBSS was also used as a control. However, no activity was recorded by the 
machine. At the second stage, the LPS-treated spermatozoa were compared with 
spermatozoa alone, the results were the same for all samples. The experiment was 
then repeated and different programmes were used, no activity was again recorded. 
Therefore, ROS production by spermatozoa induced by LPS or its fractions remains 
to be investigated further. An example of the chemiluminescence data are shown in 
Appendix 3. 
The second aim of this work was to analyse the type of cell death which 
occurred in spermatozoa incubated with LPS, Kdo, or lipid A. We investigated two 
independent assays for measurement and quantification of apoptosis in treated 
spermatozoa that might be adequate tools to prove the apoptotic properties of 
treatments used in this study. One of these investigations was performed by flow 
cytometry, which allows measurement of apoptosis at the single-cell level as well as 
automatic analysis of thousands of cells in a few seconds. The other method was by 
fluorimetry, which allows a quantification of caspase activity. 
High levels of ROS disrupt the inner and outer mitochondrial membranes. 
This results in the release of cytochrome c protein from the mitochondria that 
activates caspases and induces apoptosis. Apoptosis may also be initiated by ROS- 
independent pathways involving the cell surface protein Fas (Lee et al., 1997). Fas is 
a type I membrane protein that belongs to the TNF-a receptor family and mediates 
apoptosis (Krammer et al., 1994). 
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The release of pro-apoptotic factors such as cytochrome c and apoptosis- 
inducing factor (AIF) from mitochondria will then initiate the downstream caspases 
such as caspase 9 or caspase 3 to execute the apoptotic events (Desagher and 
Martinou, 2000). 
Caspase-3 activation is considered as a key element in the apoptosis 
execution programme. Caspase-3 activity, responsible for activation of specific 
DNases, DNAse I and DNAse H, which induce apoptosis, has been strongly 
implicated in human pathologies (Reed, 2001). The presence of caspase-3 in human 
sperm has been recently detected which suggests the existence of a caspase- 
dependent apoptosis in human semen (Kim et al., 2001; Weng et al., 2002). 
Apoptosis is a cell death process, characterized by morphological and 
biochemical features occurring at different stages. A critical stage of apoptosis 
involves the acquisition of surface changes by dying cells that eventually results in 
the recognition and the uptake of these cells by phagocytes. Different changes on the 
surface of apoptotic cells such as the expression of thrombospondin binding sites 
(Pytela et al., 1985), loss of sialic acid residues (Savill et al., 1993) and exposure of a 
phospholipid-like phosphatidylserine (PS) (Fadok et al., 1992) have been previously 
described. 
Phospholipids are asymmetrically distributed between inner and outer leaflets 
of the plasma membrane with phosphatidylcholine and sphingomyelin exposed on 
the external leaflet of the lipid bilayer, and phosphatidylserine predominantly 
observed on the inner surface facing the cytosol (Op den Kamp, 1979). Exposure of 
PS on the external surface of the cell membrane has been reported for activated 
platelets and aged erythrocytes (Schroit and Zwaal, 1991). It has been also reported 
that cells undergoing apoptosis break up the phospholipid asymmetry of their plasma 
membrane and expose PS which is translocated to the outer layer of the membrane. 
This occurs in the early phase of apoptotic cell death during which the cell 
membrane remains intact (Fadok et al., 1992). This PS exposure possibly represents 
a hallmark in detecting dying cells (Barroso et al., 2000; Oosterhuis et al., 2000). 
Annexin V, belonging to a recently discovered family of proteins, the 
annexins, with anticoagulant properties (Reutelingsperger et al., 1985) has proven to 
be a useful tool in detecting apoptotic cells since it preferentially binds to negatively 
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charged phospholipids like PS. This is normally absent in the outer leaflet of the 
plasma membrane (Andree et al., 1990) in the presence of Ca2+ and shows minimal 
binding to phosphatidylcholine and sphingomyeline, which are constitutively present 
in the outer leaflet of plasma membranes (Raynal and Pollard, 1994; Vermes et al., 
1995). Therefore, this protein can be used as a sensitive probe for PS exposure upon 
the cell membrane, however, translocation of PS to the external cell surface is not 
unique to apoptosis, but occurs also during cell necrosis. The difference between 
these two forms of cell death is that during the early stages of apoptosis the cell 
membrane remains intact, however, when the cell membrane loses its integrity and 
becomes leaky, necrosis occurs (Vermes et al., 1995). Therefore, the measurement of 
annexin V binding to the cell surface as indicative for apoptosis has to be performed 
in conjunction with a dye exclusion test to establish integrity of the cell membrane. 
By conjugating fluorescein isothiocyanate (FITC) to annexin V it is possible to 
identify and quantify apoptotic cells on a single-cell basis by flow cytometry. 
Staining cells simultaneously with FITC-annexin V (green fluorescence) and the 
non-vital dye propidium iodide (PI, red fluorescence) allows the discrimination of 
intact cells (FITC-annexin V negative/PI negative), early apoptotic (FITC-annexin V 
positive/PI negative), and late apoptotic or necrotic cells (FITC-annexin V 
positive/PI positive) (Vermes et al., 1995; Oosterhuis et al., 2000; Shen et al., 2002). 
Our results using flow cytometry and fluorimetry showed that LPS and its 
constituents, lipid A and Kdo were able to induce spermatozoa death via apoptosis. 
These results were consistent with the findings of ROS scavenger experiments 
performed in the present study. In these experiments we showed indirectly that LPS 
or its fractions exert their toxicity via ROS production which could be a potential 
factor for apoptosis induction. 
Although it is established that the PS exposure on the external surface of the 
cell membrane possibly represents a hallmark in detecting apoptotic cells (Barroso et 
al., 2000; Oosterhuis et al., 2000), Goth and Stephens, (2001) demonstrated that 
chlamydiae can induce transient exposure of PS, making annexin V-based 
measurements unreliable for identifying apoptosis in chlamydia-infected cultures. 
There is also another recent report that shows anti-apoptotic activities during 
chlamydial infection (Greene et al., 2004). These workers using 17 different 
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chlamydial serovars, HeLa cells, and MS74 cells (endometrial epithelial cells) 
showed that chlamydia-infected cultures can continue to undergo DNA synthesis and 
mitosis rather than involving apoptosis. Although these two reports might put our 
present results in question, the latter researchers used HeLa and MS74 cells not 
spermatozoa for their experiments. Moreover, we confirmed our data using 
quantitation of caspase-3 activity. 
In our experiment, the results of flow cytometry in the necrosis control group 
indicated that after 6h incubation at 56° C there were still a small percentage of 
apoptototic spermatozoa present (6.4 ± 0.6%). The pan-caspase inhibitor and 
caspase-3 inhibitor used in the present study failed to inhibit apoptosis activity in this 
small number of heat-shocked spermatozoa which were FITC-annexin V positive/PI 
negative. However, results of fluorimetry using the caspase-3 inhibitor showed that it 
was able to block even this non-significant percentage of necrotic spermatozoa 
therefore showing some apoptotic activity. 
In the neutrophil control group, the result of fluorimetry showed that caspase 
activity in this group was much higher than in spermatozoa. The reason(s) might be 
that the apoptosis phenomenon and caspases in blood cells including neutrophils are 
more common than in spermatozoa. Additionally, the cytoplasmic volume of 
spermatozoa is small compared with neutrophils. 
In conclusion, we observed that the results from flow cytometry were closely 
correlated to the findings of fluorimetry. Also, all LPS preparation used in the 
present work showed more or less a similar behaviour regarding ROS production and 
induction of apoptosis. However, the results of Kdo experiments indicated that this 
unsual sugar failed to produce a signal through the TLR pathway in transfected HeLa 
cells or to stimulate TNF-a secretion in the THP-1 cell line. However, it had a 
similar effect comparable to LPS or lipid A regarding ROS induction and induction 
of apoptosis in spermatozoa. Taken together, we could suggest that Kdo might 
stimulate ROS production or apoptosis induction via a different route to LPS and 
lipid A. Therefore, more experiments are required to clarify how Kdo is able to exert 
its toxicity against spermatozoa. 
Understanding the mechanism of sperm death via ROS production and 
caspase-dependent apoptosis stimulation might be useful in treatment of infectious 
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male-factor infertility by blocking the pathways that start with the attachment of LPS 
to the LBP and terminates in apoptosis. Detection of early apoptosis in spermatozoa 
with apparently normal standard sperm parameters can also be helpful to test sperm 
before in-vitro fertilization (IVF) or artificial insemination. 
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Chapter 6 
General discussion 
6.1 Interaction between LPS and human spermatozoa 
Chlamydia trachomatis infection is one of the most common sexually 
transmitted diseases especially in western countries (Bollmann et al., 2001). While 
there is agreement on the manifestations and, in particular, the negative effects of 
Chlamydia infection on female fertility, the role of this organism in male fertility is 
still controversial (Vigil et al., 2002a). C. trachomatis causes 20-50% of 
nongonococcal salpingitis, inflammatory pelvic diseases, tubal occlusion and extra- 
uterine pregnancy in women. This organism affects female fertility through 
salpingitis (Eggert-Kruse et al., 1996) and probably through an alteration of the 
immune response. It has been suggested that antigen-antibody reactions to 
chlamydial heat-shock proteins might be an important factor for the morphological 
tissue damage and scarring leading to impaired fertility (Westrom, 1996). 
In men C. trachomatis is also the main cause of nongonococcal urethritis and 
epididymitis (Vigil , et al., 2002a). Depending on the 
diagnostic method employed 
and the population studied, there is a remarkably variable incidence of C. trachomatis 
infection in male partners of infertile couples from < 10% (Ruijs et al., 1990) to > 
50% (Hellstrom et al., 1987). C. trachomatis, like other bacteria, can adhere to 
spermatozoa (Erbengi, 1993). The study by Vigil et al., (2002) also confirmed the 
presence of elementary bodies and reticulate forms of C. trachomatis associated with 
spermatozoa but without alterations in sperm quality or function. These findings 
might provide a mechanism whereby C. trachomatis-infected spermatozoa could 
become an active transmission agent, i. e. act as 'vehicles' for the pathogens, and 
spread the disease to the female genital tract causing inflammatory processes and 
promoting the generation of antisperm antibodies. 
In spite of the report by Vigil et al., (2002) and the other studies (Bjercke and 
Purvis, 1992; Eggert-Kruse et al., 1997; Rezacova et al., 1999), there have been 
several reports especially in recent years, that confirm chlamydial infection is able to 
affect the physiology and the normal parameters of spermatozoa including motility, 
viability, and acrosome reaction (Galdiero et al., 1994; Radouani et al., 1996; 
Hosseinzadeh et al., 2000; Hosseinzadeh et al., 2001; Hosseinzadeh et al., 2003; 
Veznik et al., 2004). For example, in the latter study it was shown that normal sperm 
154 
morphology, semen volume, sperm concentration, motility and velocity in 
Chlamydiae-contaminated ejaculates were lower than Chlamydiae-negative samples. 
Previous work from our group (Hosseinzadeh, et al., 2000-2003) have also shown 
that some serovars of C. trachomatis can effect tyrosine phosphorylation of human 
sperm proteins which may be important to sperm function including capacitation 
(Sakkas et al., 2003). They also demonstrated that serovar E EBs and chlamydial 
LPS have a spermicidal effect. 
Members of the family Chlamydiaceae are Gram-negative bacteria 
containing, in their EBs, an LPS which consists of two components; lipid A, and 
Kdo. This LPS structure is similar to the rough forms of enterobacterial LPS. It is 
well known that LPS of Gram-negative bacteria in general is one of the most potent 
stimulators of innate immunity and that the lipid A moiety of LPS is responsible for 
this activity (Rietschel et al., 1994), however, Kdo is also always required for 
bacterial growth and viability, and along with lipid A is the minimal structure 
compatible with bacterial viability (Erridge et al., 2002). 
C. trachomatis possess a lipopolysaccharide of low endotoxic activity, which 
is attributed to the higher hydrophobicity of its lipid A moiety with fatty acids of 
longer chain length and the presence of nonhydroxylated fatty acids ester-linked to 
the sugar backbone (Kurminen et al., 1985; Brade et al., 1986). The fact that 
chlamydial LPS is endotoxically less active than typical LPS, e. g., enterobacterial 
LPS, does not exclude its participation in the pathogenesis of chronic inflammation 
in chlamydial infections. The low potency of C. trachomatis LPS might also provide 
a biological explanation for the asymptomatic infections caused by this organism. 
Although according to these reports based on clinical findings, the potency of 
chlamydial LPS is less than enterobacterial LPS, by several in vitro experiments we 
demonstrated that the toxicity of C. trachomatis LPS against human spermatozoa is 
about 500 times more than enterobacterial LPS including Ecoli, K. pneumoniae, and 
S. marcescenns 
Based on these considerations and the previous results of our group, the 
objectives of this thesis were: 
Firstly, to compare the potency of C. trachomatis LPS and enterobacterial 
LPS derived from bacteria, which are involved in urinary tract infections in humans, 
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acting against human spermatozoa and also to confirm that C. trachomatis LPS 
similar to other LPSs is heat-stable. Secondly, it is well established that lipid A is the 
active component of LPS and it is also presumed that this fraction of LPS is 
primarily responsible for activity against human spermatozoa. We aimed to 
investigate this characteristic of lipid A and thirdly, to examine the effect of the other 
main component of LPS, i. e. Kdo on human spermatozoa. 
Fourthly, it is suggested that the TLRs especially TLR2 and TLR4 along with 
the co-receptor CD14, are essential for recognition of a variety of pathogen-assisted 
molecular patterns (PAMPs) including LPS. Stimulation of TLR pathway by PAMPs 
can initiate a signalling cascade that involves a number of proteins including the 
secretion of pro-inflammatory cytokines such as TNF-a. Previous experiments by 
our group showed that either elementary bodies or LPS from C. trachomatis have 
deleterious effects on spermatozoa parameters including viability. To expand our 
knowledge, regarding how and by which route(s), this organism could exert its 
spermicidal activity; we investigated the behaviours of the aforementioned LPS 
fractions in terms of stimulation of TLR pathways and induction of TNF-a secretion 
in experimental models on HeLa and THP-1 cell lines. 
Finally, it is also known that stimulation of TNF-a induces an increase in 
ROS production via mitochondria, and that ROS in turn may be detrimental and even 
lethal to the host via the activation of apoptotic pathways. From our hypothesis of the 
effect of C. trachomatis LPS leading to increased sperm death it was important to 
understand whether it was via apoptosis or necrosis or both. 
C. trachomatis serovar E is the most frequently occurring serotype in genital 
C. trachomatis infections. C. trachomatis serovar LGV which is endemic in parts of 
Africa, Asia, and south America, also leads to an infection with a more significant 
infection of the lymphatic system and may cause a disseminated infection (Moulder, 
1991; Morre et al., 2000). For these reasons, we decided to focus on these two strains 
in our study regarding the effects of either EBs or LPSs on human spermatozoa. 
Although we succeeded to produce a reasonable amount of EBs and LPS from these 
two serovars which could be enough for our designed experiments, however, we also 
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aimed to isolate two main LPS fractions namely Kdo and lipid A from C. trachomatis 
LPS. 
Unfortunately, since C. trachomatis EBs are hazardous and difficult to grow 
in large quantities which is time-consuming, this hampered the preparation of large 
amounts of chlamydial LPS required for isolation of its fractions. Alternatively, we 
used commercial lipid A and Kdo to further understand their effect against 
spermatozoa. 
Endotoxin (LPS) is a heat-stable complex which can maintain its activities 
against host cells at boiling point for 30 min. Since to the best of our knowledge no 
conclusive previous work has been reported on the effect of heated-C. trachomatis 
EBs on human spermatozoa, we wanted to confirm the stability of LPS components 
of EBs against heating. Our results showed that the toxicity of EBs against 
spermatozoa was unaffected by heating at either 56 °C or 100 °C since the mortality 
rate of spermatozoa did not alter markedly in the presence of heated EBs, compared 
to spermatozoa which were treated with non-heated EBs. To neutralise EB toxicity 
and to exclude the effect of cell wall proteins which could be toxic (Galdiero et al., 
1988) and interfere with our results, in control groups, heated-EBs were pre- 
incubated with polymyxin B (PMB) which interacts strongly with phospholipids and 
binds to the lipid A portion of endotoxin and inactivates these molecules. The results 
from the control group spermatozoa also showed that PMB could inhibit the death of 
spermatozoa incubated with heated-EBs and that we speculated that no activity 
would be present from the other components of EBs i. e. proteins. Based on these 
results, we suggested that the LPS component of EBs was primarily responsible for 
the toxicity of heated EBs against spermatozoa. Although, in their 1971 study, 
Teague et al., demonstrated that Ecoli killed by boiling for 10 min, had no effect on 
human spermatozoa, the dose of killed bacteria incubated with spermatozoa was not 
stated in their study. 
Another facet of C. trachomatis LPS investigated in this study was the 
potency of this endotoxin compared to enterobacterial LPS against human 
spermatozoa. Although there are a number of reports claiming that C. trachomatis 
LPS is 10 (Heine et al., 2003) to 100 (Qureshi et al., 1997) times less active than 
typical LPS such as enterobacterial LPS, this activity is not related to spermatozoa. 
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Our findings, previous work of our group, and also Galdiero and co-workers's results 
(1994) have shown that LPS from C. trachomatis is able to interfere with normal 
parameters of spermatozoa including viability and motility at a concentration of 500 
times less than E. coli LPS that was used by Galdiero et al., (1988) (0.1 µg/ml vs 50 
pg/ml respectively). 
In this study we compared not only the spermicidal activities of E. coli LPS 
against C. trachomatis LPS but two other enterobacterial LPSs, K. prieumoniae and 
S. marcescens. Our results indicated that while LPS from C. trachomatis killed 
spermatozoa at 0.1 pg/ml, three other LPSs from the Enterobacteriaceae family had 
a deleterious effect on spermatozoa viability when the concentration was increased to 
50 pg/ml. 
Dumoulin et al., were to the best of our knowledge the first researchers who 
investigated the effect of S. marcescens LPS on spermatozoa. In their 1991 study, 
they reported that this LPS even at 500 pg/ml had no spermicidal activity which 
contradicts our results. However, there are two significant differences between their 
study and our investigation that might explain the controversial results of these two 
studies. Firstly, in their study they obtained a spermatozoa pellet by centrifugation of 
semen using Whittingham's T6 culture medium supplemented with low-endotoxin 
bovine serum albumin that was totally different from the percoll gradient method that 
we used for sperm praparation. Secondly, to estimate sperm survival, they counted 
the number of motile spermatozoa using a Makler counting chamber, however, we 
assessed sperm viability using the HOS test. 
This range in potency of LPSs from two different families, Chlamydiaceae 
and Enterobacteriaceae, used in this research might be related to a number of factors 
including the chemical conformation of these LPSs, especially their lipid As which 
are responsible for toxicity. Detailed studies on the structure-function relationships of 
lipid A have indicated that the number, type and distribution of fatty acids in lipid A 
(Heine, et al., 2003) and also the shape of the lipid A component in terms of being 
conical or cylindrical (Netea et al., 2002) determine whether LPS exhibits weak or 
strong bioactivity against host cells. 
The structure of LPS from serovar E is very similar to that of serovar L2 with 
two GlcN, three Kdo residues, and two phosphates. The pentasaccharide fatty acid 
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composition for serovar E is also very similar to that reported for serovar L2 (Heine, 
et al., 2003). Although we were not able to find any studies describing the chemical 
structure of serovar L1 used in this study, it seems that the LPS of different serovars 
of C. trachomatis show only minor variations, especially if these serovars belong to a 
similar biovar such as serovar L1 and L2, which have been classified in the LGV 
biovar along with two other serovars, L2a and U. 
A comparison of structures of lipid A from different Enterobacteriaceae and 
C. trachomatis reveals that this component in the latter organism contains five fatty 
acids with up to 22 carbon atoms however, in Enterobacteriaceae, lipid A possesses 
six fatty acids with up to 16 carbon atoms. Organisms within the two families also 
have two different inner core structures. While enterobacterial LPS contains two 
residues of Kdo and three residues of heptose, chlamydial LPS has only a Kdo tri- 
saccharide. 
Apart from the differences in the chemical structure of these LPSs, based on 
our investigations and other relevant studies we would also suggest that the type of 
host cells, the conditions and environment where the organism challenges the host 
cells i. e. in vitro or in vivo, might be important for determining whether pathogens 
show a weak or a strong activity against their host. 
Although it is well established that lipid A is the principal virulence fraction 
of LPS and consequently is responsible for the pathogenicity of bacterial LPS, 
nevertheless, little is known about the toxicity of Kdo which is bound to lipid A and 
is also indispensable for bacterial bioactivity. Our attempts to separate Kdo from 
C. trachomatis LPS failed for the aforementioned reasons, however, we were able to 
isolate a small amount of lipid A from chlamydial LPS which unfortunately was 
insufficient for all experiments. Accordingly, Kdo and further amounts of lipid A 
were obtained commercially with the aim of studying their direct effects on 
spermatozoa, and further understanding their roles in stimulation of TLR signalling 
pathways and TNF-a production using HeLa and THP-1 cell lines respectively. 
Based on the immunobiological and endotoxic properties of lipid A reported 
in the recent literature (Schromm et al., 2000; Tanamoto et al., 2001; Hashimoto et 
al., 2003; Ogawa et al., 2003), we hypothesised that lipid A could also exert its 
toxicity against spermatozoa. This hypothesis was established when the mortality 
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rate of spermatozoa markedly increased in the presence of lipid A. Further 
supporting evidence was that anti-CD14 antibody and PMB inhibited the spermicidal 
activity of lipid A. 
In the TLR signalling pathway, LPS binds to LPS binding protein (LBP) and 
CD14 acts as a co-receptor which presents the complex of LPS-LBP to TLRs. This 
pathway could finally terminate in cell death. Blocking this potentially lethal 
pathway by different routes including anti-CD 14 antibody could prevent cell death. 
PMB treatment of spermatozoa incubated with LPS or its fractions is also another 
alternative method that was utilised in our studies to investigate the pathogenicity of 
these components. 
In the case of Kdo and its interaction with spermatozoa, Kdo exhibited two 
different behaviours in our earlier experiments. Similar to lipid A, Kdo was able to 
significantly induce death of spermatozoa. However, unlike lipid A, pre-incubation 
of spermatozoa with anti-CD14 antibody or PMB did not alter the spermicidal 
activities of Kdo. Although the role of the polysaccharide moiety of LPS which 
includes Kdo in induction of colony stimulating factors, interferon or IL-1 secretion 
has been described (Haeffner-Cavaillon et al., 1989), to the best of our knowledge 
the spermicidal property of Kdo, has not been reported. 
These interesting findings led us to clarify the mechanism of sperm death 
induced by Kdo and also by LPS or lipid A using experimental models. In these 
experiments, two cell lines, HeLa and THP-1, were exploited to enable us to 
investigate the role of these LPS components in stimulation of the TLR pathway and 
in TNF-a production which potentially culminates in cell death. 
6.2 LPS and TLR signalling 
Recognition of microbial infection and initiation of host defense responses is 
controlled by multiple mechanisms including Toll-like receptors. TLRs recognize 
molecular products derived from all the major classes of microbes including bacteria, 
viruses, yeasts and fungi. Mammalian cells express at least 10 TLRs, and among 
them, TLR4 is the major LPS receptor, TLR2 recognizes, peptidoglycan, lipoteichoic 
acid, and also LPS. These receptors have recently emerged as a key component of 
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the innate immune system that detects microbial infection and triggers antimicrobial 
host defense responses. TLRs activate multiple steps in the inflammatory reaction 
that help to eliminate the invading pathogens and coordinate systemic defenses. 
Induction of these receptors results in the expression of pro-inflammatory cytokines, 
such as TNF-a. However, overproduction of cytokines is toxic and could threaten 
host cell life. 
Our data showed that LPS from both serovars of C. trachomatis, E and LGV, 
signalled through TLR2 and TLR4, however, lipid A from E. coli was able only to 
produce a signal through TLR4 in transfected HeLa cells and interestingly, Kdo 
failed to signal via either TLR2 or TLR4. In a similar study, Erridge et al., (2004) 
reported that LPS from C. trachomatis LGVI, signals only via TLR2. However, our 
results showed that this serovar could also signal via TLR4. It would appear that this 
apparent difference in TLR signalling may be due to different batches of extracted 
LPS. 
Based on the importance of TLRs in recognition of pathogens and also our 
results which demonstrated that chlamydial LPS, lipid A, and Kdo are toxic for 
spermatozoa, we tried to find the mechanisms of pathogen-induced cell signalling in 
spermatozoa that could be via TLRs. Previous work of our group using anti-TLR 
antibodies with the aim of blocking these receptors in human spermatozoa, did not 
produce significant results. In another attempt, we treated wild-type mouse 
spermatozoa with these LPS fractions under the same conditions of human 
spermatozoa. This study would be continued with TLR knock-out mouse 
spermatozoa if the results of the former experiment were conclusive. However, the 
mortality rate of spermatozoa from the wild-type mouse incubated with chlamydial 
LPS, lipid A or Kdo did not alter appreciably from the control. These results are 
consistent with the earlier research performed by Weil et al., (1998). They 
demonstrated that mouse spermatozoa do not respond to staurosporine or 
cycloheximide. As these reagents are apoptotic, they suggested that caspases 
involved in apoptosis are absent in mouse spermatozoa. 
Although our attempts at finding a role of TLRs in recognition of LPS 
fractions by spermatozoa were inconclusive, the question of the mechanism of cell 
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signalling in spermatozoa remains to be solved and further work should determine 
whether TLRs are involved in interaction of spermatozoa with LPS fractions. 
Further investigations into the IFN-'y-induced THP-1 cell line treated with 
chlamydial LPS, lipid A or Kdo revealed that all these spermicidal components, 
except Kdo, stimulated TNF-a secretion from this cell line. Spermicidal activity was 
the only property of Kdo which was observed in these experiments. 
6.3 ROS production, apoptosis and human spermatozoa 
The next stage of our studies focused on the mechanism of sperm death 
induced by chlamydial LPS, commercial lipid A and Kdo. Following the suggested 
TLR pathway and its products, namely cytokines including TNF-a, it was suggested 
that using TNF-receptor 1 (TNF-R1), TNF-a stimulates ROS production via 
mitochondria (Schulze-Osthoff et al., 1993). Male genital tract infection may lead to 
several consequences, including the release of pro-inflammatory cytokines and the 
production of ROS (Jeremias and Witkin, 1996). ROS in turn plays an important role 
in the pathogenesis of many reproductive processes which might lead to male 
infertility. Since ROS can interfere with sperm functions such as motility, the 
acrosome reaction and threaten the survival of spermatozoa (de Lamirande and 
Gagnon, 1995; Aitken, 1999), exposure of spermatozoa to ROS has been associated 
with cellular injury, that includes DNA damage and lipid peroxidation (Potts et al., 
2000). 
In the study by Segnini et al, (2003), sperm membranes of infertile males 
with positive IgA antibodies against C. trachomatis showed a higher level of lipid 
peroxidation than that of infertile males with negative IgA antibody, and it is 
possible that this could be a route by which C. trachomatis affects fertility. 
In order to counteract the toxic effects of ROS, seminal plasma contains a 
number of antioxidant mechanisms. Semen contains high levels of ascorbate, urate 
and thiol groups and also lower amounts of glutathione and a-tocopherol 
(Ochsendorf et al., 1998). Moreover, the antioxidant enzymes catalase, superoxide 
dismutase, glutathione peroxidase and glutathione reductase have been detected in 
seminal plasma (Yeung et al., 1998). 
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fin indirect experiments using five different ROS scavangers; ascorbic acid, 
catalase, reduced glutathione, superoxide dismutase, and a-tocopherol, since the 
viability of spermatozoa incubated with LPS and lipid A was preserved, and these 
two products were also active in TLR signalling and TNF-a production in our 
experimental models, we concluded that these products possibly exert their toxicity 
via ROS production induced by TLR pathway stimulation. Although, ROS 
scavengers counteracted the spermicidal activity of Kdo, as we described earlier this 
fraction was not active in TLR signalling or TNF-a secretion; this might suggest a 
different route for its activity. 
Granulocytes and macrophages are known to produce ROS, which could 
increase the level of lipid peroxidation or DNA damage. To avoid significant 
interference by these cells, in ROS scavenger experiments, we utilized spermatozoa 
preparations using a percoll gradient method and the results of immunocytochemistry 
and the cytocentrifuge preparation technique confirmed that spermatozoa 
preparations were free of cellular contamination at the minimum detection level 
(< 143 leukocytes/ 1xW spermatozoa for the immunocytochemistry technique or 
1000 leukocytes for the cytocentrifuge preparation technique). However, it is 
acknowledged that contaminating leukocytes could be producing ROS and therefore 
complicating our findings. 
Our findings from ROS scavenger experiments, encouraged us to expand our 
knowledge concerning the type of LPS-induced spermatozoa death and to 
differentiate whether this was due to, necrosis or apoptosis. That is why we followed 
our investigations employing flow cytometry for measurement of apoptosis and 
fluorimetry for quantification of caspase activity. 
Apoptosis is a process of cell death manifested by fragmented nuclei with 
condensed chromatin and shrunken cytoplasm. One of the crucial intracellular 
signalling events in apoptosis is the sequential activation of caspases, a family of 
cysteine proteases (Villa et al., 1997). Among the fourteen caspases described to 
date, caspase-2, -8, -9, and -10 facilitate the caspase activation cascade and are called 
initiators. Activation of these initiator caspases can lead either to cytochrome c 
release from mitochondria, which in turn activates downstream effector caspases, or 
to direct activation of downstream caspases (Wolf and Green, 1999). The 
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downstream effector caspases, such as caspase-3, -6, and -7, execute apoptotic 
responses by cleaving various cellular protein substrates vital for cell functions (so- 
called death substrates). Caspase-3 is considered to be the main effector caspase of 
apoptotic cell death. 
Caspases 1,3,8, and 9 are also present in human spermatozoa and can 
become activated, particularly after freezing and thawing, and are associated with 
changes in the outer cell membrane. Caspases 1,3, and 8 and 9 are localised in the 
postacrosomal region and in the the midpiece respectively (Paasch et al., 2004). 
The fluorimetry results of our investigations showed a considerable increase 
in activity of caspase-3 in spermatozoa treated with either C. trachomatis LPS, lipid 
A, or Kdo. Measurement of apoptosis using flow cytometry confirmed that these 
fractions were able to induce spermatozoa death via apoptosis. These results were 
also consistent with the findings of HOS tests used for testing the viability of 
spermatozoa. 
Interestingly, apart from the results of TLR signalling and TNF-a production, 
in all other experiments performed in this study including the HOS test, use of ROS 
scavengers, FITC-annexin V/PI staining, and quantification of caspase-3 activity, 
chlamydial LPS, lipid A and Kdo all behaved in a similar manner. In Figure 6.1, we 
illustrate a hypothetical model of how chlamydial LPS exerts its spermicidal activity. 
Although we tried to isolate lipid A and Kdo from C. trachomatis LPS and 
investigate their effect on spermatozoa, as described earlier, our attempts were 
inconclusive as we produced only a small amount of lipid A, and instead the 
commercial alternative of these reagents were used. To better understand the 
pathophysiology of chlamydial lipid A and Kdo, further work should therefore focus 
on these two LPS fractions derived from C. trachomatis LP S. 
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Hypothetical model of how human sperm 
are killed by Chlamydia trachomatis 
EB's release LPS 
j apoptosis 
? TLR's 
ROS 
generation 
Figure 6.1. Hypothetical model of how Ctrachomatis LPS interacts with human 
spermatozoa. 
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6.4 Final conclusion 
In the studies described in this thesis, we confirmed that C. trachomatis LPS 
like other LPSs is a heat-stable complex as it was able to keep its spermicidal activity 
when it was heated to 56°C or 100°C for 30 min. It is clinically established that 
C. trachomatis LPS is weak compared to typical LPSs such as enterobacterial LPS, 
however, in in vitro experiments chlamydial LPS showed a potency of about 500 
times more than enterobacterial LPS, against human spermatozoa. In attempts to 
understand the effect of two main LPS fractions which are involved in toxicity or 
bioactivity of LPS, lipid A and Kdo, on viability of spermatozoa, we demonstrated 
that these fractions could also be toxic for spermatozoa. Although Kdo was shown to 
be spermicidal, unlike LPS or lipid A it was not affected by anti-CD14 antibody or 
polymyxin B. Chlamydial LPS and commercial lipid A from E. coli signalled via 
TLR2 and/or TLR4 in the transfected-HeLa cells whilst synthetic Kdo did not signal 
with either of these two TLRs. TNF-a production was also activated by chlamydial 
LPS or lipid A but not Kdo in IFN-y-induced THP-1 cells. In spite of these 
differences that were observed for Kdo, similar to chlamydial LPS or lipid A, the 
spermicidal activity of Kdo was inhibited by ROS scavengers. Also, all three 
fractions used in our studies induced sperm apoptosis which was primarily caspase- 
mediated. 
In conclusion, although Kdo induced apoptosis in spermatozoa since it did 
not interact via CD14, signal via TLRs, or activate TNF-a production it would 
appear that Kdo exerts its activites via a different route to chlamydial LPS or lipid A. 
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6.5 Future work 
In the preceding chapters we tried to increase our understanding of 
pathogenicity of C. trachomatis LPS interacting with human spermatozoa. Despite 
the ever-increasing knowledge concerning different aspects of this organism which 
could threaten public health or even human life, there is still a need for better 
understanding of this pathogen. As diseases associated with chlamydial infection 
including infertility, genitourinary tract infections in male and females and 
ophthalmic disease continue to increase, the burden of such diseases is enormous. 
The complications of chlamydial infections are distressing and expensive, including 
infertility, ectopic pregnancy, and chronic pelvic pain. 
Many investigators around the world are working on different facets of this 
organism such as genomic sequencing, development of chlamydial serology or 
diagnostic tests for genital infection. In recent years, including work in our 
laboratory, chlamydia research has succeeded in producing more information 
regarding the effect of either elementary bodies or LPS from C. trachomatis on 
standard parameters of human spermatozoa. We continued this work focusing mostly 
on the LPS fractions and their effects on spermatozoa, the role of LPS and its 
fractions in signalling via TLRs and apoptosis induction in spermatozoa. 
Based on the present results, we believe this project deserves more attention 
and must be continued in the future with the following subjects: 
1) Isolation of lipid A and Kdo from C. trachomatis LPS. 
2) Challenge of spermatozoa with C. trachomatis lipid A and Kdo regarding the 
mechanism of spermatozoa death and whether it is via apoptosis. 
3) Role of C. trachomatis LPS and its fractions in ROS production. 
4) The role of TLRs in cell signalling of spermatozoa when exposed to LPS fractions 
especially Kdo. 
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Appendices 
Appendix 1 
Reference values of semen variables 
Semen analysis is an integral part of the workup of couples consulting for 
infertility. The availability of semen renders possible direct examination of male 
germ cells, giving precious data that are not accessible for female germ cells. It 
should be mentioned that semen is an exception amongst biological fluids since its 
parameters display very wide intra and inter-individual variations. Therefore semen 
analysis should be repeated to decrease these variations and confirm abnormal 
parameters. The following reference values give the description of a semen sample 
analysed according to the methods described by WHO, 2000. 
Volume: 2.0 ml or more 
pH: 7.2 or more 
Sperm concentration: 20 x 106 spermatozoa/ml or more 
Total sperm count: 40 x 106 spermatozoa or more 
Motility: 50% or more motile (grade a +b`*) or 25% or more with progressive 
motility (grade a) within 60 min after collection. 
*, Rapid progressive motility. **, Slow or sluggish progressive motility. 
Morphology: Has not been established yet by the WHO. Depends on the laboratory 
criteria, varies from 30% or more to 50% or more. Previous data suggest that the 
fertilization rate in vitro decreases if there are less than 15 percent normal-shaped 
sperm, as defined by the WHO manual. 
Vitality: 75% or more live 
White blood cells: Less than 1x106 /ml 
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Appendix 2 
The Makler counting chamber for rapid semen evaluation 
Chamber description: The Makler counting chamber is only 10 microns 
deep: 1/10th of the depth of ordinary hemocytometers, making it the shallowest of 
known chambers. Constructed from two pieces of optically flat glass, the upper layer 
serves as a cover glass, with a1 sq. mm fine grid in the centre subdivided into 100 
squares of 0.1 x 0.1 mm each. Spacing is firmly secured by four quartz pins (see 
figure below). 
Analysis technique: A small, uncalibrated drop from a well-mixed undiluted 
specimen is placed in the centre of the chamber by means of a simple rod and 
immediately covered. A microscopic objective of x 20 is required. 
Motility evaluation: Non-motile sperm are counted within an area of nine or sixteen 
squares in the centre of the grid. Moving sperms are then counted, and graded if 
desired. The procedure is repeated in several areas. Percentage of motility and its 
quality are then calculated. 
Figure: Makler counting chamber 
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Appendix 3 
Chemiluminescence data 
Measurement of ROS activity was carried out in spermatozoa incubated with 
0.1 µg/ml of C. trachomatis LPS from serovar LGV with and without I mM of 
ascorbic acid using a luminometer as previously described by Urata et al., (2001). 
Briefly, 0.075 pg/ml of phorbol 12-myristate acetate (PMA) (Sigma, UK) was added 
to the mixture of 5x 106 spermatozoa/ml and 30 pg/ml of luminol (5-amino-2, 
3dihydro-1,4 phthalazinedione) (Sigma, Uk) as a probe, and the luminescence was 
recorded for 30 min. Earl's balanced salt solution (EBSS) alone was used as a 
background measurement. Data are shown in the following table. 
5 min 10 min 15 min 20 min 25 min 30 min 
EBSS 36928 36638 36498 36420 36324 36304 
Sperm 36744 36526 36206 35123 35993 36024 
Sperm +L 37435 37158 37025 37036 36908 36797 
Sperm +L+P 37908 37690 37475 37398 37311 37305 
Sperm + Aa 36761 36533 36300 36164 37183 36174 
Sperm + Aa +L 37533 37231 37001 37033 36925 36968 
Sperm + Aa +L+P 37453 37321 37284 37087 37034 37069 
Sperm + LPS 36533 36221 35945 35832 35847 35856 
Sperm + LPS +L 37391 37054 36887 38901 36765 36645 
Sperm + LPS +L+P 37880 37439 37195 37196 36931 37065 
Sperm + LPS + Aa 36170 35997 35727 35367 35337 35270 
Sperm + LPS + Aa +L 37461 37098 36931 36893 36870 36802 
Sperm + LPS + Aa +L+P 37749 37445 37187 37084 37113 36911+ 
Time course of ROS production in human spermatozoa in response to LPS. Aa, 
ascorbic acid. L, luminol. P, phorbol. 
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